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APPROACHES TOWARDS THE SYNTHESIS OF SAXITOXIN ANALOGS 
Zetekitoxin AB is a toxin isolated from the Panamanian golden frog (Atelopus zeteki).  The 
structure and activity of zetekitoxin AB was a mystery for 30 years until 2004 when it was 
elucidated by Yamashita and coworkers1.  It was found to be a potent analog of Saxitoxin, a 
marine neurotoxin.  Saxitoxin is a sodium channel blocker and has been used extensively as a 
research probe.  Zetekitoxin AB shows an affinity profile similar to saxitoxin, but is considerably 
more potent.  Due to the endangerment of the Panamanian golden frog there is no source of 
zetekitoxin AB, preventing further studies.   
Presented herein is a concise synthesis of 4,5-epi-11-hydroxy-saxitoxinol, which utilizes 
D-ribose to direct an asymmetric Mannich reaction.  This approach allows many modes of 
reactivity, which can be used to potentially access various analogs of saxitoxin with novel 
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Chapter 1: Introduction 
1.1 Neurotoxins 
Neurotoxins represent one of the many types of toxins, which are classified by their 
biological target.  The common classifications of toxins are: cytotoxins, which affect cells; 
hepatotoxins, which affect the liver; and neurotoxins, which affect the nervous system.  The 
classes of toxins themselves are divided into different groups based on their mode of action.  
Neurotoxins, for example, can exhibit toxicity by ion channel disruption, altering the blood brain 
barrier, synaptic vesicle release inhibition and cytoskeleton disruption.   
1.1.1 Ion Channels 
The basis of nerve transmissions is the action potential, which is the buildup and fall of an 
electrical membrane potential.  This potential is controlled by the flow of ions through 
membrane-bound proteins known as ion channels.  There two main classes of ion channels: 
voltage-gated and ligand-gated.  Voltage-gated channels rely on a membrane potential to open or 
close the channel, whereas a ligand-gated channel requires the binding of a small messenger 
molecule.  The most common voltage-gated channels are the sodium, potassium, calcium and 
chloride channels.  Sodium and potassium channels control the action potential of a nerve and 
calcium channels are responsible for smooth muscle and cardiac muscle contraction.  Chloride 
channels are less understood than the rest, but have been shown to be responsible for regulating 
cell pH and maintaining the proper cell volume.  
1.1.2 Neurotoxins Affecting Ion Channels 
There are many toxins that act on ion channels.  A few examples are shown in Figure 1.  
Saxitoxin (1), from marine dinoflagellates and tetrodotoxin (2), from species of puffer fish are 
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very potent sodium channel blockers, which prevent the transport of sodium ions.  Aconitine (3), 
a toxin isolated from Aconitum spp., displays a different mode of toxicity by binding to sodium 
channels leaving them open to the transport of sodium ions.  Besides small molecule toxins there 
are also peptide toxins such as the conatoxins.  Conatoxins are isolated from the venom of 
marine cone snails and act on the potassium, sodium or calcium ion channels, depending on the 
individual toxin.  
 
Figure 1 Ion Channel toxins 
1.1.3 Therapeutics Targeting Ion Channels 
Since ion channels are paramount in the transmission of nerve signals and the overall 
function of the nervous system, there are many disorders that result from ion channel problems.  
Modulation of the sodium channel, for instance, can cause increased or decreased sensitivity to 
pain.1  Epilepsy and migraines can be the result of changes in various ion channels.2 Due to the 
wide variety of disorders related to ion channels, many drug discovery programs targeting them 
have been created.  Many drugs targeting ion channels have been approved (Figure 2) and there 
are many in clinical trials.3  An early example, currently in use, is Lidocaine (4), which was 
developed in 1943, and has been used for many years in surgical and topical applications as an 
analgesic.  It prevents pain signals by blocking fast voltage-gated sodium channels.  Valium 
(Diazepam, 5), another famous ion channel modulator, is used for the treatment of anxiety, 











































of chloride ions.  The anticonvulsant carbamazepine (6) stabilizes the closed form of the sodium 
channels and potentiates GABA receptors.  
 
Figure 2 Drugs targeting Sodium Channels 
Naturally occurring toxins have not only allowed for the isolation and determination of the 
different ion channels, but have been useful as starting points for the development of new 
therapeutics.  A good example of a natural product derived drug is Ziconotide, which was 
developed by the Elan Corporation for the treatment of severe and chronic pain.  Ziconotide is a 
synthetic version of a ω-conotoxin peptide, which modulates pain by selectively blocking the 
N-type voltage-gated calcium channel.  The saxitoxin family of compounds, described below, 
shows good potential for the development of molecular probes and therapeutics.  
1.2 Saxitoxin and Analogs 
1.2.1 Isolation and Structure Determination 
During the summer of 1927, San Francisco was the site of mass poisoning.4 The result was 6 
dead and over 100 people ill, all from consuming poisoned mussels collected in the area.  These 
shellfish became toxic when they consumed the marine plankton, Gonyaulax catenella.5  
Sommer and coworkers were able to isolate the toxin by extracting the livers from 4360 kg of 
mussels collected in California.6,7 Rapoport and coworkers originally proposed the structure of 
saxitoxin as 7 and 8,8 which they later revised to saxitoxin (1), after obtaining an x-ray structure 

















Figure 3 Saxitoxin and proposed structures. 
Saxitoxin (1) was found to be a tricycle containing a bisguanidine, purine core, a geminal 
diol and a carbamoyl group.  Modifications at five key positions of the core, gives the saxitoxin 
family (Figure 4).  Since the discovery of saxitoxin, over 50 analogs have been isolated and 
characterized.11  
 
Figure 4 Analogs of saxitoxin 
The most notable structures are saxitoxin (1), neosaxitoxin (9), gonyautoxin 3 (10) and the 

























Saxitoxin (STX), 17 8
R1: H, OH 
R2: H, OH, OSO3-
R3: H, OH, OSO3-
R4: H, OH, OCONH2, OCONHSO3-,
















Figure 5 Common saxitoxin analogs 
1.2.2 Zetekitoxin AB 
Zetekitoxin AB is the most interesting member of the saxitoxin family due to its highly 
complex structure and extreme toxicity.  As such it deserves its own section.  First isolated from 
the skins of the Panamanian golden frog (Atelopus zeteki) by Mosher and coworkers in 1969, the 
toxicity of these brightly colored frogs has been known since the late 1800’s.12  Unlike other 
Atelopus sp., A. zeteki is only found in a single local region (Valle de Anton) in Panama, where 
as the other species can be found in northern Panama and Costa Rica.13  Originally named 
atelopidtoxin, it was renamed to zetekitoxin AB after isolating tetrodotoxin from Atelopus varius 
and chiriquitoxin from Atelopus chiriquiensis, indicating its unique occurrence in Atelopus 
zeteki.  The designation AB comes from initial suggestion that it was a mixture of two different 
toxins.  Unlike toxins found in both terrestrial and marine environments like tetrodotoxin, 


























































only terrestrial saxitoxin analog known to date, all other analogs being isolated from marine 
environments. 
Studies on zetekitoxin AB were halted due to the endangerment of the Panamanian golden 
frog.  It wasn’t until 2004 when Yotsu-Yamashita and coworkers were able to determine the 
structure, from a ~0.3 mg sample that was originally collected in the early 1980’s.14  
Amphibian toxins are not biosynthesized within the organism and instead are sequestered 
from their dietary sources.15,16 Daly and coworkers were able to demonstrate this by showing 
frogs raised in captivity do not contain any of the toxins.  They were later able to collect various 
species of arthropods and find many of the amphibian toxins in their extracts.17  Also, when 
puffer fish are raised in captivity they contain no toxin.  Since the frogs require a specific diet to 
sequester the toxin, studying the biosynthesis of zetekitoxin AB is not possible at the moment 
because the dietary source is unknown.   
1.2.3 Toxicity 
Saxitoxin (1) and analogs are potent sodium channel blockers.  They work by directly 
binding to the pore opening of sodium channels cutting off the flow of sodium ions and thereby 
shutting down nerve signals.  Zetekitoxin AB (11) is by far the most potent member of the 
saxitoxin family, exhibiting an IC50 of 280 pm towards human heart cells, making it ~1000 
times as potent of saxitoxin (Table 1).  Zetekitoxin AB’s (11) remarkable potency makes it a 
great target for synthesis, as no natural material can be isolated from nature due to the 
endangerment of Atelopus zeteki. 
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Table 1 The IC50 of Saxitoxin and Zetekitoxin AB on human heart (hH1A), rat brain (µ1), and 
rat skeletal muscle (rBr2A) voltage-dependent sodium channels. 
Sodium channel Human heart Rat brain Rat skeletal muscle 
Saxitoxin (nM) 160± 14 0.97±0.01 4.1±0.5 
Zetekitoxin AB (pM) 280± 3 6.1±0.4 65±10 
 
1.2.4 Human Impact and Control 
Paralytic shellfish poisoning is the result of consuming shellfish containing various toxins, 
such as saxitoxin (1).  The shellfish accumulate toxins by consuming toxin-producing 
dinoflagellates.  These toxic shellfish result in major losses to the fishing industry due to costly 
toxin monitoring programs and loss of shellfish.  This creates the need to develop cost-effective 
methods to assay the level of marine toxins found in shellfish.  
1.3 Saxitoxin Biogenesis 
The origin of the saxitoxin skeleton has been the subject of intense research since its 
discovery.  There were several different proposals of the biogenesis of saxitoxin (Figure 6).  
Since the core contains a purine skeleton, the simplest possibility is that saxitoxin is derived from 
a Michael addition of a purine unit into an acrylate type derivative (Figure 6A).  Saxitoxin could 
also be derived from C7 sugar 16 (Figure 6B).  The proposal of the saxitoxin skeleton being 
derived from a unit of arginine (18) with an additional C2 building block (Figure 6C) was the 
best proposal.  This is because several other similar guanidine-containing natural products, such 
as dibromophakellin (21) and oroidin (20), are hypothesized to come from arginine (Figure 7).18 
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Figure 6 Possible biosynthetic origins of saxitoxin.19 
 
Figure 7 Possible biosynthetic origin of phakellin. 
1.3.1 Feeding Experiments 
Shimizu and coworkers pioneered the work on saxitoxin biogenesis, by relying heavily on 
feeding studies.  Initial feeding studies with labeled arginine, ornithine, and histidine led to 
random incorporation of 13C, indicating that they never reached the site of synthesis in intact 
form.20 Their first success came when a [2-13C] glycine feeding study showed significantly 
higher labeling at the C12 and C11.20  Labeled glycine (22) enters the tricarboxylic acid (TCA) 
cycle, eventually scrambling the radiolabeling at the C3 and C4 position of arginine (18), which 















































































Oroidin, 20 Dibromophakellin, 21
 9 
 
Scheme 1 [2-13C]Glycine feeding experiment. 
A feeding study of [1,2-13C]acetate (28) to Gonyaulax tamarensis resulted in an unexpected 
labeling pattern.21 Labeled acetate (28) should give [10,11-13C]gonyautoxin (33), however 
radiolabeled carbon was also incorporated in the C5 and C6 position giving gonyautoxin 34 
(Scheme 2).   
 
Scheme 2 [1,2-13C]Acetate feeding study showing radiolabel incorporation at C10 and C11 and 
unexpectedly at C5 and C6. 
An exciting turn in the elucidation of the biosynthetic pathway came when Shimizu 
discovered that using Aphanizomenon flos-aquae, instead of Gonyaulax tamarensis, in feeding 
studies allowed larger labeled molecules to be absorbed while remaining intact, avoiding the 
scrambling they observed previously.  Feeding studies with labeled [1-13C]arginine 35 and 




































































































that C1 in arginine was lost during the synthesis as CO2 and C6 is from a Claisen-type 
condensation of an acetate unit (Scheme 3C).21 Further a doubly labeled [2-13C,2-15N]ornithine 
(37) was synthesized and fed to Aphanizomenon flos-aquae, which resulted in the expected 
incorporation into neosaxitoxin (Scheme 3B).19  Two experiments with mono-labeled acetate 
showed the direction of the acetate incorporation (Scheme 3C).  
 
Scheme 3 Origin of  C5 and C6. 
The last piece of the puzzle was the origin of C13.  After failed feeding studies with labeled 
CO2 and formate, Shimizu observed that feeding [1,2-13C]glycine (43) gave [13-13C]neosaxitoxin 
(49).  This can be explained by glycine transferring the C2 carbon to tetrahydrofolate, forming 
methylene tetrahydrofolate (45).  This was further solidified by a feeding study with 
[3-13C]serine (44), which is a good methyl donor to tetrahydrofolate.  Since methylene 






















































































Arginine, 36: X= NHC(NH)NH2
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S-adenosylmethionine (SAM), a feeding study with [methyl-13C]methionine (47) was done.  This 
feeding study resulted in the strongest incorporation of radiolabeling at C13, demonstrating that 
SAM is the active methylating reagent (Scheme 4).19  
 
Scheme 4 Origin of C13. 
To study the mechanism of the methylation several deuterium labeling experiments were 
conducted.22 In the first experiment, [1,2-13C]acetate-d3 (50) was fed to Aphanizomenon 
flos-aquae resulting in the incorporation of deuterium at C5, which is indicative of a 1,2-hydride 















































































Scheme 5 [1,2-13C]acetate-d3 feeding experiment. 
A second feeding study with [Me-13C-Me-d3]Methionine (54) was conducted showing the 
loss of one of the methyl deuteriums.  This indicates that the methylene is epoxidized followed 
by ring opening to aldehyde 57, which is then reduced to the alcohol 58 (Scheme 6). 
 
Scheme 6 [Me-13C-Me-d3]Methionine feeding experiment. 
After piecing together all of the labeling experiments, Shimizu proposed a biosynthetic 
pathway (Scheme 7).23  The biosynthesis of saxitoxin starts with a Claisen-type condensation of 
an acetate 60 with arginine (18) followed by an amidino transfer from guanidine giving 62.  
After cyclization of guanidine 62, C6 is methylated by SAM (63).  The resulting methyl group 
undergoes a 1,2-hydride shift to form olefin 67, which is then epoxidized.  Epoxide 68 opens to 
the aldehyde 69, which is reduced to alcohol 70.  This proposal is missing a few key details.  
There is neither indication of the timing of the formation of the 6-membered ring nor any details 































































































Scheme 7  Hypothetical biosynthesis proposed by Shimizu based of various feeding studies. 
1.3.2 Isolation and Characterization of the Saxitoxin Gene Cluster 
In 2008, many years after Shimizu’s research Neilan and coworkers were able to isolate the 
saxitoxin gene cluster.24  Neilan cleverly was able to locate the gene cluster by noticing that 
several other natural products contained a carbamoyl group and that saxitoxin probably had a 
gene similar to those natural products.  He proposed that an O-carbamoyltransferase (OCTASE) 
was responsible for the installation of the carbamoyl group.  By aligning the gene sequence of 
several different OCTASE gene sequences from different organisms he was able to create a 
primer sequence that contained degenerate residues in the positions that were not conserved 
amongst all the different OCTASE genes.  Using this synthetic PCR primer Neilan and 
coworkers were able to use gene-walking techniques to isolate the entire saxitoxin gene cluster.  
By combining mass spectrometry techniques and a blast analysis, Neilan was able to revise 
































































































Shimizu’s, but it indicates that the cyclization of the 6-membered ring occurs just after the 
formation of olefin 72. 
 
Scheme 8 Revised biosynthesis based on STX gene cluster analysis. 
Neilan later isolated and compared the genes from several different cyanobacteria that 
produce different saxitoxin analogs.  Using this data he was able to deduce the genes responsible 

































































































Scheme 9 Revised biosynthesis tailoring reactions of dcSTX based on STX gene cluster 
analysis. 
1.4 Previous Synthetic Achievements 
Saxitoxin has attracted much attention from the synthetic community since its discovery due 
to its dense highly substituted core, which contains more heteroatoms than carbons.  The highly 
polar nature of Saxitoxin also leads to new synthetic challenges.  A detailed description of all the 
previous work towards the synthesis of Saxitoxin and its analogs are described in the following 
sections. 
1.4.1 Kishi 
  Kishi completed the first total synthesis of (±)-saxitoxin in 1977 (Scheme 10)27.  Starting 
from vinylogous carbamate 85, condensation with benzyloxyacetaldehyde and silicon 
tetraisothiocyanate followed by a hot toluene workup resulted in bicyclic thiourea ester 86.28  
Treatment of the ester with hydrazine and then nitrosyl chloride followed by heating in benzene 
resulted in a Curtius rearrangement, which was quenched with ammonia giving urea 87.  



















































































trifluoride etherate in acetonitrile followed by acidic ring closure of the urea in a warm acetic 
acid and trifluoroacetic acid mixture giving tricycle 88.  Tricyclic urea 88 was converted to 
diguanidine 89 by treatment by treatment with triethyloxonium tetrafluoroborate and sodium 
bicarbonate in dichloromethane followed by heating in ammonium propionate at 135°C.  
Bisguanidine 89 was debenzylated with boron trichloride in dichloromethane at 0°C and was 
isolated as the hexaacetate (treated with acetic anhydride and pyridine).  Treatment of 
hexaacetate 90 with N-bromosuccinimide in wet acetonitrile followed by heating in methanol at 
100°C gave decarbamoylsaxitoxin (80).  Decarbamoylsaxitoxin (80) was treated with 
chlorosulfonyl isocyanate in formic acid at 5°C, followed by a hot water workup giving 
(±)-saxitoxin (1).   
 
Scheme 10 Kishi’s racemic synthesis of saxitoxin.  (a) benzyloxyacetaldehyde, Si(NCS)4, PhH, 
rt; (b) MePh, 110°C, 75% (2 steps); (c) NH2NH2, H2O, CH2Cl2; (d) NOCl, CH2Cl2, -50°C; (e) 
PhH, 90ºC; (f) NH3, PhH, rt, 75% (4 steps); (g) 1,3-propanedithiol, BF3•OEt2, MeCN, rt; (h) 
AcOH, TFA, 50°C, 18hr, 50%; (i) Et3OBF4, NaHCO3, CH2Cl2, rt; (j) EtCO2NH4, 135°C, 33% (2 
steps); (k) BCl3, CH2Cl2, 0°C; (l) Ac2O, py, rt, 75% (2 steps); (m) NBS, wet MeCN, 15°C; (n) 















































(±)-saxitoxin, 1 decarbamoylsaxitoxin, 80
a, b c-f g,h
i, j
k, lm, no, p
NH2
O
85 86 87 88
8990
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Later, in 1992, Kishi published the asymmetric synthesis of (-)-decarbamoylsaxitoxin (96) 
(Scheme 11) proving that the unnatural enantiomer of saxitoxin was not active towards the 
sodium channel.29  This was accomplished using (R)-glyceraldehyde 2,3-acetonide, instead of 
using benzyloxyacetaldehyde, to induce enantioselectivity in the cyclization reaction.  Acetonide 
93 was cleaved to the diol with tosylic acid and the thiourea was protected with Meerwein’s 
reagent to give iminothioester 94.  The diol was then cleaved with lead tetraacetate and the 
resulting aldehyde was reduced with sodium borohydride.  The alcohol was benzylated under 
acidic conditions followed by treatment with hydrogen sulfide to give thiourea 95.  This thiourea 
was then taken through the same sequence of reactions described above to furnish 
(-)-decarbamoylsaxitoxin (96). 
 
Scheme 11 Kishi’s asymmetric synthesis of decarbamoylsaxitoxin.  (a) (R)-glyceraldehyde 2,3 
acetonide, Si(NCS)4, PhH, rt; (b) MePh, 110°C, 72% (2 steps); (c) p-TsOH, MeOH, quant.; (d) 
Et3OBF4, NaHCO3, CH2Cl2, 85%; (e) Pb(OAc)4, EtOAc; (f) NaBH4, MeOH, 0ºC, 82% (2 steps); 
(g) Cl3CC(=NH)OBn, TfOH, 4Å MS, CH2Cl2, 63%; (h) H2S, 91% 
1.4.2 Jacobi 
The second synthesis of  (±)-saxitoxin was completed by Jacobi in 1984 (Scheme 12).30  






































precedence of tin tetrachloride followed by the protection of the carbonyl as the thioketal with 
1,3-propanedithiol and boron trifluoride etherate.  The ester was then hydrolyzed to the acid with 
potassium hydroxide and then activated with trifluoroacetic acid anhydride which cyclized to 
bicyclic imide 98.  The imide was opened with benzylhydrazine and was converted to 
azomethine imine 100 with methyl glyoxylate hemiacetal and boron trifluoride etherate, which 
underwent a kinetically controlled 1,3-dipolar cycloaddition giving pyrazolidine derivative 
101.31  The resulting stereochemistry was corrected by first epimerization with sodium 
methoxide in methanol followed by reduction of the ester with sodium borohydride.  The 
hydrazide was reduced to the hydrazine with borane dimethyl sulfide complex, which was then 
debenzylated with transfer hydrogenation conditions and then acylated to give activated species 
102.  The activated hydrazine was then submitted to sodium in liquid ammonia, which cleaved 
the nitrogen-nitrogen bond and spontaneously cyclized to tricycle 104.  Tricycle 104 intercepts 
Kishi’s synthesis and in 5 steps was converted to (±)-saxitoxin.  
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Scheme 12 Jacobi’s synthesis of saxitoxin.  (a) ClCOCH2CO2Et, SnCl4, MeNO2, 60%; (b) 
1,3-propanedithiol, BF3•Et2O, 74%; (c) KOH, H2O, 80%; (d) TFAA, PhH, 92%; (e) 
PhCH2NHNH2, THF, 74%; (f) MeOCH(OH)CO2Me, BF3•EtO2; (g) NaOMe, MeOH then 
NaBH4, 72%; (h) BH3•DMS, 98%; (i) Pd, AcOH, HCO2H; (j) PhOCSCl, 80%; (k) Na, 
NH3, -78°C; (l) Ac2O, py.; (m) Et3OBF4, KHCO3 (2 steps); (n) EtCO2NH4, 130°C then Ac2O, 
py. 40-50%; (o) NBS, wet MeCN, 15°C; (p) MeOH, 100°C, 30% (2 steps); (q) NBS, wet MeCN, 
15°C; (r) MeOH, 100°C, 30% (2 steps); (s) Chlorosulfonyl isocyanate, HCO2H, 5°C then hot 
H2O, 50% 
1.4.3 Du Bois 
After years of no new saxitoxin synthesis papers, Du Bois published the total synthesis of 
(+)-saxitoxin (Scheme 13Scheme 10)32.  Du Bois approach to saxitoxin forms the last ring 
similarly to Kishi’s route, but his strategy proceeds through the initial formation of guanidine 
containing macrocycle 113, which contains all the necessary functional groups and 







































































and then submitted to Du Bois’ rhodium-catalyzed sulfamate C-H insertion reaction, giving 
hemiaminal 106.33 This hemiaminal undergoes an acid-promoted addition of zinc acetylide 107 
giving acetylene 108.34  The acetylene was hydrogenated with Lindlar’s catalyst to afford the 
desired cis-olefin followed by displacement of the tosyl group with sodium azide followed by 
protection of the sulfamate with p-methoxybenzyl chloride.  Azide 104 was then reduced with 
Staudinger’s conditions followed by the installation of the pseudothiourea.  The alcohol was then 
converted to the azide by first converting to the tosyl group followed by SN2 displacement by 
sodium azide.  The PMB group was then removed with ceric ammonium nitrate (CAN) and 
guanidinylated via a two-step process using a N-dichloromethylenesulfonamide followed by 
displacement of the remaining chloride with hexamethyldisilazane (HMDS) giving guanidine 
104.  The sulfamate protecting group was then hydrolyzed in hot aqueous acetonitrile giving 
azido alcohol 111.  The azide was reduced with trimethylphosphine followed by immediate 
exposure to silver nitrate and triethylamine, generating carbodiimide 112 which spontaneously 
cyclized to guanidine-containing 9-membered ring 113.  The primary carbamoyl group was 
installed by treatment with trichloroacetyl isocyanate.  The olefin then underwent stereoselective 
ketohydroxylation with a catalytic osmium trichloride and Oxone system. Hydroxyketone 114 
undergoes spontaneous ring contraction giving [6,5]-ring 115.  Further treatment with boron 
trifluoroacetate in trifluoroacetic acid (TFA) gave saxitoxinol (116), which was oxidized to 




Scheme 13 Du Bois’ first-generation synthesis of saxitoxin.  (a) ClSO2NH2, DMA/MeCN (b) 2-4 
mol% Rh2(OAc)4, PhI(OAc)2, MgO, CH2Cl2 92% (2 steps) (c) TsOCH2CH2C≡CZnCl, BF3•OEt2, 
70% (d) H2, Pd/CaCO3/Pb, THF; (e) NaN3, nBu4NI, DMF, 90% (2 steps); (f) PMBCl, nBu4NI, 
K2CO3, MeCN, 85%; (g) Me3P, THF/H2O; (h) MeS(Cl)C=NMbs, iPr2NEt, MeCN, 72% (2 
steps); (i) Tf2O, py., DMAP, CH2Cl2; (j) NaN3, DMF, -15°C, 70% (2 steps); (k) CAN, 
tBuOH/CH2Cl2, 74%; (l) KOtBu, Cl2C=NMbs; then (Me3Si)2NH, 70% (+20% of 6); (m) aq. 
MeCN, 70°C, 95%; (n) Me3P, THF/H2O; (o) AgNO3, Et3N, MeCN, 65% (2 steps); (p) 
Cl3CC(O)NCO, THF/MeCN, -78°C; then K2CO3, MeOH, 82%; (q) 10 mol% of OsCl3, Oxone, 
Na2CO3, EtOAc/MeCN/H2O, 57%; (r) B(TFA)3, TFA, 82%; (s) DCC, TFA•py., DMSO, 70%. 
Mbs = p-MeOC6H4SO2. 
Du Bois later published a second-generation synthesis which was higher yielding and more 
scalable (Scheme 14).35 This synthesis changed the preparation of 9-membered ring 113.  The 
synthesis starts from L-serine methyl ester (117) which is converted in 3 steps to aldehyde 118 
by first protecting the amine with Boc anhydride (Boc2O), protection of the alcohol with 



























































































hydride (DIBAL).  Aldehyde 118 was converted to nitrone 119 by condensation with 
N-(4-methoxybenzyl)hydroxylamine followed by nucleophilic attack by magnesium acetylide 
120 giving hydroxylamine 121.  This acetylene was converted to 9-member ring 113 in 6 steps 
(Scheme 14). 
 
Scheme 14 Du Bois’ second generation synthesis of saxitoxin.  (a) Boc2O, Et3N, THF, 95-99% 
(b) TBDPSCl, im., DMF, 95%; (c) iBu2AlH, CH2Cl2, 71%; (d) PMBNHOH, MgSO4, CH2Cl2, 
76%; (e) MbsN=C(SMe)NH-CH2CH2C≡CMgCl (120), THF, -78°C, 78%; (f) p-TsNHNH2, 
NaOAc, THF, H2O, 100°C, 78%; (g) Zn, Cu(OAc)2, AcOH, H2O, 70°C, 81%; (h) 
MbsN=C(SMe)NHBoc 65, HgCl2, Et3N, CH2Cl2, 74%; (i) HCl, MeOH, 52%; (j) AgNO3, Et3N, 
MeCN, 73%; (k) TFA, 60°C, 91%. 
In Du Bois’ effort to create many saxitoxin analogs, he later published the total synthesis of 
gonyautoxin 3 (10), for which he came up with new methodology (Scheme 15).36  This synthesis 
deviated from Du Bois’ original synthesis, as it no longer proceeded through his novel 
9-membered ring intermediate.  Instead Du Bois uses a rhodium-catalyzed amination reaction, 
which he developed.  The preparation of amination precursor 122 starts by coupling L-serine 
methyl ester (117) to pyrrole-1-carboxylic acid, which is later cyclized in a Pictet-Spengler type 













































Treatment of precursor 124 with Rh2(esp.)2 and PhI(OAc)2 generates tricycle 125, which 
presumably goes through a nitrene intermediate.36  Functional group manipulation of tricycle 125 
leads to olefin 126, which is then dihydroxylated to diol 127, which is further elaborated to 
gonyautoxin 3 (10) in 4 steps. 
 
Scheme 15 Du Bois’ synthesis of gonyautoxin 3.  (a) pyrrole-1-carboxylic acid, DCC, Et3N, 
CH2Cl2, 65%; (b) TBDPSCl, im., DMF, 97%; (c) iBu2AlH, CH2Cl2, -90°C; (d) allylamine, 
BF3·OEt2, CH2Cl2, 56% (2 steps, >20:1 trans/cis); (e) Pd(PPh3)4, 1,3-dimethylbarbituric acid, 
CH2Cl2; then Na2CO3, TcesN=C(SMe)Cl, 94%; (f) EtOSO2CF3, 2,4,6-tri-tert-butylpyrimidine, 
CH2Cl2, 47°C, 78%; (g) NH3, NH4OAc, MeOH, 60°C, 82%; (h) CCl3C(O)Cl, iPr2NEt, 
CH2Cl2, -20°C, 87%; (i) 5 mol% Rh2(esp.)2, PhI(OAc)2, MgO, CH2Cl2, 42°C, 61%; (j) Et3SiH, 
BF3·OEt2, CH2Cl2, 81%; (k) nBu4NF, THF; (l) Cl3CC(O)NCO, CH2Cl2, -20°C; then MeOH,76% 
(2 steps); (m) 2 mol % OsO4, NMO, THF/H2O, 81%; (n) PhC(O)CN, DMAP, 
CH2Cl2/MeCN, -78°C, 67%; (o) DMP, CH2Cl2, 79%; (p) H2, Pd/C, TFA, MeOH; then NH3, 



















































































































After publishing the synthesis of decarbamoyloxysaxitoxin in 200737 and the synthesis of 
saxitoxin in 2009,38 Nagasawa published the second synthesis of (+)-gonyautoxin 3 (10) 
(Scheme 16) using his previously developed methodology.39 This synthesis starts by utilizing a 
1,3-dipolar cycloaddition between methyl crotonate 131 and nitrone 132 to install the required 
stereocenters.  Functional group manipulation and guanidine installation leads to bicycle 136.  
Nagasawa utilizes a novel 2-iodoxybenzoic acid (IBX) oxidation to install the required 
hemiaminal.  The last ring was closed by first activating the hemiaminal with an acetate and then 
zinc chloride-promoted ring closure.  Protecting group manipulation followed by oxidation gave 
ketone 140, which could be elaborated to decarbamoylsaxitoxin.  To further elaborate this 
substrate to gonyautoxin 3, Nagasawa forms the triisopropylsilyl (TIPS) enol ether, which is then 
epoxidized to give compound 141, which is then opened to the alcohol.  The alcohol was then 




Scheme 16 Nagasawa’s synthesis of gonyautoxin 3.  (a) No solvent, 40°C then DBU, 
CH2Cl2, -60°C then Zn dust, AcOH, -60°C to r.t. 70%; (b) CbzCl, K2CO3, CH2Cl2, 0°C then 
MeOH, r.t; (c) TiCl3, Zn dust NaOAc, HCl, MeOH CH2Cl2, 0°C; (d) BocN=(SMe)NHBoc, 
HgCl2, Et3N, DMF; (e) ClCH2SO2Cl, iPr2NEt, CH2Cl2, 98%; (f) TBAF, THF, 0°C, 83%; (g) 
(COCl)2, DMSO, Et3N, -78°C; (h) IBX, DMSO, Et3N, 50°C, 94%; (i) NaBH4, MeOH, 0°C, 
77%; (j) Pd(OH)2/C, H2, MeOH; (k) BocN=(SMe)NHBoc, HgCl2, Et3N, DMF 60% (2 steps); (l) 
i. Ac2O, cat. DMAP, py. then evaporate ii.  ZnCl2, CH2Cl2 98% one pot; (m) K2CO3, MeOH, 
0°C, 94%; (n) DMP, CH2Cl2 99%; (o) NaHMDS CH2Cl2, -40°C then TIPSCl, 97%; (p) mCPBA, 
CH2Cl2, aq. NaHCO3, 33%; (q) CH2Cl2 0°C then Et3N, MeOH, 76%; (r) TFA then H2O; (s) 
SO3-DMF 2,6-tBu2-4-Me-Py, NMP, 51% (2 steps). 
During Nagasawa’s studies towards the synthesis of saxitoxin he came across an interesting 
byproduct.  When alcohol 142 was treated with IBX and DMSO, instead of getting aminal 143, 
he obtained hemiaminal 146 in a 45% yield.  Looking into the mechanism gave him the idea of 
using oxalyl chloride instead of IBX, which would prevent the hydroxyl transfer shown in 






































































































Scheme 17 Unexpected cyclization 
Even though byproduct 146 was unexpected, Nagasawa was interested in the biological 
properties of this type of compound and decided to synthesize some  other similar analogs and 
test their ability to block sodium channels (Scheme 18).40  Once saxitoxin analogs (-)-FD-STX 
(153), (-)-FD-dcSTX (150), and (-)-FD-doSTX (146) were prepared they were tested for activity.  
Patch clamp studies with Nav1.4 (TTX sensitive) and Nav1.5 (TTX resistant) channels were 
tested with both (-)-FD-STX (153) and (-)-FD-dcSTX (150).  (-)-FD-STX (153) showed 
concentration-dependent inhibitory effect with IC50 values of 3.8 and 118 µm towards Nav1.4 
and Nav1.5 respectively.  (-)-FD-dcSTX (121) showed concentration-dependent inhibitory effect 
with IC50 values 16 and 182 µm towards Nav1.4 and Nav1.5 respectively.  On the other hand, 
(-)-FD-doSTX (146) showed no activity.  Interestingly, (-)-FD-dcSTX (150) showed irreversible 
binding to the sodium channel, which is unprecedented for all STX and TTX type molecules.  
























































Scheme 18 Synthesis of tricyclic saxitoxin analogs.  (a) H2, Pd(OH)2/C, MeOH; b) 
CbzN=C(SMe)NHCbz, HgCl2, Et3N, DMF, 85%(2 steps); c) NaOMe, THF/MeOH, 0°C, 65%; 
d) IBX, DMSO, 70°C, 24%; e) H2, Pd(OH)2/C, MeOH; f) 3N HCl, 78% (2 steps); g) Ac2O, 
pyridine (py), 50°8C, 96%; h) DDQ, CH2Cl2, H2O, 94%; (i) trichloroacetyl isocyanate, CH2Cl2, 
then K2CO3, MeOH, 34%; j) IBX, DMSO, 70°C, 20%; k) H2, Pd(OH)2/C, MeOH; l) TFA, 
CH2Cl2, 82% (2 steps). 
1.4.5 Nishikawa 
Nishikawa takes a completely different approach towards saxitoxin analogs (Scheme 19) by 
utilizing a bromocyclization of propargyl and homopropargyl guanidines.41  Using this approach, 
Nishikawa published the synthesis of decarbamoylsaxitoxinol in 2011.42  Starting from Garner’s 
aldehyde (derived from L-serine) in 3 steps Nishikawa prepared alkyne 155, which was 
guanidinylated with concomitant displacement of the mesylate and hemiaminal formation giving 
aziridine alkyne 156.  Sodium azide opening of the aziridine, deprotection and mesylation of the 
primary alcohol, acetate deprotection and Boc deprotection gave cyclization precursor 158.  
When alkyne 158 was treated with pyridinium hydrobromide perbromide (pyHBr3) and 
potassium carbonate in dichloromethane it underwent cyclization to intermediate 159.  Azide 
































































































of the N-benzyloxycarbamoyl (Cbz) groups by hydrogenation over palladium on carbon, 
followed by treatment with boron trifluoroacetate in trifluoroacetic acid, furnished 
decarbamoylsaxitoxinol (80) in good yield. 
 
Scheme 19 Nishikawa’s synthesis of decarbamoylsaxitoxinol.  (a) TBSOCH2CH2C≡CH, nBuLi, 
HMPA toluene, -78°C, 54%; (b) MsCl, Et3N, CH2Cl2 r.t quant.; (c) TFA, CH2Cl2, H2O then 
Amberlite IRA-410, MeOH; (d) Et3N, DMF then CbzN=C(SMe)NHBoc, HgCl2 Et3N DMF, 
95% (3 steps); (e) TBSCl, Et3N, CH2Cl2, DMF, r.t. (f) Ac2O, Et3N, DMAP, CH2Cl2, r.t., 90% (2 
steps); (g) NaN3 DMF, r.t; (h) TBAF, THF, r.t; (i) MsCl, Et3N, 0°C to r.t.; (j) KCN, EtOH, r.t; 
(k) TFA, CH2Cl2, r.t; (l) PyHBr3, K2CO3, CH2Cl2, H2O, 24% (6 steps); (m) Ac2O, Et3N, CH2Cl2; 
(n) NaBH4, MeOH 32% (2 steps); (o) Me3P, CH2Cl2 then MeOH/12M HCl (5:1); (p) 
CbzN=C(SMe)NHCbz, HgCl2, Et3N, DMF, 60°C, 51% (2 steps); (q) 10% Pd/C, H2, MeOH, 
EtOAc; (r) B(TFA)3, TFA, 73% (2 steps). 
1.4.6 Looper 
Just after Nishikawa published the synthesis of decarbamoylsaxitoxinol, Looper and 
coworkers published the elegant synthesis of saxitoxin using a similar approach (Scheme 20).43 
Like Nishikawa, Looper also cyclized a propargyl guanidine, but he utilized his silver acetate- 





































































able to assemble propargyl/homopropargyl bisguanidine 160 in 9 steps from L-serine methyl 
ester.  Propargyl guanine 160 was transformed into tricycle 161 by adding 1 equivalent of silver 
acetate followed by another equivalent of silver acetate and 2 equivalents iodine followed by 5 
equivalents of acetic acid (AcOH).  Tricycle 161 was hydrogenated over palladium hydroxide 
followed by mesylation of the primary alcohol.  Hydrolysis of oxazolidinone 162 with cesium 
carbonate in ethanol gave the alcohol, which underwent spontaneous cyclization to the tricyclic 
core 163.  Alcohol 163 was oxidized with Dess-Martin periodinane (DMP) and deprotected with 
trifluoroacetic acid to give (+)-saxitoxin (1) in good yield. 
 
Scheme 20 Looper’s synthesis of saxitoxin.  (a) BnOCH2CH2C≡CH, iPrMgCl, THF -78°C 
to -55°C 9:1 dr (86% brsm); (b) Cu(OAc)2, Zn, AcOH, H2O, 92%; (c) 1M HCl in MeOH 40°C, 
89%; (d) KOCN, MsCl, CH2Cl2, 78%; (e) BocN=C(MeS)NHBoc, HgO, Et3N, CH2Cl2, 83%; (f) 
i. AgOAc (1eq.) ii. AgOAc (1eq.), I2 (2eq.) iii. AcOH (5eq.) 57-67%; (g) Pd(OH)2, iPrOH H2 @ 
80 PSI, 67%; (h) MsCl, Et3N, DMAP, CH2Cl2, 77%; (i) Cs2CO3, EtOH, 0°C to r.t, 61%; (j) 





























































































1.5 Conclusion and Goals 
Saxitoxin and its analogs have attracted the attention of many researchers since its 
discovery.  Recently, isolation of the biosynthetic gene cluster and many years of feeding studies 
have allowed the biosynthetic pathway to be elucidated.  Synthetic achievements by numerous 
chemists have allowed the synthesis of many natural products and analogs.  The combined effort 
of chemists and biologists has given us a better understanding of sodium and other ion channels 
resulting in a better understanding of neuroscience.  
This research will focus on total synthesis of saxitoxin analogs, Zetekitoxin AB being the 
primary goal.  The total synthesis of Zetekitoxin AB will prove (or disprove) the structural 
assignment and advance methodology in the synthesis of these dense, highly functionalized polar 
molecules.  Synthesis will allow a variety of analogs to be produced, which can be used towards 




Chapter 2: Synthesis of Saxitoxin Analogs 
Retrosynthetic Analysis of Zetekitoxin AB 
A retrosynthetic analysis of Zetekitoxin AB (11) reveals that it could arise from core 
structure 165, followed by a late stage installation of the oxazolidine (Scheme 21).  This 
oxazolidine could come from a 1,3-dipolar cycloaddition of allyl alcohol on nitrone 164.  The 
sulfate ester and N-hydroxycarbamoyl group would be installed at the very end of the synthesis.  
The core structure 165, which is very similar to saxitoxin, could arise from the condensation of 
two guanidines on a central carbonyl and the nucleophilic attack on carbon 12, displacing a 
leaving group.  The order of these cyclizations can be changed allowing many different 
approaches in this synthesis.  Ketone 167 could arise from protected diamino ester 168, which in 
turn could be formed from a Mannich-type reaction on ribose-derived imine 169.  Mannich 
precursor 169 could be formed from D-ribose (8) in a few steps.  D-Ribose was chosen as a 
starting material because it contains the entire backbone of saxitoxin and all the necessary 
functional group handles minus a glycine equivalent.  
 













































































Initial investigation into the synthesis of zetekitoxin AB (11) began with the study of 
saxitoxin (1), as it is the core.  Disconnecting one of the three rings of saxitoxin reveals three 
different approaches to the bicycle (Scheme 22).  All three of these intermediates have been used 
in the synthesis of saxitoxin and its analogs.27,30,32,37,41,43 The current retrosynthetic plan should 
allow access to all three of these intermediates. Determining which of these three routes will be 
useful for the D-ribose approach represents a major synthetic challenge, as there are essentially 
unlimited choices to explore.  The first step in this synthesis is the development of a successful 
Mannich reaction so that each of these intermediates can be explored. 
 
Scheme 22 Previous breakdown of saxitoxin core. 
2.1 Development of the Mannich Reaction 
2.1.1 Precedence 
There are a variety of natural products and therapeutic compounds that contain 








































total synthesis of (2S,3R)-capreomycidine (180) (Scheme 23).46  The key step in this sequence is 
the addition of the aluminum enolate of Williams’ glycine template 175 to imine 176.  This 
reaction proved to be very difficult as most imine substrates for this reaction failed to give any 
product.  This demonstrated that the reaction was very substrate dependent, which would make it 
very difficult to apply towards the synthesis of saxitoxin. 
 
 
Scheme 23 Williams’ synthesis of capreomycidine.  (a) i. LiHMDS ii. Me2AlCl iii. 9 
THF, -78°C, 60% (b) BocN=C(SMe)NHBoc, Et3N, AgOTf, DMF, rt, 3hr. 74% (c) 1.7% HF, 
MeCN, rt, 2 hr., 70-91% (d) DIAD, PPh3, THF, 0°C, 15 min to rt 1 hr. 87% (e) H2, PdCl2, 115 
psi, 4 days (f) 0.5M HCl, Δ 1.5 hr. 95% (2 steps) 
The goal was to use ribose-derived imine 181 and Williams’ lactone 182 to form the 
saxitoxin backbone with the desired stereochemistry in a manner similar to the above precedents 














































Scheme 24 Proposed Mannich reaction. 
2.1.2 Initial Attempts 
To test out the Mannich reaction the imine of protected ribose was synthesized in 3 steps.  
The diol and lactol of ribose were protected in a single step by treating ribose with acetone and 
methanol in the presence of hydrochloric acid (Scheme 25).47   With protected ribose 185 in 
hand, it was then submitted to Swern oxidation conditions, which gave the aldehyde in a 79% 
yield.48  It was later discovered that a TEMPO and TCC oxidation was superior to the Swern 
oxidation because it was complete in 15 min. and required no column chromatography.49,50   
 
Scheme 25 Formation of ribose derived aldehyde 185. 
Ribose-derived aldehyde 185 was treated with benzylamine and alumina to give 
benzylimine 182.  This imine was then subjected to the conditions previously developed in the 
group.  After treatment of the Williams’ lactone with NaHMDS followed by transmetallation 
with dimethylaluminum chloride, benzyl imine 182 was added.  Unfortunately, the reaction only 













































Scheme 26 Initial Mannich reaction attempts. 
Since there was no reaction with benzylimine 182, O-methyloxime 187 was prepared 
because it is much smaller and a successful reaction would indicate that the problem is due to the 
sterics of the benzyl group.  Oxime 187 was submitted to the same conditions, resulting only in 
the recovery of starting material.  Since this reaction did not give any product it was assumed 
that the reaction was failing because the imine was not electrophilic enough for the addition of 
the aluminum enolate.  This result was not too surprising because in the synthesis of 
capreomycidine (180), as mentioned earlier, the Mannich reaction was found to be very substrate 
dependent.   
 
Scheme 27 Failed Mannich reaction 
2.1.3 Masked Imines as Reactive Mannich Precursors 
To overcome this synthetic hurdle, it was thought that installing a strong electron-
withdrawing group on the nitrogen would lead to a successful reaction.  In literature, most 




























































nucleophilic attack.51  These imines are not very useful in this synthesis because of the harsh 
reaction conditions required to deprotect the resulting amine.  There are two criteria that need to 
be met in order for the Mannich product to be useful.  First the withdrawing group needs to be 
easy to remove and second it must be stable to the basic nucleophilic conditions required for the 
Mannich reaction.   
After careful examination of various amine-protecting groups, the carbamate protecting 
groups seemed to be the best choice as they can be conveniently removed under a variety of 
different conditions.  A literature study into acyliminium ions and acylimines indicated that they 
were not stable intermediates and hydrolyze rapidly.  This also indicates that they should be 
highly reactive electrophiles in the desired Mannich reaction.  The majority of acyliminium or 
acylimines in literature were masked and then formed in-situ.  Such examples are benzotriazole 
and sulfone adducts of acylimines.52,53 Petrini and coworkers have pioneered the use of α-amido 
sulfones, demonstrating their stability and versatility in chemical synthesis.53 The standard 
conditions used to prepare amido sulfones use the appropriate aldehyde, sodium 
benzenesulfinate, and a carbamate in the presence of formic acid.54  After developing these 
conditions, Petrini and coworkers developed methodology to prepare amido sulfones from acid- 
sensitive aldehydes using a carbamate, benzenesulfinic acid and magnesium sulfate as a 
dehydrating agent.55   
Amido sulfones are versatile because they eliminate under acidic or basic conditions to 
generate acyliminium ions (191) or acylimines (192), which can undergo addition reactions by a 
variety of different nucleophiles (Scheme 28).  This allows the simultaneous formation of 
electrophilic acylimines (192) and nucleophilic metal enolates under basic conditions and 
acyliminium ions (191) and enols under acidic conditions, allowing for the formation of a 
 37 
carbon-carbon bond.  This methodology looked promising and was applied towards the synthesis 
of saxitoxin analogs. 
 
Scheme 28 Amido sulfones. 
2.1.4 Successful Mannich Reaction 
Ribose-derived aldehyde 185 was submitted to Petrini’s conditions using t-butyl, benzyl or 
methyl carbamate resulting in the formation of amido sulfones 194, 195 and 196 (Scheme 29). 
These amido sulfones were stable to chromatography and could be stored in the freezer with no 
apparent decomposition.  
 
Scheme 29 Formation of amido sulfones 194-196 
Amido sulfone 195 (1 eq.) was added dropwise to cold THF containing 2.5 eq. of the 
sodium enolate of glycine template 186, which was prepared by stirring with sodium 
hexamethyldisilazane (NaHMDS), and allowing to stir for 1 hr. at -78°C.  After quenching with 
sodium bicarbonate, Mannich product 198 was isolated in a 78% yield (Scheme 30).  This 
reaction utilized an extra equivalent of lactone 186 because formation of the amido sulfone 
requires one equivalent of base.  To minimize the use of the glycine template it was thought that 
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lactone 186 was used along with 2 equivalents of NaHMDS the yield was diminished to 57%.  
NMR analysis of the resulting product showed a single diastereomer and at this point the 
stereochemistry was a mystery.  These results solidify the conclusion that benzylimine simply 
was not reactive enough to participate in the Mannich reaction.  This methodology was also 
applied to amido sulfones 194 or 196 giving products 197 or 199, respectively. 
 
Scheme 30 Successful Mannich reaction. 
With several Mannich products in hand, the next step was to develop conditions to deprotect 
the lactol, which is necessary to access the secondary alcohol.  Mannich product 199 was used 
because the methyl carbamate group is stable to acidic conditions, which will be necessary for 
the desired transformation.  This reaction was expected to be difficult as it would be nearly 
impossible to deprotect the lactol without deprotection of the acetonide.  This was indeed the 
case as, when compound 199 was treated with aqueous HCl in THF, no product was observed 
































Scheme 31 Failed hydrolysis of lactol. 
2.1.5 Useful Mannich Substrate 
This problem could be remedied by replacing the lactol-protecting group with one that could 
be deprotected under conditions that don’t require aqueous acid.  A benzyl group was decided to 
be the best option as it could be removed by hydrogenation and could be installed in the same 
fashion as the methyl ether.  Benzyl ether protected ribose acetonide 214 was previously 
prepared in literature by treating D-ribose with benzyl alcohol and acetone in the presence of 
sulfuric acid.56 The alcohol was then submitted to the TEMPO/TCC oxidation, which proceeded 
smoothly to give desired aldehyde 201, which was converted to the amido sulfone as previously 
described (Scheme 32). 
 
Scheme 32 Synthesis of amido sulfones 203-205. 
This new substrate could potentially solve the deprotection problem, it created a new 
problem.  The glycine template used contains several groups that are sensitive to hydrogenation 
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require reprotection.  Also, since ribose is a chiral molecule it has the potential to direct the 
Mannich reaction without requiring the expensive enantiopure glycine template.   
Glycine ethyl ester benzophenone imine (207) has been used in Mannich addition reactions 
and the benzophenone imine can be removed under mild aqueous conditions.57   This template is 
commercially available, but it is more economically prepared via glycine ethyl ester HCl (205) 
and benzophenone imine (206), which can be prepared by a Grignard reaction between phenyl 
magnesium bromide (209) and benzonitrile (208) (Scheme 33).58 
 
Scheme 33 Preparation of the benzophenone imine of glycine ethyl ester. 
Amido sulfones 202-204 were treated with the lithium enolate of glycine 207, which was 
formed by pretreatment with LDA.  This reaction proceeded smoothly as expected giving a good 
yield of Mannich products 211-213.  The purification of these substrates was difficult as the 
glycine template co-spotted with the product. Mannich product 211 could be purified by 
crystallization from hexanes.  Crystals of Mannich product 211 allowed for the absolute 
stereochemistry to be determined by x-ray crystallography.  Since the absolute stereochemistry 





















Scheme 34  Preparation of Mannich Products 211-213 
2.1.6 Scale-up of Mannich Substrate 
Previous attempts to produce protected ribose 214 from D-ribose (170) on 100-gram scale 
gave low yields (9%).  Decreasing the temperature from reflux to 70-75 degrees significantly 
increased the yield.  It was also noticed that the sodium carbonate was not effective in 
neutralizing all the acid.  If the acid was not completely neutralized, when the temperature was 
increased to remove the benzyl alcohol the mixture turned black, reducing the yield.  
Neutralizing with Et3N was more effective due to solubility and effectively solved the problem.  
These two modifications increased the yield to 51% on a 150-gram scale.  This reaction was then 
scaled up to 400g giving a 50% yield (Scheme 35).   
Conversion of sodium benzenesulfinic acid to benzene sulfinic acid by treatment of a 
solution of the salt in water with HCl followed by an ether extraction was low yielding.  This 
procedure was simplified by dissolving the salt in a small amount of water and then acidifying 
with 12M HCl and filtering off the product.  The product was then dried under vacuum overnight 
to giving a much better yield with much less work. 
 Purification of amido sulfone 194 was previously done by column chromatography.  






























although better than chromatography, led to a gel-like product that was not always pure and was 
hard to reproduce.  This procedure was optimized after noticing that the product is not soluble in 
ether, but the starting materials are.  When the crude product was stirred in ether, amido sulfone 
194 crashed out resulting in a 62% yield on ~40g scale  (Scheme 35).   
 
Scheme 35 Optimized synthesis of Mannich product 211. 
2.2 Bis-Guanidinylation Approach 
2.2.1 Retrosynthesis 
The first approach taken toward synthesis of the core of zetekitoxin AB was to deprotect 
both of the amines and install both guanidines simultaneously (Scheme 36).  At the start of this 
project this approach was unprecedented, until Looper’s synthesis in 2011.43  Both guanidines 
would then be condensed on a centralized ketone to give a [6,5]-fused ring system 215.  The 
primary alcohol could then be converted to a leaving group, which could then undergo an attack 













































Scheme 36 Retrosynthesis of the saxitoxin core via diamine 217. 
2.2.2 Formation of diamine and installation of guanidines 
In order to access diamine 217 the Boc and benzophenone imine protecting groups would 
have to be removed (Scheme 37).  The removal of the Boc group was more problematic then 
expected, as treatment with TFA, HCl and a variety of other acids failed to give the desired 
product.  Thermal and microwave conditions also proved to be problematic.  It was later 
discovered that Ohfune’s conditions worked very well for this transformation.59  Treatment of 
211 with TMSOTf and 2,6-lutidine in CH2Cl2 cleanly removed the Boc group in ~20 minutes.  
The benzophenone imine was then hydrolyzed with 1M HCl in THF to give diamine 217.  The 
isolation of the diamine was problematic at first because it was very soluble in water.  The first 
isolation technique was a simple biphasic extraction.  Unfortunately, this resulted in a low yield 
(~30%).  Neutralization with sodium bicarbonate followed by removal of the solvent under 
vacuum followed by lyophilization of the water gave a mixture of diamine 217 and mixed salts, 
which were then extracted with EtOAc.  This gave a better yield, but was still not acceptable.  A 
biphasic extraction with n-butanol improved the yield drastically, but it was found that 
evaporation of the mixture without neutralization gave the best yield of the diamine 217 as the 
bis-hydrochloride salt.  This crude mixture of diamine 217 HCl was of sufficient purity for the 
next reaction.  The diamine was then guanidinylated with pseudothiourea 218, HgCl2, and Et3N 
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Scheme 37 Synthesis of bisguanidine 219. 
Guanidinylating agent 218 was prepared by treating S-methylisothiourea hemisulfate (220) 
with 1 eq. of Boc2O and 4M NaOH in CH2Cl2.  Bis-Boc-protected product 222 was observed, 
but compound 221 was the major product. 
 
 
Scheme 38 Preparation of reagent 221. 
2.2.3 Debenzylation 
With bisguanidine 219 in hand the next goal is the removal of the benzyl ether to access 
lactol 223, which would then need to be reduced.  To affect this transformation several 
hydrogenation conditions were screened.  Hydrogenation with 10% Pd/C or 20% Pd(OH)2/C at 
80 psi led to a complex mixture (Scheme 39).  
 














































































To simplify the reaction the labile Cbz groups were changed to a methyl carbamate.  
Guanidinylation reagent 224 was synthesized by treating known Boc-protected S-methyl 
isothiourea 221 with methyl chloroformate and 4M NaOH.   
 
Scheme 40 Preparation of reagent 224. 
 Diamine 217 was then treated with reagent 224 along with mercuric chloride, and 
triethylamine in dimethylformamide to give bisguanidine 225.  Unfortunately, hydrogenation of 
compound 225 with palladium hydroxide at 80 psi gave back starting material after 2 days.  
Compound 225 was also treated with DDQ in an attempt to remove the benzyl group, but this 
resulted in decomposition.  Several other conditions were screened, but none led to the desired 
product (Scheme 41). 
 
Scheme 41 Failed hydrogenation of benzyl ether 226.  Conditions: 20% Pd(OH)2/C or 10% 
Pd/C, H2, 80 psi, THF; DDQ, CH2Cl2/H2O, 45ºC; Na, NH3 or hν 
Since removal of the benzyl ether proved difficult in the presence of the guanidines it was 
thought that removing the benzyl group before installation of the guanidines could be effective  
(See section Late-Stage Guanidine installation for more detailed information). 
After putting this route on hold for a while, screening more hydrogenation conditions led to 
















































Pd(OH)2/C at 100 psi in MeOH for ~18 hours to give lactol 226 in good yield (Scheme 42).  The 
success of this reaction was due to the combination of high catalyst loading, high pressure and 
methanol as the solvent.  Using THF instead of methanol slowed the reaction down so much the 
reaction only returned starting material.  Another issue was the purity of the starting material.  
When insufficiently purified the reaction shuts down, probably due to residual sulfide 
contaminates from the guanidinylation.  This reaction was later optimized by switching the 
solvent system to a 5:1 THF/MeOH, improving the yield from ~70% to 85%, but increasing the 
reaction time to ~30 hours.   
 
Scheme 42 Successful deprotection of benzyl ether 225. 
2.2.4 Reduction of Lactol and Oxidation of Alcohol 
To access the secondary alcohol the lactol must first be reduced.  Treatment of lactol 226 
with excess sodium borohydride in methanol gave a complex mixture (Scheme 43).  Reduction 
conditions using stoichiometric borohydride as well as the slow addition of borohydride also 
failed to give results.  Other reducing agents such as NaHB(OAc)3, NaCNBH3 were screened, all 































Scheme 43 Failed lactol reduction.  Conditions: NaBH4, THF or MeOH; NaHB(OAc)3, MeOH; 
NaCNBH3, MeOH 
To avoid the problems that occur under reducing conditions, a couple of different attempts 
to open the lactol with nucleophiles were made.  Compound 226 was treated with methoxyamine 
HCl and pyridine in methanol giving ring-opened oxime 228 (Scheme 44).  The secondary 
alcohol was oxidized with Dess-Martin periodinane giving ketone 229.  This reaction was not 
reproducible.  Most times the reaction was low yielding, except in one case the reaction went 
spot to spot by TLC.  Fresh oxidant was tested to try to reproduce reaction, but in all cases the 
clean reaction was never reproduced. 
 
Scheme 44 Preparation of ketone 229. 
Since phosphorus ylides are nucleophilic, but not very basic a Wittig reaction was attempted 
on the lactol 226.  The lactol was added to the phosphorus ylide of PPh3CH2Br, which was 






































































Scheme 45 Unsuccessful Wittig reaction. 
After considerable frustration it was discovered that lactol 226 could be reduced by NaBH4 
in MeOH at 0°C to give a mixture of the diol 227 and triol 231 (Scheme 46).  This reaction went 
unnoticed for a very long time because the reaction time is very short (~5 min.) and it requires a 
large excess of hydride.  If the amount of hydride is reduced the reaction time is increased and no 
product is isolated.  If the reaction goes a minute over, which is very easy to do, the yields drop 
off terribly. To further complicate things, the starting material co-spots with the product on TLC 
and the only difference is a slight difference in color when stained in ninhydrin.  
 
Scheme 46 Sucessful lactol reduction. 
Standard TBS conditions of the diol (TBSCl, DMAP or imidazole and Et3N in DMF or 
CH2Cl2) gave no reaction so more reactive conditions were used.  Treatment of diol 227 with 
TBSOTf and 2,6-lutidine at -78°C in CH2Cl2 proceeded very quickly giving rise to TBS ether 
232.  This reaction had to be carefully monitored to avoid the bis-TBS protection of the primary 





























































primary alcohols of triol 231.  Treatment of both secondary alcohols with Dess-Martin 
periodinane gave ketones 233 and 235 (Scheme 47). 
 
Scheme 47 Preparation of ketone 233 and 235. 
The yield of triol 231 was ~10% so a more economical synthetic route was explored 
(Scheme 48).  Thus by treating ester 225 with super hydride or sodium borohydride a low yield 
of the primary alcohol was obtained.  Alcohol 236 was then TBS-protected using TBSCl, 
DMAP, and Et3N in CH2Cl2 to give silyl ether 237.  This methodology was put on hold as the 
small quantity of triol previously obtained was taken forward. 
 









































































































2.2.5 Deprotection of Guanidines 
Before attempting the guanidine deprotection of ketone 233 or 235 a model study was 
completed.  Bisguanidine 225 was treated with potassium tert-butoxide (KOtBu) in methanol, 
which gave what looks to be a mixture of compounds 238 and 239 (Scheme 49).  Both the NMR 
and MS data agreed that both methyl carbamates were gone, but the ethyl ester also was missing.  
It is assumed that one of the guanidines cyclized on the ester forming either a 5 or 6 membered 
ring, unfortunately the mixture could not be sufficiently purified to fully characterize.  
 
Scheme 49 Deprotection of methyl carbamates. 
Even with the failed model study, ketone 233 was treated with KOtBu in methanol.  This 
reaction led to the deprotection of the methyl carbamates and the loss of the ethyl ester giving 
compounds 240 and 241 as expected from the previously described model system.   
 
Scheme 50 Deprotection of ketone 233. 
To prevent this side reaction it was thought that using aqueous hydroxide instead of 
tert-butoxide could simultaneously hydrolyze methyl carbamates and the ester, giving the free 








































































in methanol and stopped as soon as the starting material was gone by TLC.  This resulted in a 
mixture of products containing the methyl carbamates and loss of the ester by NMR but the MS 
showed a single mass.  This indicated that the ester was successfully hydrolyzed, but the basic 
reaction conditions were racemizing the center next to the ketone or the ester.  If the reaction was 
allowed to continue longer than the time required to consume starting material the products 
became increasingly polar and purification became impossible.  
 
Scheme 51 Hydrolysis of ester 233. 
In order to prevent the cyclization of the guanidines on the ester, ketone 235 was taken 
forward.  Treatment of ketone 235 with KOtBu in methanol led to the deprotection of both 
guanidines which spontaneously cyclized on the central ketone (verified by IR) giving products 
like 244 and 245 (Scheme 52).  Unfortunately, racemization was still a problem and no 






























Scheme 52 Cyclization of ketone 243. 
2.2.6 Differentiated guanidines 
To simplify the problems of cyclization as previously mentioned (Deprotection of 
Guanidines) it was thought that by differentiating the guanidines that the number of products 
could be reduced in half, possibly allowing some to be purified and characterized.  Also, the use 
of the Teoc protecting group instead of the methyl carbamate would allow neutral or slightly 
acidic deprotection conditions, which could prevent racemization (Scheme 54). The path towards 
differentiating the guanidines proved to be much more difficult than expected, but led to some 
interesting new discoveries.  
The most straightforward approach, starting from Mannich product 211, was to remove the 
Boc group and then install the first guanidine, followed by acid hydrolysis of the benzophenone 
imine and subsequent installation of the second guanidine (Scheme 53).  Thus, Mannich product 
211 was treated with TMSOTf and 2,6-lutidine to remove the Boc group and the crude material 
was guanidinylated with reagent 222, triethylamine and mercuric chloride to give guanidinylated 














































The hurdle and death of this route came unexpectedly from what was thought to be the 
simple removal of the benzophenone imine-protecting group.  When imine 246 was treated with 
the previously developed conditions (1M HCl/THF), only trace amine 247 was obtained.  
Treatment with various conditions all resulted in failure (Scheme 53).  
 
Scheme 53 Hydrolysis of benzophenone imine 246.  Conditions: 10% Pd/C or 20% Pd(OH)2, 
H2, MeOH EtOAc or THF; 2M citric acid, THF; hydroxylamine or hydrazine, MeOH. 
Nevertheless, the miniscule amount of amine 247 obtained was guanidinylated to give 
differentiated guanidine product 249.  Unfortunately, due to the low yielding step this 
methodology had to be abandoned and other routes were investigated. 
 
Scheme 54 Preparation of bisguanidine 249. 
It was thought that if the benzophenone imine could be reduced to amine 250 and the 
nitrogen was not too sterically hindered (unlikely!) that it could then be guanidinylated to 
compound 251 (Scheme 55).  Imine 246 was treated with sodium cyanoborohydride and acetic 
acid in methanol giving amine 250, which when submitted to guanidinylation conditions only 
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Scheme 55 Failed guanidinylation of amine 250. 
Since removing the benzophenone imine was not successful, an alternate sequence of 
reactions was necessary.  It was thought that removal of the benzophenone imine first followed 
by guanylation would be best.  Unfortunately, this would not be possible because the next step 
would require removal of the Boc group and the other Boc groups would interfere.  It was 
hypothesized that swapping the Boc group out for a Cbz group would fix this problem.  With 
large quantities of Mannich product 211 on hand, it was thought that the fast route to this 
compound was to just swap protecting groups.  Thus, Mannich product 211 was submitted to the 
previously developed deprotection conditions and the product was taken on crude (Scheme 56).  
The crude material was treated with CbzCl, and sodium carbonate in a biphasic mixture of 
CH2Cl2 and water.  Interestingly the results were not as expected.  The Cbz group and 
benzophenone imine was found to be on the opposite nitrogens.  The migration was due to the 
formation of intermediate aminal 253.  Since all previous reactions utilized diamine 217, this 
compound remained mischaracterized until now.   
This result required going back through all previous work to make sure that no other 
compounds were mischaracterized.  It turns out that all the previous compounds, except for 
hemiaminal 253, were characterized correctly.  Of particular interest is preparation of compound 







































regioselectivity when aminal 253 is treated with CbzCl versus when it is guanidinylated.  The 
fact that it shows 100% regioselectivity is even more baffling. 
 
Scheme 56 Regioselectivity of aminal 253. 
Cbz migration product 254 was unexpected, but still is just as useful as compound 212 
(Scheme 57).  When product 254 was treated with the previous developed imine deprotection 
conditions (1M HCl/THF) there was no reaction.  This was a bit worrisome at first, but when 
treated with 4M HCl the reaction was successful, giving the amine.  The requirement of a lower 
pH could be due to the increased steric environment surrounding the imine.  The amine was 
guanidinylated with reagent 222, using standard conditions, giving compound 255.  The Cbz 
group was easily removed over the benzyl ether by hydrogenation with 10% Pd/C at 1 atm 
hydrogen.  The resulting amine was guanidinylated to give differentiated guanidine 256.  Its 
worth mentioning now that when this reaction was first run there was an unknown impurity that 
looked strikingly similar to the product, but was discarded and wasn’t looked into.  The 
identification of this compound turned out to be an interesting discovery and will be discussed in 


































































Scheme 57 Preparation of bisguanidine 256. 
To make sure this sequence produced the correct product and to reduce the step count by 
1, Cbz Mannich 254 was submitted to the same sequence of reactions to get to the differentiated 
guanidine product.  When the NMRs of the two differentiated products were compared, they did 
not match as expected (Scheme 48).  This result meant another migration occurs somewhere else 
in the sequence.  There are only two possibilities of migration.  Either a Cbz group migrated or a 
guanidine migrated.  An intense NMR analysis of all the free amine intermediates led to the 
discovery of a guanidine migration.  This migration occurred after removal of the Cbz group 
from compound 258.  Upon further analysis of this reaction it actually was a 3:1 mixture of 
migration to no migration.  Further analysis of the Cbz deprotection of Cbz migration product 
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Scheme 58 Guanidine migration. 
This led to the idea that it might be possible to exploit this migration and differentiate the 
guanidines directly from diamine 217, that was previously prepared (Scheme 59).  Treatment of 
diamine 217 with one equivalent of guanidinylating reagent led to a 2:1 mixture of 246 and 261.  
This indicates that the migration only occurs due to the formation of a nucleophilic N-anion 
during the Cbz deprotection.  Only a trace amount of bisguanidinylated product was observed.  
Unfortunately, it was not possible to migrate the guanidines under the reaction conditions, 
slightly acidic or basic conditions.  This further supports the idea that the N-anion is required to 



































































Scheme 59 Selective guanidinylation 
With differentiated bisguanidine compound 256 in hand, the next known sequence of 
reactions were carried out as shown in Scheme 60.  Compound 256 was hydrogenated with 20% 
Pd(OH)2/C at 100 psi in THF/MeOH (5:1) to give lactol 262.  This lactol was then reduced to 
diol 263 with sodium borohydride.  
 
Scheme 60 Preparation of diol 263. 
The primary alcohol of diol 263 was TBS protected using TMSOTf and 2,6-lutidine in 
dichloromethane giving TBS ether 264.  Once protected the secondary alcohol was oxidized to 
ketone 265 with Dess-Martin periodinane (Scheme 61). 
 














































































































It was expected that differentiated guanidine product 265 would undergo the same side 
reactions as previously shown (Scheme 49).  Nevertheless with the differentiated guanidine 
product 268 in hand the deprotection and cyclization was attempted (Scheme 62).  The result, as 
expected, was the deprotection of the methyl carbamate with cyclization onto the ethyl ester, 
resulting in compound 268, which showed signs of racemization. 
 
Scheme 62 Undesired cyclization of guanidine. 
To prevent the unwanted cyclization it was thought that reducing the ester to the alcohol or 
forming the acid would allow the desired transformation (Scheme 63).  Reduction of lactol 262 
to triol 263 with sodium borohydride did not work as well as expected from previous results. 
However, enough material was generated to move forward.  Triol 263 was bis-TBS protected 
using TBSOTf and 2,6-lutidine to give compound 264.  Alcohol 264 was then converted to 
ketone 265 in good yield using the Dess-Martin oxidation.  When ketone 265 was treated with 















































could not be characterized by NMR.  It seems that the basic conditions led to racemization next 
to the ketone. 
 
Scheme 63 Unsuccessful guanidine cyclization. 
When ketone 265 was treated with LiOH in THF (Scheme 64), the ester was hydrolyzed, (as 
seen by NMR and mass spectrometry), but the product could not be fully characterized because it 
looks like the basic conditions also led to a complex mixture of diastereomers.   
 
Scheme 64 Hydrolysis of ester 265. 
After having several problems with basic deprotection conditions, the methyl carbamate 
group was abandoned.  The Teoc and Troc carbamates were the next logical choices because of 
























































































isothiourea 221 with Teoc-Cl or Troc-Cl and triethylamine in CH2Cl2.  The yield of this reaction 
was surprisingly low (~30%) and was optimized (>90%) by using saturated sodium bicarbonate 
instead of triethylamine as the base (Scheme 65).  
 
Scheme 65 Preparation of reagents 248 and 268. 
Troc-containing benzyl ether 269 was made using the same methodology that produced 
compound 249.  Unfortunately, the Troc group did not hold up to the hydrogenation required to 
remove the benzyl ether (Scheme 66).  
 
Scheme 66 Preparation of lactol 270. 
A model study was used to verify that the Teoc group could be removed in the presence of 
the ethyl ester (Scheme 67).  When compound 249 was treated with TBAF and AcOH in THF 
the Teoc group was successfully removed with no signs of cyclization.  
 











































































 After this result, benzyl ether 247 converted to ketone 276 using known methodology 
(Scheme 68).    
 
Scheme 68 Preparation of ketone 276. 
Unfortunately, the model study did not accurately portray the outcome of the deprotection of 
the advanced substrate.  When ketone 276 was treated with the same deprotection conditions 
(TBAF, AcOH in THF) the deprotected guanidine cyclized on the ester and also removed the 
TBS group (Scheme 69).  The result was probably lactol 277, which showed up as a mixture of 
diastereomers.  
 









































































































2.2.7 Late-Stage Guanidine installation 
Before it was known that the benzyl group could be removed by hydrogenation (2.2.3 
Debenzylation), a modified route that installed the guanidines later in the synthesis was 
attempted (Scheme 70).  The idea was to leave both nitrogens protected, until after the 
debenzylation and reduction of the lactol to diol 278.  The nitrogens would then be deprotected 
and guanidinylated. 
 
Scheme 70 Late stage guanidinylation retrosynthesis. 
The first approach was to hydrogenate Mannich product 211 to remove the benzyl ether and 
the benzophenone imine at the same time (Scheme 71).  Hydrogenation with 10% Pd/C was 
sluggish and led to a complex mixture of products at elevated pressure and temperature.  When 
compound 211 was dissolved in THF/H2O and treated with 20% Pd(OH)2/C at 80 PSI the 
reaction took 5 days, eventually  leading to a single product.  The temperature was raised to 
100ºC, which gave the same results in 21 hours.  Unfortunately, the product was not the lactol 
and free amine as expected.  The amine intermediate that formed cyclized on the lactol to give 
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Scheme 71 Unexpected bridged bicycle formation. 
It was thought that if the amine were protected with a withdrawing group, i.e. Boc, then the 
amine would no longer be nucleophilic enough to cyclize (Scheme 72).  This tactic worked very 
well, as when compound 283 was treated with the same hydrogenation conditions it led 
exclusively to lactol 284. 
 
Scheme 72 Hydrogenation of benzy ether 283. 
  Monitoring the reaction shown in Scheme 71 by TLC showed that the benzophenone imine 
fell off first in the reaction followed by benzyl group.  This led to the idea of trapping the amine 
in situ, preventing the cyclization and saving a couple steps (Scheme 73).  Since Boc anhydride 
is well known in literature to trap amines formed during hydrogenation it was the first reagent 
chosen.  This ended up working very nicely, as when Boc anhydride was added to the 




































Scheme 73 Boc protection/hydrogenation of compound 211.  
It looked like the little bit of bicycle 282 that formed the reaction was getting converted to 
the product.  It was thought that if a withdrawing group such as a Boc or a guanidine was 
attached to the secondary amine, it might allow the opening of the hemiaminal ether to the lactol 
(Scheme 74).  Unfortunately, the treatment of bicycle 282 with Boc anhydride at 100ºC led to no 
reaction.  Looking back, this reaction might have been successful if a stronger base was used 
under aqueous conditions.  The guanidinylation of bicycle 282 was successful, but when 
compound 287 was treated with 1M HCl to hydrolyze the hemiaminal ether, the guanidine was 
hydrolyzed instead. 
 
Scheme 74 Unsuccessful ring opening strategy of biycycle 282. 
Regardless, with lactol 285 in hand the next step was to reduce the lactol to the diol (Scheme 



























































sodium borohydride gave the triol exclusively.  Many different hydride reagents were screened 
to effect this transformation, but no conditions worked.  All the reactions using milder reagents 
resulted in the recovery of starting material.  Interestingly, super hydride (lithium 
triethylborohydride) reduced the ester over the lactol in low yield. 
 
Scheme 75 Reactions of lactol 285. 
To prevent the reduction of the ester group, 285 was hydrolyzed to carboxylic acid 291 
using LiOH and THF/H2O (Scheme 76).  The lactol was then reduced to the diol using either 
sodium borohydride or Super Hydride.  Super hydride was found to work better because no over-






















































Scheme 76 Failed reduction strategy of lactol 285. 
Even though the synthesis of the desired diol could not be achieved, triol 288 was taken 
forward in the synthesis (Scheme 77).  Both of the primary alcohols were protected by treatment 
with TBSCl, Et3N and DMAP in CH2Cl2 to give bis-TBS ether 294 in good yield.  The Boc 
groups were then removed by treating compound 294 with TMSOTf and 2,6-lutidine to give 
diamine 296.  Unfortunately the yield for this reaction was very low and would not be useful for 
a multistep synthesis.  The small amount of diamine 296 was then guanidinylated to give 
bisguanidine 298.  Initially, the oxidation of compound 298 was sluggish and required many 
equivalents of Dess-Martin periodinane to give ketone 300.  It was eventually noticed that the 
alcohol was protected as a TMS ether, which for some reason was stable.  This was easily 
removed by stirring in 1M HCl in THF.  After the alcohol was successfully deprotected the 
oxidation with Dess-Martin periodinane proceeded smoothly.  This alcohol was then oxidized to 
ketone 300 with Dess-Martin periodinane.  
The Boc deprotection seemed to be troublesome because of the labile TBS protecting 
groups.  It was thought that replacing them with the more robust TBDPS groups might solve this 







































Scheme 77 Preparation of ketone 300 and 301. 
The triol was also protected as triacetate or tripivoyl ester (302 and 303) and submitted to 
Ohfune’s conditions, but the reactions were very messy and no product was isolated (Scheme 
78).  The Boc deprotection of TBS-protected triol 288 was also attempted with the milder 
TBSOTf, but this reaction was not successful.   
 






























































Ac2O or PivCl, 


































The next series of Boc deprotections were carried out in the microwave (Scheme 79).  TBS 
ether 294 was dissolved in DMF or MeCN and heated at various temperatures (up to 200ºC) in 
the microwave resulting only in complex mixtures.   
 
Scheme 79 Failed thermal lysis of Boc groups. 
Pfizer developed some base-promoted Boc deprotections using KOtBu in THF/H2O and 
another group reported a similar reaction using cesium carbonate/methanol.60  When TBS-
protected triol 294 treated with cesium carbonate or KOtBu and microwaved in methanol, it led 
to a complex mixture of products.  However when triol 288 was microwaved under the same 
conditions it led to a single product (Scheme 80).  Compound 310 was guanidinylated and then 
TBS-protected to give TBS ether 311.  The MS gave a peak that corresponded to incorporation 
of one guanidine and the loss of a water molecule.  The NMR showed only one guanidine, but 
two t-butyl groups and no olefin protons.  The data indicated the presence of a tetrahydrofuran, 
but unfortunately, the data was not conclusive.  Mechanistically, to form tetrahydrofuran 310, the 
secondary alcohol would have to attack oxazolidinone 309 losing CO2.  This reaction is 
interesting, but not useful for this synthesis.  This does however show preferential deprotection 
of the Boc group with the primary alcohol.  If the secondary alcohol were protected, it should 



















Scheme 80 Unexpected rearrangement. 
Due to the stubbornness of the BOC deprotection, the most obvious solution is to avoid 
using the BOC groups all together.  This would require a new protecting group,  which has to 
meet two requirements.  First it must be stable to hydrogenation conditions and second it must be 
stable to sodium borohydride.  The first group tested was the Fmoc group (Scheme 81).  Amine 
312 was treated with Fmoc-OSu and sodium bicarbonate in THF/H2O giving carbamate 313.  
Unfortunately, the Fmoc group was not stable to any hydrogenation conditions.   
 
Scheme 81 Fmoc protecting group strategy.  Conditions: 20% Pd(OH)2/C, H2, MeOH;10% Pd/C, 
H2, MeOH; 10% Pd/C, H2, AcOH, THF 
Some more research into protecting groups led to the Teoc group, which should be stable to 
hydrogenation conditions as well as to sodium borohydride.  Teoc-Cl (317) was prepared from 
phosgene (316) and 2-(trimethylsilyl)ethanol (315) (Scheme 82). The Teoc-Cl was used 
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converted to the more stable Teoc-OSu (319), by treatment with N-hydroxysuccinimide (318), 
which worked well albeit with slightly longer reaction times.  
 
Scheme 82 Preparation of Teoc-Cl and Teoc-OSu. 
Amine 312 was treated with Teoc-Cl or Teoc-OSu to give carbamate 320, followed by   
hydrogenation over palladium hydroxide on charcoal to give lactol 321, which was subsequently 
reduced with sodium borohydride to give triol 322 (Scheme 83).  The next step in the synthesis is 
the removal of the Teoc group followed by guanidinylation of the amine.  The Teoc group on 
triol 322 was treated with various deprotection conditions, but unfortunately amine 323 was not 
isolated.   
 
 
Scheme 83 Unsuccessfull teoc protection strategy.  Conditions:  TBAF, MeOH or THF; HF, 
































































2.3 Reductive Amination Approach 
Using reductive amination to install an amine at the lactol of ribose was a goal that was 
attempted at many different times during the course of this project.  The idea was that the core of 
saxitoxin (165) could come from hemiaminal intermediate 324 or spirohemiaminal 325, which 
could be derived from amine 326 (Scheme 84).  This amine could be formed directly from a 
reductive amination on lactol 327. 
 
Scheme 84 Reductive amination approach. 
2.3.1 Oxazolidinone Formation 
Investigating the reduction of ester 320 and 328 put the reductive amination route in motion 
by the discovery of a useful product, which was completely overlooked at first (Scheme 85).  
When ester 328 was treated with super hydride (lithium triethylborohydride) alcohol 329 was 
formed along with a significantly more polar product (331).  Microwave irradiation of alcohol 
329 resulted in a single product, which matched the unidentified compound.  NMR and MS 
analysis revealed that the mystery compound is oxazolidinone 331, which forms by nucleophilic 
of the alcohol on the carbamate.  It was thought that by using a milder reducing agent that 




















































Scheme 85 Formation of oxazolidinone 331. 
Deprotection of benzyl ether was effected with palladium hydroxide on carbon in 
THF/MeOH giving an 88% yield of lactol 332 (Scheme 86).  
 
Scheme 86 Preparation of lactol 332. 
The isolation of oxazolidinone 331 led to the idea of using it in a route that utilizes reductive 
amination in the synthesis of saxitoxin analogs (Scheme 87). Reductive amination of lactol 332 
followed by installation of an S-methylpseudothiourea could give compound 333.  This 
pseudothiourea could then undergo an intramolecular guanidinylation to give 9-membered ring 
334, which is similar to an intermediate in Du Bois synthesis (see 1.4.3 Du Bois).  This 













































Scheme 87 Potential 9-member ring approach to saxitoxin. 
The synthesis of oxazolidinone 331 was optimized by taking Mannich product 211 and 
swapping out the benzophenone imine for a methyl carbamate to give compound 336 (Scheme 
88).  Compound 336 was reduced to the alcohol with lithium borohydride and crude mixture was 
refluxed in methanol with KOH to give oxazolidinone 331 in good yield.  
 
Scheme 88 Optimized preparation of oxazolidinone 331. 
2.3.2 Initial Reductive Amination Attempts 
Very early on in this project reductive amination reactions were tested on various 
substrates.  The first success was the reductive amination of ribose-2,3-acetonide (337) with 
dibenzylamine (Scheme 89).  This reaction initially failed over and over again until it was 
discovered that adding 3 eq. of acetic acid promoted the reaction, giving dibenzylamine 338.  





























































1.  LiBH4, MeOH







Scheme 89  First successful reductive amination. 
Later in the course of this project, numerous lactols were prepared and submitted to 
reductive amination conditions (Scheme 90).  Many different acids and amines were screened, 
but every time the outcome was recovered starting material.  Since forming oximes from the 
lactol was previously demonstrated on other substrates, a stepwise reductive amination was 
tested. 
 
Scheme 90 Failed reductive amination. 
2.3.3 Reductive Amination: A Stepwise Approach 
Lactol 332 was treated with hydroxylamine HCl and pyridine in methanol to give oxime 341 
(Scheme 91).  Treatment of the oxime with lithium borohydride failed to give amine 342.  
Catalytic hydrogenation of the oxime over 10% Pd/C also failed to give amine 342.  Several 
other hydride conditions as well as hydrogenation condition were tested, but none led to the 





























Scheme 91 Oxime reduction attempts. 
It was not until about a year later that a literature study revealed that Raney-Ni is commonly 
used to reduce oximes to amines.  Shocked that such obvious conditions were overlooked, oxime 
341 was hydrogenated over Raney-Ni, giving a low yield (~10-50%) of amine 342 (Scheme 92).  
The byproduct of the reaction was determined to be hemiaminal 343.  This reaction was 
extremely irreproducible and scale-up made the yields worthless.  Many different hydrogenation 
conditions were screened, but all of them were low yielding. 
 
Scheme 92 Reduction of oxime 341. 
2.3.4 Formation of the 9-Member Ring 
Amine 342 was treated with reagent 344 to give product 333, in excellent yield.  Isothiourea 
333 was then treated with standard guanidinylation conditions to give a clean product (347) in 
very high yield with a mass matching the desired compound.  Treatment of 347 with 

















































Scheme 93 Unknown cyclization of compound 333. 
 The failed Dess-Martin oxidation indicated that the carbodiimide intermediate might have 
cyclized on the secondary alcohol.  This was proven not to be the case by protecting alcohol 333 
with a TBS group before the cyclization (Scheme 94).  Isothiourea 345 was then cyclized and 
treated with TBAF, which resulted in the same mystery compound (347). 
 
Scheme 94 Formation of compound 347. 
Since the mass of the mystery compound matched desired compound 346 and the alcohol 
was not free it was hypothesized that the guanidinylation of the oxazolidinone activated it 
enough that it was electrophilic enough to get attacked by the alcohol, forming carbonate 347 
















































Scheme 95 Identity and formation of compound 347. 
To test this theory, the 347 was treated with potassium carbonate in methanol, which gave a 
single compound (Scheme 96).  This compound was treated with Dess-Martin in 
dichloromethane to give a mixture, which was determined, by NMR and mass spectrometry to be 
ketone 349 and hemiaminal 350. 
 
Scheme 96 Preparation of ketone 349 and hemiaminal 350. 
With this great result in hand, all that was left to get to the real system is swap out the Boc 
group for a guanidine and install the carbamoyl group (Scheme 97).  The Boc group was 
removed by treating oxazolidinone 331 with TMSOTf and 2,6-lutidine in CH2Cl2 to give amine 
351, which was guanidinylated with isothiourea 222.  This Boc deprotection was used for a long 
time until it was discovered that using TBSOTf instead, followed by fluoride workup, was much 
more scalable and higher yielding.  Guanidine-containing oxazolidinone 352 was converted to 


































































Scheme 97 Synthesis of amine 355. 
With amine 355 in hand, it was converted to the isothiourea 356 with reagent 344 and 
triethylamine in CH2Cl2 (Scheme 98).  It was thought that the carbonate formed after the 
cyclization could be opened with ammonia instead of methanol to install the carbamoyl group 
found in saxitoxin.  This turned out to work wonderfully, as when the cyclization reaction was 
complete it was quenched with concentrated ammonium hydroxide giving 9-member ring 357 in 
great yield, containing the required carbamoyl group.  
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2.3.5 Reductive Amination 
The stepwise reductive amination gave terrible yields and was difficult to reproduce, but 
proved that the route was viable.  Determined to improve the overall yield of 9-member ring 357, 
an intense study into using a “one pot” reductive amination ensued.  Since the oximes are so 
easily formed from the lactol, it was assumed that the problem with the reaction was not a steric 
problem, but a problem with the nucleophilicity of benzyl amines.  The only working example of 
reductive amination on a ribose-derived lactol required acetic acid to assist in opening the lactol 
to the aldehyde (Scheme 89).  Since acetic acid was the key ingredient, maximizing the acetic 
acid without destroying the hydride reagent became the immediate goal. 
Digging into the literature revealed that sodium cyanoborohydride is stable to pH 3.  To 
get a handle on how much AcOH is required to get a pH of around 3 it was decided to add 
bromocresol green to the reaction mixture.  Bromocresol green changes from blue to yellow at a 
pH of 3.8, which would indicate the maximum amount of acid possible to avoid destruction of 
the sodium cyanoborohydride.  Lactol 321 was the first substrate tested because there were 
several hundred milligrams already in hand.  To a mixture of lactol 321, benzyl amine (20 eq.) 
and sodium cyanoborohydride (10 eq.) and trace bromocresol green was added acetic acid until 
the solution turned bright yellow.  It turned out that it required 100 equivalents of AcOH to reach 
the desired pH!  At this pH it took 4 days for the starting material to be consumed, resulting in an 
inseparable mixture of two compounds (Scheme 99).  NMR data showed the loss of the ester 
peak and incorporation of the benzyl group.  Mass spectrometry indicated the formation of amide 
358 and 8-member ring amide 359.   
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Scheme 99 Unexpected products from reductive amination. 
Even though this result was not expected, it demonstrated that reductive amination is 
possible, just not in the presence of the ethyl ester.  Fortunately, lactol 353 contains no ethyl ester 
and should be a great substrate for this reaction.  When this reaction was tested on lactol 353 it 
was found that ~160 equivalents of AcOH were required to reach the desired pH.  Now that the 
proper pH was obtained the reaction went to completion after stirring overnight to give desired 
benzylamine 360 in >70% yield (Scheme 100).  It was later discovered that the reaction could be 
run at high very concentrations using AcOH as the solvent and only 3 equivalents of amine 
giving the desired benzyl amine in a couple of hours.  At this low pH the sodium 
cyanoborohydride decomposes slowly, but since the reaction is fast it lasts long enough to allow 
the reaction to go to completion.   
 
Scheme 100 Desired reductive amination product. 
With benzylamine 360 in hand, the previously described sequence was used to make 
9-member ring 362 (Scheme 101).  This proceeds smoothly but requires more time and has a 













































Scheme 101 Preparation of 9-member ring 362. 
The next step in the sequence was to remove the benzyl group and intercept the previously 
developed pathway (Scheme 102).  Unfortunately, all attempts to hydrogenate off the benzyl 
group failed.  In all cases, only starting material was recovered, even when hydrogenated with 
high pressure, high catalyst loading and long reaction times (>1 week). 
 
Scheme 102 Failed debenzylation of compound 162. Conditions:  Pd/C, Pd(OH)2C, or PdCl2; 
MeOH, EtOAc, THF or AcOH;  H2 100 psi; 25-100°C; with or without HCl. 
Since the benzyl group could not be removed from the 9-member ring, benzylamine 360 was 
hydrogenated to hopefully improve the yield of amine 355 (Scheme 103).  Unfortunately, the 
hydrogenation gave low yields, similar to the reduction of oxime 354 with Raney-Ni.  The 
problem with forming the free amine could be similar to the problem described previously where 
the amine can attack the other guanidine, giving migration products or, in this case, maybe it can 





































































Scheme 103 Hydrogenation of benzylamine 360. 
Since hydrogenation would not work at removing the benzyl group from the 9-member ring, 
it was thought that a 2,4-dimethoxybenzyl (Dmb) group might be easier to remove.  It could 
potentially be removed at the ketone stage by an oxidative cleavage (ceric ammonium nitrate 
(CAN) or 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ)) or maybe at the end of the synthesis 
with an acidic global deprotection.  This substrate was prepared in the same way as the benzyl 
ether-containing ring was.  Unfortunately, when ketone 366 was treated with boron 
trifluoroacetate in trifluoroacetic acid and worked up the same way as previously described, 
nothing was isolated.  
 









































































































Since the last step did not work the same as on the deprotected substrate, the removal of the 
Dmb group was attempted on multiple substrates along the way to see if the other pathway could 
be intersected.  Treatment of Dmb protected isothiourea 364 with DDQ gave no reaction and 
treatment with CAN was very messy (Scheme 105).  This is not surprising due to the ability of 
CAN to oxidize sulfur atoms. 
 
Scheme 105 Failed oxidative cleavage of Dmb. 
Since the Dmb group couldn’t be removed from the isothiourea, 9-member ring 365 was 
treated under the same conditions.  DDQ gave no reaction, but CAN reacted rapidly to give an 
inseparable mixture of two compounds that gave a single mass, which is suspected to be a 
mixture of E and Z isomers of compound 367 (Scheme 106).  Treatment of the mixture with 
various acidic conditions only returned starting material. 
 






























































To make sure the free alcohol wasn’t causing some sort of problem with the deprotection 
step, the deprotection was also attempted on ketone 366, giving suspected compound 368, which 
is similar to compound 367 (Scheme 107). 
 
Scheme 107 Oxidation of Dmb with CAN. 
The sequence of reactions previously described using Bn or Dmb amine was extended to 
PMB amine.  Reductive amination of lactol 353 with PMB amine, acetic acid and sodium 
cyanoborohydride in methanol gave benzyl amine 369 in a 62% yield (Scheme 108). 
 
Scheme 108 Reductive amination with PMB amine. 
With benzyl amine 369 in hand, it was treated with reagent 344 and triethylamine in 
dichloromethane to give compound 370 (Scheme 109).  With this compound in hand, treatment 
with mercuric chloride and triethylamine followed by addition of ammonia in water gave alcohol 























































Scheme 109 Synthetic route to ketone 373.  
Just like in the case with the Dmb group, PMB amine 373 was treated with CAN resulting in 
the oxidation, but not cleavage of the PMB group (Scheme 110). 
 
Scheme 110 CAN oxidation of PMB-protected guanidine. 
Since the removal of the Bn, PMB and Dmb group did not occur under acid or oxidative 
conditions, access to compound 357 was not possible.  Unfortunately, the only way to access this 
compound was by installing the amine through formation of an oxime and reduction with Raney 
nickel, which resulted in very low yields.   
It was thought that the o-nitrobenzyl (oNB) protecting group would be easier to remove 





























































































formation and subsequent hydrolysis of an iminium ion from the enamine.  Forming the iminium 
ion requires donation of electrons from the guanidine, which has been shown to be fairly difficult 
by Du Bois and other groups.  It is hypothesized that this step is what is preventing the cleavage.  
The photolysis mechanism of an o-nitrobenzyl (oNB) shows that iminium formation is bypassed, 
which could allow the cleavage to occur more readily.  Photolysis precursor 376 was prepared in 
3 steps from lactol 353.  
 
Scheme 111 Preparation of oNB protected 9-member ring. 
O-Nitrobenzylamine 376 was dissolved in wet THF, degassed with argon and submitted to 
UV radiation (Scheme 112).  After ~20 minutes of irradiation the oNB group was successfully 
cleaved giving compound 357, which matched all previously obtained data, thus bypassing the 
Raney-Ni reaction and allowing access to large quantities of hemiaminal 377.  
 










1. oNBNH2, AcOH, 
NaCNBH3 MeOH









































































The oxidation of alcohol 357 led to a mixture of ketone 378 and hemiaminal 377.  This is 
unlike in Du Bois’ saxitoxin synthesis, where the hemiaminal is the only product isolated.  This 
is more than likely due to the wrong stereochemistry.  The use of Spartan 10 software allowed 
the calculation of the energy differences between hemiaminal 377 and the epi-377, which has the 
correct stereochemistry.  The energy difference between the two epimers was calculated to be 10 
kcal/mol.  This energy difference is significant and indicates that if the epi-377 were synthesized 
then the hemiaminal should be the dominant form. 
 
Figure 8 Energy difference (Erel) between epimers 377 and 377B 
Since the Mbs group is fairly difficult to remove, alternative reagents to replace compound 
344 were sought.  Reagents 383 and 384 were prepared from dimethyl carbonimidodithioate 382 
by treatment with their respective chloroformate (Scheme 113).  Treatment of compound 382 
and 384 with sulfuryl chloride gave 385 and 386, respectively.  
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Scheme 113 Preparation of reagent 385 and 386. 
Boc-containing reagent 389 was thought to be the ideal substrate as Boc groups are very 
easy to remove from guanidines and it would not require an additional deprotection step.  
Unfortunately, all attempts to form the Boc adduct of compound 389 failed miserably (Scheme 
114).  Even with compound 382 in hand, no Boc protecting conditions gave any product.  Using 
phosgene to prepare t-butyl chloroformate, which is only stable at low temperatures, has not been 
tested. 
 
Scheme 114 Failed preparation of reagent 390. 
With reagent 386 in hand, the same the sequence was performed as previously described 
(Scheme 115).  The sequence worked about the same except the first acylation step was much 

















































Scheme 115 Preparation of 9-member ring 392. 
Another reagent screened was CbzNCS, which was prepared in one step by treating KSCN 
with CbzCl in a mixture of toluene and acetonitrile.61 Unfortunately, the yield of this reaction 
was very low.  Treatment of amine 390 with CbzNCS gave thiourea 393, which was then treated 
with mercury to form 9-membered ring 392 (Scheme 116), in low yield.  The acylation step was 
very fast and clean, but the cyclization proved to be more problematic.  The reaction when stirred 
with excess mercuric chloride and triethylamine would not go to completion even if left 
overnight.  Some product was isolated, but the main product seemed to be a mercury adduct of 
the starting material.  The NMR looked the same as the starting material, but upon standing 
overnight, a dark mercury precipitate formed in the NMR tube.  
 
Scheme 116 Alternate preparation of 9-member ring 392. 
O-Nitrobenzylamine 392 was deprotected by irradiation with UV to give compound 395, 
which was submitted to Dess-Martin periodinane (Scheme 117).  Unfortunately, this reaction 















































































Scheme 117 Failed oxidation of ketone 395. 
2.3.6 Isolation and Characterization of Polar Compounds 
It was at this time when the compounds became so polar that monitoring reactions and 
isolating compounds became a major hurdle, so this section is devoted to the methods used to 
overcome these problems.  The only solution to this problem was to learn how to run reverse 
phase column chromatography and HPLC.  At the time the only materials at hand were some 
C18 reverse-phase TLC plates and some C18 silica gel.  The outcomes of the reactions were 
inconclusive because of difficulties monitoring reactions by reverse-phase TLC and purifying by 
reverse-phase flash chromatography.  The lab had two HPLC systems, a HP 1050 (analytical) 
and a Waters 600E (semi-preparative).  Unfortunately, both machines were broken and had been 
sitting, covered with dust, in some cabinets for almost a decade.  Out of pure frustration, 
chemistry was put on hold and the machines were dusted off and set up on a previously cluttered 
lab bench.   
The HP 1050 had a broken multichannel gradient valve (MCGV), a leaky injector and 
system-wide clogs.  The lines were all individually purged one by one until the flow was 
consistent.  The leaky injector was found to contain a scratched rotor plate (from improper 
needles being used), which was easily replaced with a new part.  It was at this time that several 
dozen old, dried-out columns were individually flushed (forwards and backwards) and tested for 










































Since the MCGV was broken the HPLC required isocratic runs from premixed solvents.  After 
some time for getting the hang of HPLC separations, the MCGV was replaced and the machine 
was in tip-top working order.  
The Waters HPLC was a bit more troublesome.  Setting up the machine was not easy.  Since 
the machine lacked the data acquisition card, a computer could not be hooked up.  This meant 
that an IEEE cable could not be used to connect the different modules (controller, detector, pump 
and fraction collector).  All the connections had to be made via individual wire connections.  
After resorting to the user manuals many times the 20 or so the connections were finally made.  
Since the machine couldn’t be hooked up to a computer, the only way to view the chromatogram 
was on a tiny LCD display that was smaller and had less resolution than my Ti-89 graphing 
calculator.  Learning to operate the machine manually required the intense study of the user 
manuals.   
The machine functioned fairly well at first until the check valves started to get stuck.  To test 
the valves individually required graphing the pressure.  The broken pressure sensor and lack of a 
computer made this impossible.  After replacing the pressure sensor, a method to connect to a 
computer was required.  After obtaining a data acquisition (DAQ) card and building an OP AMP 
circuit to amplify the 0-10mV signal to the 0-1V range required for the DAQ card, it was finally 
possible to graph the pressure on a laptop (after learning how to do some basic programming in 
LabVIEW and DASYLab).  The problems with the check valves were sorted out and eventually 
fixed.  After the successful purification of a couple of compounds, the fraction collector broke 
down and the detector bulb burned out.  The detector bulb was replaced and the electronics 
specialist fixed the fraction collector.   
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 Using the HPLC resulted not only in the purification of some compounds, but the ability to 
monitor reactions by reverse-phase TLC because of the development of working solvent 
systems.  This newly learnt technique was extended to reverse-phase flash chromatography, 
which allowed crude reaction mixtures to be cleaned up in preparation for further purification by 
HPLC.  Unfortunately, in most cases what looked like one compound by TLC turned out to be 
several compounds by HPLC, so unless the reaction was very clean, HPLC had to be used for all 
reverse-phase separations.   
Now that the HPLCs were fixed it was possible to monitor reactions and to isolate 
compounds from the reactions in the following sections.  It is worth noting that many of the early 
attempts at these reactions probably failed simply due to the lack of reverse-phase purification 
techniques.  Even with these newly learnt techniques, the purification and characterization of 
these compounds is extremely difficult.  Proton NMR didn’t provide too much data, as there are 
relatively few protons to look at.  Carbon NMR spectra are also difficult to get because of very 
weak signals from the guanidine carbons.  To overcome these limitations, 2D NMR techniques 
were used.  Experiments such as gCOSY, HSQC, HMBS, and TOCSY were paramount in the 
structural determination of the polar compounds. 
2.3.7 Progress towards β-Hydroxysaxitoxinol 
Reductive amination has been the most fruitful route thus far towards the synthesis of 
saxitoxin analogs as it allowed the installation of the last nitrogen required on the backbone.  In 
order to synthesize hydroxysaxitoxinol, ketone 378 or hemiaminal 377 must be deprotected and 
cyclized under acidic conditions (Scheme 118).  The following sections will focus on these 
intermediates and their analogs.  
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Scheme 118 Potential conversion of compound 378, 373, or 366 to hydroxysaxitoxinol. 
Ketone 366 also has the potential to be deprotected and cyclized to hydroxysaxitoxinol (397) 
in a single step. Submitting compounds 378, 373, 366 to Du Bois’ conditions was a messy 
reaction and no compounds were isolated (Scheme 119).  
 
Scheme 119 Failed deprotection/cyclization of compound 378, 373, and 366. 
A stepwise approach was taken for this reaction.  Thus treating ketone 373 with 5 eq. of 
TFA in dichloromethane resulted mono in Boc deprotection, and cyclization to give hemiaminal 










































































Scheme 120 Mono-Boc deprotection. 
Compound 373 was treated with TsOH in MeOH and water to give hemiaminal 399 after a 
day (Scheme 121).  Upon stirring an additional two days, elimination product 400 was isolated. 
 
Scheme 121 Formation of [9,5]bicycle 400. 
Lewis acids were also tested on ketone 373.  Ketone 373 was treated with tin tetrachloride in 
MeCN, effectively cleaving the Boc groups, cyclizing to the hemiaminal and eliminating to 
enamine 401 (Scheme 122).  This compound is interesting as it is the only example where the 
acetonide has remained intact after a successful Boc deprotection, and elimination reaction. 
 

































































































Treatment of compound 373 with 6M HCl/MeOH and stirring for 3 days gave diol 402 as 
the major product (Scheme 123).  This reaction was fairly clean and the product was easy to 
purify. 
 
Scheme 123 Formation of bicycle 402. 
With enamine 402 in hand, treatment with acidic conditions should allow the transannular 
cyclization to hydroxysaxitoxinol (397) in a single step, as long as the PMB group is labile 
(Scheme 124).  This type of ring closure is very similar to Baran’s synthesis of palau’amine 
(405) except the amide is replaced with a guanidine.62  Unfortunately, this reaction was messy 





























Scheme 124 A. Barans’ Palau’amine ring contraction mechanism.  B. Ring contraction proposal 
for the synthesis of saxitoxin derivatives. 
To simplify this reaction, a method to make the same substrate minus the 
guanidine-protecting group was explored.  Enamine 408 was synthesized in the same manner as 
before by treating ketone 407 with 6M HCl/MeOH for 3 days (Scheme 125).  The o-nitrobenzyl 
protecting group was easily removed by exposure to UV radiation, giving deprotected enamine 
409.  
 
Scheme 125 Formation of compound 409. 
As the reactivity of ketone 407 was being explored, the analogous reactions were tested on 
















































































































β-hydroxysaxitoxinol (397).  All that is required to make β-hydroxysaxitoxinol (397) from 
hemiaminal 377 is a global deprotection, epimerization and dehydrative cyclization.  This could 
possibly be done in a single step, as all the protecting groups are acid labile and the cyclization is 
acid promoted.  A similar reaction was accomplished at Stanford in the Du Bois research group 
using a boron trifluoroacetate in trifluoroacetic acid (Scheme 126).32  Hemiaminal 377 submitted 
several times to Du Bois’ procedure, unfortunately the desired transformation was not successful.  
 
Scheme 126 Failed dehydrative cyclization. 
The complexity of this reaction is very apparent.  To successfully make this a one-pot 
reaction requires the deprotection of two Boc groups, an acetonide and an Mbs group followed 
by iminium ion formation, epimerization and cyclization.  To figure out this reaction, all the 
intermediates would have to be characterized in order to see the reaction progression.  In order to 
do this, a stepwise approach was taken.  Treating hemiaminal 377 with 5 eq. of TFA in CH2Cl2 
slowed the reaction down enough that one Boc group was removed (Scheme 127). 
 
























































Since tin tetrachloride is known to promote mild Boc deprotections of guanidines and as an 
oxophilic Lewis acid, it was tested on hemiaminal 377 (Scheme 128).63  It was thought that it 
would not only cleave the Boc groups but also promote iminium ion formation and cyclization.  
Unfortunately, when hemiaminal 377 was treated with tin tetrachloride only a messy reaction 
ensued and no products were isolated, although MS indicated some product was formed.  
 
Scheme 128 Failed tin tetrachloride promoted dehydrtive cyclization. 
Treatment of hemiaminal 377 with 6M HCl in MeOH gave a single product, which was 
shown by NMR and mass spectroscopy to be an enamine.  Unfortunately, when the enamine was 
treated with TFA, the desired aminal formation did not occur.  Instead the resulting product 
showed loss of water and still contained the enamine.  When the ketone 377 was treated with 
TFA instead of HCl it was not possible to isolate the enamine intermediate and only the 
dehydrated product was isolated.   
Characterization of these compounds was not easy as two pathways can be envisioned, both 
pathways giving compounds that would be indistinguishable by NMR and mass spectroscopy 
(Scheme 129).  In pathway A, the hemiaminal could undergo elimination to give enamine 412, 
which could eliminate water giving reactive intermediate 413.  This intermediate could undergo 
transannular attack by the guanidine to give tricycle 414.  In Pathway B, the external guanidine 






























undergo similar reactions to pathway A, giving intermediate 415, which could cyclize to tricycle 
416.  
 
Scheme 129 Proposed Pathways 
To determine which (414 or 416) was the product, it was necessary to go back and look at 
the same reactions on ketone 407 containing the o-nitrobenzyl protecting group on the guanidine 
(Scheme 130).  This protecting group would prevent the hemiaminal formation allowing only the 
formation of enamine 408.  Enamine 408 was deprotected and when compared to the previously 
made compound, it was a perfect match.  Compound 408 was then treated with TFA to give 417, 












































































































showing that it was indeed linear tricycle 416 and not fused tricycle 414.  This sequence of 
reactions prove that when the hemiaminal/ketone mixture is submitted to acidic conditions that 
the ketone state (or hemiaminal containing 5,9 ring system) is favored, as the only products 
formed are enamine 409 and linear tricycle 416.  
 
Scheme 130 Preparparation of linear tricycle 416 and 417. 
These results narrowed the focus down to hemiaminal/ketone mixture 377/378, as leaving 
the o-nitrobenzyl protecting group on after the 9-membered ring is formed serves no purpose.  
Since linear tricycle 416 is completely useless for this synthesis, methods to avoid this side 
reaction became the main focus.  To prevent the external guanidine from cyclizing on the ketone, 
the Boc protecting groups were changed to Cbz groups.  Starting with lactol 332, reductive 
amination with o-nitrobenzyl amine HCl, sodium cyanoborohydride, sodium acetate and acetic 
acid in methanol gave o-nitrobenzyl amine 418 (Scheme 131).  The o-nitrobenzylamine was then 
converted to the S-methylpseudothiourea with reagent 344 and triethylamine.  Surprisingly, this 




































































consequence because after treatment of the mixture with mercuric chloride and triethylamine, 
followed by ammonia, conversion to cyclic product 419 occurred in good yield. 
 
Scheme 131 Preparation of compound 419. 
The Boc group was removed from compound 419 to give the amine, which was submitted to 
standard guanidinylation conditions to give compound 421 (Scheme 132).  The guanidinylation 
step gave urea 422 as the major product.  This urea has not been observed in any other 
guanidinylation reactions thus far and it is not understood why this reaction is a special case.  
With compound 421 in hand, the o-nitrobenzyl group was removed by photolysis followed by 
oxidation of the alcohol with Dess-Martin periodinane to give desired ketone 423. 
 






























1.  Et3N, MeCN, 344































































Submitting ketone 423 to TFA gave no reaction (Scheme 133) and when treated with aq. 
HCl in methanol, the acetonide was removed after stirring overnight.   
 
Scheme 133 Failed ring contraction.  Conditions: TFA, no reaction; 6M HCl/MeOH, loss of 
acetonide 
Since TFA and aq. HCl conditions failed to give results, stronger acidic conditions were 
sought.  This led me back to the exploration of Du Bois’ conditions.  Treatment of ketone 423 
with a solution of B(TFA)3 in TFA for 20 hours gave a tremendous result.  These conditions 
resulted in the cleavage of the remaining Cbz and Mbs protecting groups in addition to 
cyclization to aminal 425.  Enamine 426 was also formed along with the aminal in a 3:1 mixture 
favoring the aminal. 
 
Scheme 134 Successful preparation of saxitoxin analog 425. 
This fantastic result led to the reinvestigation of Du Bois’ conditions on the bis-Boc 
protected substrate.  If the Cbz groups fall off under the reaction conditions, why does this 



































































promotes the formation of the hemiaminal and traps it, leaving only the [5,6]bicycle and none of 
the ketone.  This hypothesis indicated that the procedure used on ketone 378 has a major 
problem.  The ketone was first dissolved in TFA followed by the addition of B(TFA)3 in TFA.  
Since the Boc groups are so labile in TFA, they already are cleaved by the time the boron reagent 
is added.  The free guanidine is then able to form the undesirable hemiaminal, which was then 
trapped by the boron!  To remedy this problem a cold solution of B(TFA)3 in TFA was added 
directly to a chilled flask containing ketone 378.  This procedural change fixed the problem, as 
the reaction now showed no signs of tricycle 416 and resulted in a mixture of aminal 425 and 
enamine 426 in a 1.5:1 ratio, favoring the aminal (Scheme 135).   
 
Scheme 135 Preparation of 425  and 412. 
This reaction presumably proceeds by boron activation of the hemiaminal causing 
elimination of water giving the iminium ion.  The iminium ion then undergoes elimination giving 
the enamine or guanidine cyclization giving the aminal.  The question now is: What is the 
stereochemistry of the aminal?  Does the aminal arise from the guanidine cyclizing on the 
initially formed iminium ion or from an iminium ion formed from the tautomerization of the 
enamine?  If the enamine does tautomerize, this would effectively cause the desired 
epimerization of the stereocenter adjacent to the guanidine.  Fortunately, this can be tested by 










































reaction should go to completion leaving only the aminal.  Unfortunately, after running the 
reaction for 48 hours the only product isolated was tricycle 426 (Scheme 136).  This indicates 
that the absolute stereochemistry is as shown in Scheme 135.  This stereochemistry was also 
demonstrated through NOESY correlations.  Interestingly, this product arises from pathway A 
previously described in Scheme 129, but unlike linear tricycle 416, fused tricycle 414 is a single 
diastereomer.  The conformation of the formed stereocenter was confirmed by NOESY 
correlations as shown in Scheme 136. 
 
Scheme 136 Formation of unique fused tricycle 352. 
 Since this reaction shows that the aminal can eliminate, forming the enamine, which 
continues to react forming fused tricycle 414, does the enamine initially arise from the 
elimination of the aminal or the iminium ion and can the ratio of products be improved in favor 
of the aminal?  This idea was tested by letting the reaction stir at 5°C for 20 hours, not allowing 
the reaction to warm up.  This resulted in the same 1.5:1 mixture favoring the aminal, containing 
a small amount of products that were not fully deprotected.  This indicates that the rate of 
cyclization slightly favors the aminal.  When the reaction was allowed to stir for 48 hours at 5°C, 
a 1:1 mixture of aminal 425 and tricycle 414 was isolated (Scheme 137).  This indicates that at 
cold reaction temperatures, the aminal is fairly stable to elimination while the enamine is rapidly 

































Scheme 137 Alternative deprotection conditions. 
2.4 Synthetic Summary and Conclusion 
Presented below is the culmination of synthetic achievements described in this dissertation 
(Scheme 138).  The most advanced compound produced is 4,5-episaxitoxinol, which was 
prepared in 17 steps overall from D-ribose.  The synthesis highlights a Mannich type reaction to 
form the key carbon-carbon bond between a glycine building block and a D-ribose derivative.  
The orthogonal protecting group strategy allows complete control of the molecule, which could 
allow for the preparation of many different analogs.  Future work on this project would focus on 
fixing the stereochemistry formed by the Mannich reaction early on, which should allow for the 
















































1. oNBNH2, AcOH, 
NaCNBH3 MeOH




































































































































































Chapter 3: Experimental Section 
3.1 General Considerations 
Unless otherwise noted, materials were obtained from commercial sources and used without 
purification.  All reactions requiring anhydrous conditions were performed under positive 
pressure of argon using flame dried glassware.  Dichloromethane, diisopropylamine, 
triethylamine, tetrahydrofuran, dimethylformamide, diethyl ether, and toluene were degassed 
with argon and passed through a solvent purification system (J.C. Meyer of Glass Contour) 
containing either alumina or molecular sieves.  Flash chromatography was performed on Merck 
silica gel Kieselgel 60 (230-400 mesh) from EM science with the indicated solvent.   
 1H-NMR spectra were recorded on Varian, 300, 400, or 500 MHz spectrometers as 
indicated.  The chemical shifts (δ) of proton resonances are reported relative to CDCl3, 
DMSO-d5, D2O, CD3OD, and acetone-d6 using the following format: chemical shift 
[multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant(s) 
(J in Hz), integral].  13C-NMR spectra were recorded at 100 or 125 MHz.  The chemical shifts of 
carbon resonances are reported relative to the deuterated solvent peak, except D2O, which was 
internally referenced. 
Infrared spectra were recorded on a Bruker Tensor 27 FTIR spectrometer.  All absorptions 
are reported in cm-1. Spectra were recorded as films deposited from deuterated NMR solvent 
solutions on NaCl plates followed by solvent evaporation.  Peaks reported in the IR are described 
using the following conventions: w = weak, m = medium, s = strong, vs = very strong, sh = 
shoulder, and br = broad. 
 Mass spectra were obtained at the Colorado State University CIF on a Fisons VG 
Autospec.  Optical rotations were obtained with a 1mL, 1 dm cell on a Rudolf Research Autopol 
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III polarimeter operating at 589 nm in CHCl3.  HPLC separations were obtained on a Waters 
600E HPLC system using the indicated column and eluent conditions. 
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3.2 Experimental Procedures 
Compound 194:  tert-butyl ((R)-((3aS,4S,6R,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[3,
4-d][1,3]dioxol-4-yl)(phenylsulfonyl)methyl)carbamate. 
 
To a solution of aldehyde 201 (36.9 g, 1 eq.) in CH2Cl2 (1.3 L) was added t-butyl carbamate 
(18.3 g, 1.2 eq.), phenylsulfinic acid (28.3 g, 1.5 eq.), and magnesium sulfate (19 g).  This 
mixture was allowed to stir overnight and was filtered through glass wool.  The solution was 
then evaporated in vacuo and the product was crashed out with ether to give 42.4 g (62%) of 194 
as a white powder.  1H-NMR (400 MHz; CDCl3): δ  7.81 (s, J = 8.2, 1.4 Hz, 1H), 7.74 (d, J = 7.4 
Hz, 1H), 7.47 (d, J = 5.1 Hz, 2H), 7.40-7.23 (m, 6H), 7.03 (dd, J = 7.5, 1.9 Hz, 1H), 4.99 (s, 1H), 
4.88 (d, J = 5.9 Hz, 1H), 4.75 (d, J = 5.9 Hz, 1H), 4.53 (s, 1H), 4.44 (ddd, J = 11.6, 9.7, 1.9 Hz, 
1H), 4.11 (dq, J = 10.6, 10.0, 7.0 Hz, 1H), 4.06 (d, J = 13.3 Hz, 1H), 3.90 (dq, J = 10.7, 7.1 Hz, 
1H), 1.45 (s, 9H), 1.44 (s, 3H), 1.29 (s, 3H), 1.08 (t, J = 7.1 Hz, 3H). 13-C NMR (101 MHz; 
cdcl3): δ 170.2, 155.7, 137.0, 132.4, 130.0, 128.32, 128.23, 128.10, 127.9, 127.56, 127.49, 112.0, 
108.0, 86.3, 85.4, 81.9, 79.5, 69.5, 64.8, 61.1, 54.3, 28.2, 26.2, 24.6, 13.9. IR (Dep. CDCl3): 





































To a solution of LDA in dry THF at -78°C was added a glycine 207 in THF (-78°C) dropwise.  
The resulting yellow solution was stirred for 1 hour and amido sulfone 194 in THF (-78°C) was 
added dropwise.  The reaction was stirred 20 min. and then quenched with sat. NH4Cl and 
allowed to warm to rt.  The organic phase was seperated and washed with brine.  The aqueous 
phase was extracted 3x with EtOAc followed by brine.  The combined organic extracts were 
dried over sodium sulfate and evaporated.  The resulting oil was dissolved in hexanes and was 
evaporated.  This process was repeated until solids formed which were removed by filtration to 
give 211 as a white powder, which could be recrystallized from hexanes.  [!]!!"= -31 (c 0.38, 
CHCl3).  1H-NMR (400 MHz; CDCl3): δ  7.74 (d, J = 7.4 Hz, 1H), 7.49-7.26 (m, 11H), 7.03 (dd, 
J = 7.5, 1.9 Hz, 2H), 6.15 (s, 1H), 5.80 (d, J = 9.7 Hz, 1H), 4.99 (s, 1H), 4.88 (d, J = 6.0 Hz, 1H), 
4.75 (d, J = 5.9 Hz, 1H), 4.53 (s, 1H), 4.44 (ddd, J = 11.6, 9.7, 1.9 Hz, 1H), 4.10 (dq, J = 10.6, 
7.1 Hz, 1H), 4.09 (d, J = 12.0 Hz, 1H), 4.05 (d, J = 11.2 Hz, 1H), 4.03 (d, J = 11.6 Hz, 1H), 3.90 
(dq, J = 10.7, 7.1 Hz, 1H), 1.45 (s, 9H), 1.44 (s, 3H), 1.29 (s, 3H), 1.08 (t, J = 7.1 Hz, 3H). 13-C 
NMR (101 MHz; cdcl3): δ 170.4, 155.9, 137.2, 132.5, 130.2, 128.60, 128.51, 128.42, 128.28, 
128.07, 128.01, 127.81, 127.75, 127.67, 112.2, 108.2, 86.5, 85.5, 82.1, 79.7, 69.7, 65.0, 61.3, 
54.5, 28.4, 26.4, 24.8, 14.1. IR (Dep. CDCl3): 3428 (br), 2980 (vs), 2938 (vs), 1739 (vs), 1714 














































Compound 213:  (2R,3R)-ethyl 3-((3aR,4R,6R,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydro-furo
[3,4-d][1,3]dioxol-4-yl)-2-((diphenylmethylene)amino)-3-((methoxycarbonyl)amino)propanoate. 
 
Glycine 207 (420 mg, 2.5eq.) in THF (7.5 ml) was cooled to -78C and LDA (1.58mmol, 
2.5eq.) was added.  The resulting bright yellow solution was stirred for 30 mins and a solution of 
amido sulfone 204 (300mg, 1eq. in 2ml THF) at -78C was added dropwise. The reaction was 
allowed to stir at -78C until complete by TLC (~5min) and quenched with NaHCO3 (sat.).  The 
mixture was allowed to warm to room temp and was extracted 3x with ethyl acetate.  The 
organic layers were combined washed with NaCl (sat.) and dried over Na2SO4.  The solvents 
were removed in vacuo and the crude material was purified via flash chromatography (20% 
EtOAc/hexane) to give 213 as a white solid (314mg, 83%). 1H-NMR (500 MHz; CDCl3): δ  7.69 
(d, J = 7.5 Hz, 2H), 7.49-7.26 (m, 11H), 7.07 (d, J = 7.0 Hz, 2H), 6.05 (s, 1H), 5.01 (s, 1H), 4.91 
(d, J = 5.9 Hz, 1H), 4.75 (d, J = 5.9 Hz, 1H), 4.49 (s, 1H), 4.42 (t, J = 10.2 Hz, 1H), 4.16 (d, J = 
12.0 Hz, 1H), 4.07 (dq, J = 10.6, 7.1 Hz, 1H), 4.04 (d, J = 12.0 Hz, 1H), 3.97 (d, J = 11.4 Hz, 
1H), 3.92 (dq, J = 10.6, 7.1 Hz, 1H), 3.68 (s, 3H), 1.44 (s, 3H), 1.30 (s, 3H), 1.05 (t, J = 7.1 Hz, 
3H). 13C NMR (126 MHz; cdcl3): δ 170.03, 169.93, 157.0, 137.6, 137.0, 132.4, 130.0, 128.36, 
128.24, 128.20, 128.14, 127.9, 127.6, 112.1, 108.0, 86.4, 85.4, 82.0, 69.5, 64.6, 61.2, 54.9, 52.2, 
















































Compound 214:  ((3aR,4R,6R,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol
-4-yl)methanol. 
 
To a suspension of D-ribose (150 g) in benzyl alcohol (990 mL) and acetone (600 mL) was 
added sulfuric acid (12 mL) drop wise.  The mixture was heated to 70-75°C and was allowed to 
stir for 4-5 hours.  The reaction was allowed to cool to room temperature and was neutralized 
with Et3N.  The acetone was removed under vacuum and the solution was washed with H2O (3x).  
The benzyl alcohol was removed under high vacuum.  The product was crashed out with Et2O 
and the solids were washed with 20% EtOAc/hexanes to give 141.7 grams (50.6%) of an off 
white solid.   [!]!!"= -96 (c 0.44, CHCl3) 
1H-NMR (400 MHz; CDCl3): δ  7.38-7.30 (m, 5H), 
5.18 (s, 1H), 4.86 (d, J = 5.9 Hz, 1H), 4.77 (d, J = 11.6 Hz, 1H), 4.67 (d, J = 5.9 Hz, 1H), 4.58 
(d, J = 11.6 Hz, 1H), 4.45 (t, J = 2.9 Hz, 1H), 3.72 (dd, J = 12.5, 2.4 Hz, 1H), 3.63 (dd, J = 12.5, 
3.6 Hz, 1H), 3.11 (s, 1H), 1.48 (s, 3H), 1.32 (s, 3H). 13-C NMR (101 MHz; cdcl3): δ 136.5, 
128.8, 128.41, 128.35, 112.3, 108.2, 88.6, 86.1, 81.7, 70.3, 64.2, 26.5, 24.8 IR (Dep. CDCl3): 


























Compound 217:   (2R,3R)-ethyl 2,3-diamino-3-((3aR,4R,6R,6aR)-6-(benzyloxy)-2,2-dimethyltet
rahydrofuro[3,4-d][1,3]dioxol-4-yl)propanoate. 
 
Compound 211 (1000mg, 1eq.) was dissolved in CH2Cl2 (15.5mL) and 2,6-lutidine (723ul, 
4eq.) was added followed by TMSOTf (982uL, 3.5eq.).  The mixture was stirred until complete 
by TLC and quenched with NaHCO3 (sat.).  The mixture was extracted with EtOAc (3x) dried 
over Na2SO4, evaporated in vacuo and taken on crude.   
The product was dissolved in THF (5mL) and 1M HCl (5mL) was added.  The mixture was 
stirred for ~20 minutes until complete by TLC.  The mixture was washed with diethyl ether (3x) 
to remove the benzophenone and then the aqueous layer was basified with NaHCO3.  The 
mixture was extracted with n-butanol (5x) and the organic extracts were combined, dried over 
Na2SO4 and evaporated in vacuo to give diamine 217 (570mg, 96.6%), which was clean by 
NMR.  1H-NMR (300 MHz; CDCl3): δ  7.34-7.29 (m, 5H), 5.19 (s, 1H), 4.97 (dd, J = 6.0, 1.1 Hz, 
1H), 4.76 (d, J = 11.9 Hz, 1H), 4.71 (d, J = 6.0 Hz, 1H), 4.50 (d, J = 11.9 Hz, 1H), 4.14 (q, J = 
7.1 Hz, 2H), 4.07 (dd, J = 10.7, 1.2 Hz, 1H), 3.98 (d, J = 2.0 Hz, 1H), 3.20 (dd, J = 10.7, 2.0 Hz, 
1H), 1.49 (s, 3H), 1.33 (s, 3H), 1.17 (t, J = 7.1 Hz, 3H). Calcd for C19H29N2O6 [M+H]: 381.2026; 






































To a solution of diamine 217 (31mg, 1eq.) in DMF (3 ml) was added reagent 218 (58.1mg. 
1.1eq.), Hg2Cl2 (48.7mg,1.1eq.) and triethylamine (75ul, 3.3 eq.).  The mixture was stirred until 
complete by TLC and the mercury salts were crashed out with ethyl acetate.  The mixture was 
filtered and the filtrate was washed with H2O.  The organic layer was washed with NaCl (sat.), 
dried over Na2SO4 and solvents were removed in vacuo.  The crude material was purified via 
flash chromatography to give product 219 (58.7mg, 77%). [!]!!"= -55 (c 0.50, CHCl3).  
1H-NMR 
(500 MHz; CDCl3): δ  11.33 (s, 1H), 11.30 (s, 1H), 9.14 (d, J = 8.9 Hz, 1H), 8.85 (d, J = 9.3 Hz, 
1H), 7.37-7.27 (m, 12H), 7.19 (m, J = 3.0 Hz, 3H), 5.44 (d, J = 8.8 Hz, 1H), 5.20 (s, 1H), 
5.19-5.16 (m, 2H), 5.12 (d, J = 12.6 Hz, 1H), 5.02 (d, J = 12.5 Hz, 2H), 4.94 (d, J = 12.2 Hz, 
1H), 4.76 (d, J = 5.9 Hz, 1H), 4.71 (d, J = 5.9 Hz, 1H), 4.56 (d, J = 12.2 Hz, 1H), 4.20 (d, J = 
10.9 Hz, 1H), 4.05-4.01 (m, 1H), 4.97-4.00 (m, 1H), 1.50 (s, 9H), 1.48 (s, 9H), 1.43 (s, 3H), 1.27 
(s, 3H), 0.99 (t, J = 7.1 Hz, 3H).  13-C NMR (126 MHz; cdcl3): δ 170.3, 163.60, 163.54, 157.11, 
157.04, 152.80, 152.69, 137.4, 137.03, 136.85, 128.55, 128.53, 128.45, 128.12, 128.06, 127.90, 
127.86, 127.66, 112.9, 108.1, 85.9, 85.5, 83.9, 83.6, 82.0, 70.2, 67.39, 67.36, 62.3, 54.0, 53.5, 
28.1, 26.6, 25.2, 13.8. IR (Dep. CDCl3): 2978.92 (w),  2934.84 (w),  1722.38 (s), 1642.19 (vs), 


























































To a solution of diamine 217 (570mg, 1eq.) in DMF (15 ml) was added reagent 224 (1.12g, 
1.1eq.), Hg2Cl2 (1.22g,1.1eq.) and triethylamine (1.88mL, 3.3 eq.).  The mixture was stirred until 
complete by TLC and the mercury salts were crashed out with ethyl acetate.  The mixture was 
filtered and the filtrate was washed with H2O.  The organic layer was washed with NaCl (sat.), 
dried over Na2SO4 and solvents were removed in vacuo.  The crude material was purified via 
flash chromatography to give product 225 (844mg, 72%).  [!]!!"= -58 (c 0.53, CHCl3). 1H-NMR 
(500 MHz; CDCl3): δ  11.34 (s, 1H), 11.30 (s, 1H), 9.14 (d, J = 8.9 Hz, 1H), 8.85 (d, J = 9.7 Hz, 
1H), 7.40 (d, J = 7.2 Hz, 2H), 7.33 (t, J = 7.3 Hz, 2H), 7.28 (d, J = 7.2 Hz, 1H), 5.40 (dd, J = 8.9, 
2.1 Hz, 1H), 5.24 (s, 1H), 5.04 (td, J = 10.3, 1.6 Hz, 1H), 4.96 (d, J = 12.2 Hz, 1H), 4.77 (dd, J = 
6.0, 1.0 Hz, 1H), 4.73 (d, J = 6.0 Hz, 1H), 4.59 (d, J = 12.2 Hz, 1H), 4.21 (dd, J = 10.7, 1.1 Hz, 
1H), 4.14-4.04 (m, 2H), 3.76 (d, J = 5.7 Hz, 1H), 3.70 (s, 3H), 3.65 (s, 3H), 1.50 (s, 9H), 1.48 (s, 
9H), 1.46 (s, 3H), 1.29 (s, 3H), 1.13 (t, J = 7.2 Hz, 3H). 13-C NMR (126 MHz; cdcl3): δ 170.1, 
164.29, 164.21, 156.94, 156.88, 152.77, 152.67, 137.5, 128.5, 127.89, 127.73, 112.9, 108.1, 86.0, 
85.4, 83.8, 83.6, 81.9, 70.1, 62.3, 53.86, 53.81, 52.9, 28.1, 26.6, 25.3, 13.9. IR (Dep. CDCl3):  

























































Compound 226:   (2R,3R)-ethyl 2,3-bis(2-(tert-butoxycarbonyl)-3-(methoxycarbonyl)guanidino
)-3-((3aR,4R,6R,6aR)-6-hydroxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)propanoate. 
 
Benzyl ether 225 (540mg) was dissolved in 5:1 THF/MeOH (6mL) and 20% Pd(OH)2/C  
(270mg) was added.  Argon was bubbled through the suspension for 5 minutes and the mixture 
was hydrogenated at 100 psi hydrogen for 24 hours.  The mixture was then filtered, evaporated, 
and purified via flash chromatography (30% EtOAc/Hexane) to give 404 mg (84.6%) of lactol 
226. [!]!!"= -1 (c 0.54, CHCl3) 
1H-NMR (500 MHz; CDCl3): δ  11.51 (s, 1H), 11.37 (s, 1H), 
9.31 (d, J = 9.7 Hz, 1H), 8.97 (d, J = 9.0 Hz, 1H), 5.63 (s, 1H), 5.13 (dd, J = 8.9, 2.0 Hz, 1H), 
4.93 (ddd, J = 11.6, 9.6, 2.3 Hz, 1H), 4.89 (d, J = 6.0 Hz, 1H), 4.68 (d, J = 5.9 Hz, 1H), 4.41 (s, 
1H), 4.32 (q, J = 7.1 Hz, 2H), 4.12 (d, J = 11.4 Hz, 1H), 3.69 (s, 3H), 3.67 (s, 3H), 1.50 (s, 8H), 
1.49 (s, 8H), 1.45 (s, 4H), 1.35 (t, J = 7.1 Hz, 3H), 1.31 (s, 3H).  13-C NMR (126 MHz; cdcl3): δ 
169.3, 164.27, 164.11, 156.4, 155.5, 153.6, 152.5, 112.8, 104.0, 88.1, 85.6, 84.6, 83.7, 82.3, 62.6, 
55.7, 52.91, 52.77, 52.3, 28.2, 26.8, 25.5, 14.1  IR (Dep. CDCl3): 1724 (s), 1619 (m), 1440 (s), 

























































Compound 229:   (2R,3R)-ethyl 2,3-bis(2-(tert-butoxycarbonyl)-3-(methoxycarbonyl)guanidino
)-4-((4S,5S)-5-((methoxyimino)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-oxobutanoate. 
 
To a solution of lactol 226 in MeOH (5mL) was added Methoxyamine HCl (15.6mg, 2 eq.).  
The reaction was stirred overnight, diluted with EtOAc and washed with H2O (3x) followed by 
brine.  The organic layer was dried over Na2SO4 and evaporated in vacuo to give the oxime 
(45.5mg), which was taken on crude. 
To a solution of the crude oxime (45.5mg, 1 eq.) in CH2Cl2 (5 mL) was added Dess-Martin 
periodinane (40.2 mg, 1.5 eq.).  The solution turned cloudy over time and was allowed to stir for 
2 hours.  The reaction was quenched with 10% Na2S2O3 and was allowed to stir until the 
biphasic system turned clear.  The mixture was extracted with EtOAc (3x), dried over sodium 
sulfate and evaporated in vacuo to give crude ketone.  The crude material was purified via flash 
chromatography (20% EtOAc/Hexanes) to give ketone 229 (19.5mg, 29%).  1H-NMR (300 MHz; 
CDCl3): δ  11.23 (s, 1H), 11.09 (s, 1H), 9.14-9.11 (m, 2H), 7.20 (d, J = 7.3 Hz, 1H), 5.78 (dd, J = 
8.2, 1.6 Hz, 1H), 5.62 (dd, J = 7.3, 1.6 Hz, 1H), 5.40 (d, J = 7.8 Hz, 1H), 4.97 (t, J = 7.6 Hz, 1H), 
4.28 (dtt, J = 10.7, 7.1, 3.5 Hz, 2H), 3.78 (s, 3H), 3.78 (d, J = 5.9 Hz, 1H), 3.65 (s, 3H), 3.64 (s, 
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To a solution of diol 227 (240mg, 1 eq.) in CH2Cl2 (20 mL) was added 2,6-lutidine (242.2 
µL, 6 eq.).  The solution was cooled to -78°C and TBSOTf  (387.8 µL, 5 eq.) was added.  The 
reaction was stirred until complete by TLC and was quenched with sat. NH4Cl.  The mixture 
was extracted with ethyl acetate (3x), dried over sodium sulfate and evaporated in vacuo.  The 
crude compound was purified via column chromatography to give TBS ether 232 (230 mg, 
82.3%).  1H-NMR (500 MHz; CDCl3): δ  11.32 (s, 1H), 11.18 (s, 1H), 8.91 (d, J = 7.3 Hz, 1H), 
8.80 (d, J = 6.1 Hz, 1H), 5.17 (t, J = 7.5 Hz, 1H), 4.82 (dd, J = 8.5, 7.0 Hz, 1H), 4.73 (q, J = 7.0 
Hz, 1H), 4.64 (dd, J = 8.8, 6.3 Hz, 1H), 4.33-4.22 (m, 2H), 3.95 (dd, J = 10.7, 2.6 Hz, 1H), 3.85 
(dd, J = 11.7, 5.0 Hz, 1H), 3.80-3.78 (m, 1H), 3.65 (s, 6H), 1.49 (s, 6H), 1.48 (s, 5H), 1.46 (t, J = 
9.3 Hz, 3H), 1.37 (s, 3H), 1.32 (s, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 13-C NMR (126 
MHz; cdcl3): δ 171.6, 163.7, 163.5, 155.9, 155.6, 152.9, 152.7, 108.9, 83.98, 83.94, 78.1, 76.7, 
61.5, 56.7, 54.6, 52.75, 52.66, 28.12, 28.06, 27.3, 26.00, 25.94, 25.2, 18.4, -5.2.  HRMS (FAB+): 






























































To a solution of compound 232 (49 mg, 1 eq.) in CH2Cl2 (5 mL) was added Dess-Martin 
periodinane (51.5 mg, 2 eq.).  The solution turned cloudy over time and was allowed to stir for 2 
hours.  The reaction was quenched with Na2S2O3 and was allowed to stir until the biphasic 
system turned clear.  The mixture was extracted with EtOAc (3x), dried over sodium sulfate and 
evaporated in vacuo to give ketone 233 (47 mg, 96.2%). 1H-NMR (500 MHz; CDCl3): δ  11.24 
(s, 1H), 11.10 (s, 1H), 9.24 (d, J = 5.0 Hz, 1H), 9.00 (d, J = 6.5 Hz, 1H), 5.77 (d, J = 7.2 Hz, 1H), 
5.72 (d, J = 8.0 Hz, 1H), 5.24 (d, J = 8.6 Hz, 1H), 4.46 (d, J = 8.6 Hz, 1H), 4.38-4.31 (m, 1H), 
4.27-4.20 (m, 1H), 3.72 (dd, J = 11.7, 2.1 Hz, 1H), 3.67 (dd, J = 11.7, 2.1 Hz, 1H), 3.63 (s, 3H), 
3.62 (s, 3H), 1.47 (s, 9H), 1.47 (s, 9H), 1.43 (s, 3H), 1.41 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H), 0.76 
(s, 9H), -0.00 (s, 3H), -0.01 (s, 3H).  13-C NMR (126 MHz; cdcl3): δ 203.7, 169.5, 164.2, 163.7, 
156.0, 155.7, 152.39, 152.36, 110.0, 83.6, 83.2, 79.78, 79.71, 62.4, 61.5, 59.7, 53.2, 52.6, 52.3, 
28.34, 28.31, 28.1, 26.5, 25.82, 25.78, 24.6, 18.8, 13.9, -5.1, -5.8 HRMS (FAB+): Calcd for 






























































To a solution of triol 231 (79 mg, 1 eq.) in CH2Cl2 (10 mL) was added 2,6-lutidine (169.7 
µL, 12 eq.).  The solution was cooled to -78°C and TBSOTf  (278.8 µL, 10 eq.) was added.  The 
reaction was stirred until complete by TLC, quenched with sat. NH4Cl, and the product was 
extracted with EtOAc (3x).  The mixture was dried over sodium sulfate, evaporated in vacuo and 
purified via flash chromatography (10-20% EtoAc/hexanes) to give TBS ether 234.  1H-NMR 
(500 MHz; CDCl3): δ  11.38 (s, 1H), 11.29 (s, 1H), 9.06 (d, J = 8.1 Hz, 1H), 8.75 (d, J = 9.4 Hz, 
1H), 5.69 (d, J = 5.1 Hz, 1H), 4.63 (ddd, J = 9.6, 7.5, 2.3 Hz, 1H), 4.55 (dtd, J = 8.2, 5.5, 2.5 Hz, 
1H), 4.32 (dd, J = 9.3, 5.8 Hz, 1H), 4.22 (q, J = 5.4 Hz, 1H), 3.89 (dd, J = 10.4, 5.5 Hz, 1H), 3.85 
(dd, J = 10.7, 5.5 Hz, 1H), 3.82 (dd, J = 10.1, 6.0 Hz, 1H), 3.67 (s, 3H), 3.67 (dd, 1H), 3.66 (s, 
3H), 1.47 (s, 9H), 1.45 (s, 9H), 1.33 (s, 3H), 1.21 (s, 3H), 0.88 (s, 9H), 0.87 (s, 9H), 0.06 (s, 3H), 
0.06 (s, 3H), 0.05 (s, 3H), 0.05 (s, 3H). 13-C NMR (126 MHz; cdcl3): δ 164.5, 163.9, 157.2, 
157.0, 152.52, 152.44, 108.8, 83.4, 82.9, 78.9, 78.2, 69.3, 63.8, 62.5, 55.9, 52.65, 52.56, 52.0, 



























































To a solution of compound 234 (0.138 mmol crude) in CH2Cl2 (10 mL) was added 
Dess-Martin periodinane (117.3 mg, 2 eq.).  The solution turned cloudy over time and was 
allowed to stir for 2 hours.  The reaction was quenched with Na2S2O3 and was allowed to stir 
until the biphasic system turned clear.  The mixture was extracted with EtOAc (3x), dried over 
sodium sulfate and evaporated in vacuo to give ketone 235 (75mg, 61.8% (2 steps)).  1H-NMR 
(500 MHz; CDCl3): δ  11.38 (s, 1H), 11.22 (s, 1H), 9.23 (d, J = 3.2 Hz, 1H), 8.88 (d, J = 8.7 Hz, 
1H), 5.55 (dd, J = 8.2, 1.9 Hz, 1H), 5.15 (d, J = 8.2 Hz, 1H), 5.03 (dtd, J = 8.7, 4.3, 1.7 Hz, 1H), 
4.39 (ddd, J = 8.1, 3.7, 2.9 Hz, 1H), 3.97 (dd, J = 10.4, 4.1 Hz, 1H), 3.83 (dd, J = 10.4, 4.9 Hz, 
1H), 3.75 (d, J = 11.4 Hz, 1H), 3.67 (s, 3H), 3.65 (s, 1H), 3.65 (s, 3H), 1.59 (s, 3H), 1.48 (s, 9H), 
1.47 (s, 9H), 1.43 (s, 3H), 0.84 (s, 9H), 0.78 (s, 9H), 0.02 (s, 3H), -0.01 (s, 3H), -0.01 (s, 
3H), -0.02 (s, 3H). 13-C NMR (126 MHz; cdcl3): δ 204.6, 164.2, 163.9, 156.4, 155.9, 152.3, 
109.8, 83.0, 79.6, 79.3, 77.2, 63.3, 61.7, 58.6, 52.49, 52.39, 52.26, 28.2, 27.91, 27.89, 26.8, 




























































To a solution of Mannich product 211 (275 mg, 1eq.) in CH2Cl2 (5 mL) was added 
2,6-lutidine (199 µL, 4 eq.) and TMSOTf (270 µL, 3.5eq.).  The solution was stirred until 
complete by TLC and was quenched with sat. sodium bicarbonate.  The mixture was extracted 
with ethyl acetate (3x), dried over sodium sulfate and evaporated.  Crude aminal 253 (0.427 
mmol crude) was dissolved in DMF and guanylating reagent 222 (185.8 mg, 1.5 eq.), and Et3N 
(267.5 µL, 4.5 eq.) was added.  After cooling the solution to 0°C, mercuric chloride (173.7 mg, 
1.5 eq.) was added and the mixture was stirred until complete by TLC.  The reaction was 
quenched by adding sat. sodium bicarbonate, sat. sodium chloride and ethyl acetate.  After 
stirring the mixture for 20 minutes the reaction was filtered through celite to remove all the 
mercury salts.  The biphasic solution was separated and the organic layer was washed with H2O 
(3x), brine and then dried over sodium sulfate and evaporated in vacuo.  The crude material was 
purified via column chromatography (10-20% EtOAc/hexanes) to give compound 246 (295 mg, 
87.9% over 2 steps). [!]!!"= -5 (c 0.42, CHCl3)  
1H-NMR (500 MHz; CDCl3): δ  11.46 (s, 1H), 
9.76 (d, J = 7.5 Hz, 1H), 7.79 (dd, J = 8.4, 1.2 Hz, 2H), 7.44-7.38 (m, 4H), 7.32-7.23 (m, 7H), 
7.09-7.07 (m, 2H), 5.11 (dd, J = 7.4, 0.9 Hz, 1H), 5.11 (s, 1H), 4.74 (d, J = 12.2 Hz, 1H), 4.64 (d, 
J = 10.7 Hz, 1H), 4.63 (d, J = 6.5 Hz, 1H), 4.50 (d, J = 5.9 Hz, 1H), 4.37 (d, J = 12.2 Hz, 1H), 
4.16 (dd, J = 9.9, 1.0 Hz, 1H), 4.07 (dq, J = 10.7, 7.1 Hz, 1H), 3.47 (dq, J = 10.7, 7.1 Hz, 1H), 























1.  TMSOTf, 2,6-lutidine
2.  HgCl2, Et3N, DMF
     88%
222211 246
 137 
MHz; cdcl3): δ 171.2, 170.7, 163.4, 156.9, 152.9, 139.2, 137.7, 135.9, 130.8, 129.7, 128.8, 
128.5, 128.3, 128.05, 128.03, 127.52, 127.45, 112.4, 108.4, 86.4, 85.6, 82.9, 81.7, 78.9, 69.7, 
63.2, 61.0, 55.7, 28.48, 28.33, 26.6, 25.2, 13.9. IR (Dep. CDCl3): 3307 (br), 2978 (s), 2939 (s), 





























Compound 250:   (2R,3R)-ethyl 2-(benzhydrylamino)-3-((3aR,4R,6R,6aR)-6-(benzyloxy)-2,2-di
methyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-3-((tert-butoxycarbonyl)amino)propanoate. 
 
To a solution of imine 211 (100mg, 1 eq.) in methanol (5 mL) was added acetic acid (44.4 
µL, 5 eq.) and sodium cyanoborohydride (97.5 mg, 10 eq.).  The mixture was stirred until 
complete by TLC and was diluted with ethyl acetate.  The mixture was washed with H2O (3x), 
brine, dried over sodium sulfate and evaporated in vacuo to give amine 250 (91.8 mg, 91.5%). 
[!]!!"= -79 (c 0.52, CHCl3)  
1H-NMR (500 MHz; CDCl3): δ  7.40 (d, J = 7.2 Hz, 3H), 7.33 (dd, J 
= 14.3, 7.3 Hz, 4H), 7.26 (dd, J = 19.1, 8.8 Hz, 6H), 7.12 (d, J = 7.3 Hz, 2H), 5.08 (s, 1H), 4.99 
(s, 1H), 4.90 (d, J = 10.4 Hz, 1H), 4.79 (d, J = 6.0 Hz, 1H), 4.75 (d, J = 5.9 Hz, 1H), 4.42 (d, J = 
12.2 Hz, 1H), 4.27 (d, J = 11.4 Hz, 1H), 4.22 (d, J = 12.2 Hz, 1H), 4.15 (t, J = 10.9 Hz, 1H), 4.15 
(t, J = 7.1 Hz, 3H), 4.04 (dq, J = 10.6, 7.2 Hz, 1H), 3.87 (dq, J = 10.6, 7.1 Hz, 1H), 3.69 (d, J = 
1.8 Hz, 1H), 2.65 (s, 1H), 1.51 (s, 3H), 1.40 (s, 9H), 1.32 (s, 3H). 13-C NMR (126 MHz; cdcl3): 
δ 173.6, 155.4, 143.7, 142.8, 137.3, 128.7, 128.41, 128.34, 127.97, 127.93, 127.7, 127.5, 127.2, 
112.4, 107.8, 86.2, 85.7, 82.5, 79.9, 69.7, 65.9, 61.5, 57.9, 55.1, 28.3, 26.6, 25.1, 14.0.  IR (Dep. 



















































To a solution of aminal 253 (7.75 mmol, 1 eq.) and sodium carbonate (1.64 g, 2 eq.) in 
CH2Cl2 (50 mL) and H2O (50 mL) at 0°C was added CbzCl (4.85 g, 30-35% in toluene, 1.1 eq.).  
The mixture was stirred until complete by TLC and the organic layer was separated.  The 
aqueous layer was extracted with CH2Cl2 (3x) and the combined extracts were dried over sodium 
sulfate and evaporated in vacuo.  The crude material was purified via column chromatography 
(10-30% EtOAc/hexanes) to give product 254 (4.45 g, 84.6% over 2 steps).  [!]!!"= -82 (c 0.22, 
CHCl3).  1H-NMR (500 MHz; CDCl3): δ  7.60 (d, J = 7.4 Hz, 2H), 7.45-7.23 (m, 10H), 7.05 (dd, 
J = 7.3, 1.6 Hz, 3H), 6.15 (d, J = 9.3 Hz, 1H), 5.17 (s, 2H), 5.13 (s, 1H), 4.90 (dd, J = 9.4, 1.4 
Hz, 1H), 4.68 (d, J = 12.3 Hz, 1H), 4.63 (d, J = 10.2 Hz, 1H), 4.56 (d, J = 6.0 Hz, 1H), 4.45 (d, J 
= 5.9 Hz, 1H), 4.36 (d, J = 12.3 Hz, 1H), 4.16 (dd, J = 10.2, 1.4 Hz, 1H), 4.11 (dq, J = 10.7, 7.2 
Hz, 1H), 3.61 (dq, J = 10.7, 7.2 Hz, 1H), 1.47 (s, 3H), 1.26 (s, 3H), 0.85 (t, J = 7.1 Hz, 3H). 13-C 
NMR (126 MHz; cdcl3): δ 171.6, 171.3, 156.6, 139.0, 137.4, 136.3, 135.8, 130.8, 129.1, 128.8, 
128.51, 128.47, 128.31, 128.12, 128.05, 127.7, 127.33, 127.20, 112.3, 108.0, 86.0, 85.4, 81.3, 
77.2, 69.3, 67.1, 63.5, 61.1, 55.6, 26.4, 25.0, 13.7 IR (Dep. CDCl3): 3266 (br), 1727 (s), 1496 (s), 




















































To a solution of compound 254 (100 mg) in THF (5mL) was added 5M HCl (2 mL).  The 
mixture was stirred until complete by TLC and was quenched with NaHCO3.  The mixture was 
extracted with EtOAc (3x), dried over sodium sulfate and evaporated in vacuo.  The crude amine 
(0.147 mmol) was dissolved in DMF and reagent 222 (51.3 mg, 1.2 eq.), and Et3N (92.4 µL, 4.5 
eq.) was added.  After cooling the solution to 0°C, HgCl2 (48 mg, 1.2 eq.) was added and the 
mixture was stirred at r.t. until complete by TLC.  The reaction was quenched by adding sat. 
NaHCO3, sat. sodium chloride and EtOAc.  After stirring the mixture for 20 minutes the reaction 
was filtered through celite to remove all the mercury salts.  The biphasic solution was separated 
and the organic layer was washed with H2O (3x), brine and then dried over sodium sulfate and 
evaporated in vacuo.  The crude material was purified via column chromatography (10-20% 
EtOAc/hexanes) to give compound 255 (65 mg, 58.2% over 2 steps). [!]!!"= -96 (c 0.54, CHCl3).  
1H-NMR (500 MHz; CDCl3): δ  11.36 (s, 1H), 8.44 (d, J = 9.3 Hz, 1H), 7.40-7.26 (m, 10H), 5.94 
(d, J = 6.7 Hz, 1H), 5.28 (s, 1H), 5.22 (d, J = 12.2 Hz, 1H), 5.10 (d, J = 12.2 Hz, 1H), 4.97 (t, J = 
9.3 Hz, 2H), 4.78 (d, J = 6.0 Hz, 1H), 4.75 (dd, J = 9.4, 2.0 Hz, 1H), 4.73 (d, J = 6.0 Hz, 1H), 
4.61 (d, J = 11.9 Hz, 1H), 4.27 (d, J = 11.4 Hz, 1H), 4.11-4.02 (m, 2H), 4.11-4.02 (m, 2H), 1.50 
(s, 9H), 1.47 (s, 3H), 1.11 (t, J = 7.1 Hz, 3H). 13-C NMR (126 MHz; cdcl3): δ 171.1, 163.1, 
156.7, 156.2, 153.1, 137.4, 136.4, 128.62, 128.52, 128.36, 128.27, 127.87, 127.81, 112.8, 108.5, 
85.6, 85.2, 83.9, 82.2, 79.4, 70.2, 67.5, 62.1, 54.5, 54.1, 28.34, 28.23, 26.6, 25.2, 14.1. IR (Dep. 










1.  1M HCl/THF
2. HgCl2, Et3N, DMF










































To a solution of benzyl ether 256 (525 mg) in 5:1 THF/methanol (6mL) was added 20% 
Pd(OH)2/C (262.50 mg).  Argon was bubbled through the resulting suspension and then it was 
hydrogenated at 100 psi for 22 hours.  The mixture was filtered evaporated and purified via flash 
chromatography to give 436 mg (93.3%) of lactol 262. 1H-NMR (500 MHz; CDCl3): δ  11.48 (s, 
1H), 11.44 (s, 1H), 9.16 (d, J = 9.4 Hz, 1H), 8.99 (d, J = 8.9 Hz, 1H), 5.61 (s, 1H), 5.13 (dd, J = 
8.9, 2.6 Hz, 1H), 4.91 (dd, J = 5.9, 1.0 Hz, 1H), 4.85 (ddd, J = 11.4, 9.3, 2.3 Hz, 1H), 4.68 (d, J = 
5.9 Hz, 1H), 4.31 (q, J = 7.1 Hz, 2H), 4.12 (dd, J = 11.2, 1.0 Hz, 1H), 3.68 (t, J = 8.2 Hz, 1H), 
3.68 (s, 3H), 1.50 (s, 9H), 1.49 (s, 9H), 1.47 (s, 9H), 1.45 (s, 3H), 1.34 (t, J = 7.1 Hz, 3H), 1.31 
(s, 3H). 13-C NMR (126 MHz; cdcl3): δ 169.5, 164.1, 163.4, 156.1, 155.7, 153.4, 152.7, 112.7, 

























































Compound 282:   (3aR,4R,6R,7R,8S,8aR)-ethyl 7-((tert-butoxycarbonyl)amino)-2,2-dimethylhe
xahydro-3aH-4,8-epoxy[1,3]dioxolo[4,5-c]azepine-6-carboxylate. 
 
To a solution of benzyl ether 211 (50 mg) in 10:1 THF/water (2mL) was added 20% 
Pd(OH)2/C (25 mg).  Argon was bubbled through the resulting suspension and then it was 
hydrogenated at 80 psi for 45 min.  The mixture was filtered evaporated and purified via flash 
chromatography (30-35% EtOAc/hexanes) to give 22 mg (76.2%) of hemiaminal 282. 
1H-NMR (400 MHz; CDCl3): δ  5.40 (d, J = 7.5 Hz, 1H), 4.92 (s, 1H), 4.74 (d, J = 5.7 Hz, 
1H), 4.73 (d, J = 5.7 Hz, 1H), 4.24 (d, J = 2.0 Hz, 1H), 4.18 (dt, J = 10.4, 7.2 Hz, 1H), 4.10 (dt, J 
= 10.6, 7.2 Hz, 1H), 3.89 (d, J = 9.5 Hz, 1H), 3.61 (d, J = 2.9 Hz, 1H), 1.46 (s, 3H), 1.40 (s, 9H), 
1.33 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H).  13-C NMR (101 MHz; CDCl3): δ 169.7, 155.0, 112.7, 






































To a solution of benzyl ether 211 (100 mg, 1 eq.) and Boc2O (169.3mg, 5 eq) in 10:1 
THF/water (5mL) was added 20% Pd(OH)2/C (50 mg).  Argon was bubbled through the 
resulting suspension and then it was hydrogenated at 80 psi at 100°C for 19 hours.  The mixture 
was filtered evaporated and purified via flash chromatography (20-30% EtOAc/hexanes) to give 
64mg (84.2%) of lactol 285.  1H-NMR (400 MHz; CDCl3): δ  5.53 (s, 1H), 5.38 (s, 1H), 4.95 (s, 
1H), 4.76 (d, J = 5.9 Hz, 1H), 4.68 (d, J = 5.9 Hz, 1H), 4.32 (t, J = 10.7 Hz, 1H), 4.22-4.13 (m, 
2H), 3.95 (d, J = 11.3 Hz, 1H), 3.58 (s, 1H), 1.46 (s, 3H), 1.44 (s, 9H), 1.41 (s, 9H), 1.30 (s, 3H), 






































To a solution if alcohol 288 in CH2Cl2 (2 mL) was added Et3N (24.7 µL, 8 eq.) and 
TBDPSCl (34 µL, 6 eq.).  The reaction was stirred overnight and evaporated in vacuo.  The 
crude mixture was purified via PTLC (20% EtOAc/Hexane) to give 13.6 mg (66.1%) of TBS 
ether 295.  1H-NMR (500 MHz; CDCl3): δ  7.70-7.65 (m, 8H), 7.43-7.35 (m, 12H), 5.16 (d, J = 
7.9 Hz, 1H), 4.81 (d, J = 8.2 Hz, 1H), 4.34 (q, J = 5.9 Hz, 1H), 4.26 (dd, J = 9.4, 5.8 Hz, 1H), 
4.14 (d, J = 5.3 Hz, 1H), 4.10-4.06 (m, 1H), 3.98 (s, 1H), 3.94 (dd, J = 11.0, 6.6 Hz, 1H), 3.87 (s, 
1H), 3.79 (dd, J = 9.9, 5.6 Hz, 1H), 3.70-3.66 (m, 1H), 3.66 (dd, J = 10.4, 6.7 Hz, 1H), 1.42 (s, 
18H), 1.29 (s, 3H), 1.27 (s, 3H), 1.07 (s, 9H), 1.05 (s, 9H). 13-C NMR (126 MHz; cdcl3): δ 
156.9, 156.0, 135.74, 135.72, 133.44, 133.38, 129.95, 129.83, 127.91, 127.83, 108.8, 79.9, 78.1, 





































To a solution of the alcohol in CH2Cl2 (2 mL) was added Et3N (12 µL, 6 eq.), DMAP (cat.), 
and TBSCl (9.8 mg, 6 eq.).  The reaction was stirred overnight and evaporated in vacuo.  The 
crude mixture was purified via PTLC (20% EtOAc/Hexane) to give TBS ether 311.  1H-NMR 
(400 MHz; CDCl3): δ  11.36 (s, 1H), 8.87 (d, J = 6.7 Hz, 1H), 7.39-7.28 (m, 5H), 5.13 (s, 2H), 
4.80 (s, 1H), 4.60 (td, J = 6.4, 3.4 Hz, 1H), 4.36 (dd, J = 6.7, 3.7 Hz, 1H), 4.21 (q, J = 6.3 Hz, 
1H), 4.12 (s, 1H), 4.05 (s, 1H), 3.94-3.88 (m, 2H), 3.70-3.62 (m, 2H), 1.51 (s, 3H), 1.46 (s, 9H), 
1.42 (s, 9H), 1.38 (s, 3H), 0.90 (s, 9H), 0.08 (s, 6H).  13-C NMR (101 MHz; CDCl3): δ 163.6, 
156.2, 155.3, 152.6, 137.2, 128.6, 128.06, 127.99, 109.4, 83.2, 81.4, 78.0, 77.40, 77.34, 72.3, 


































To a stirring solution of amine 312 (0.233 mmol crude, 1eq.) in 50% THF/H2O (6mL) was 
added NaHCO3 (58.6mg, 3 eq.) and Fmoc-OSu (94.2mg, 1.2 eq.).  The mixture was stirred 
overnight then extracted with EtOAc (3x), washed with NaCl (sat.), dried over sodium sulfate 
and evaporated.  The resulting oil was purified via flash chromatography (20% EtOAc/Hexane) 
to give 142.5 mg (87%) of carbamate 313.  [!]!!"= -70 (c 0.49, CHCl3). 
1H-NMR (500 MHz; 
CDCl3): δ  7.76 (d, J = 7.5 Hz, 2H), 7.61 (d, J = 7.4 Hz, 2H), 7.40-7.27 (m, 9H), 5.61 (s, 1H), 
5.27 (s, 1H), 4.91 (d, J = 11.7 Hz, 2H), 4.78 (d, J = 5.6 Hz, 1H), 4.75 (d, J = 5.6 Hz, 1H), 4.60 
(d, J = 11.3 Hz, 1H), 4.51 (dd, J = 10.1, 7.0 Hz, 1H), 4.41 (dd, J = 10.2, 7.6 Hz, 1H), 4.35 (t, J = 
11.0 Hz, 1H), 4.25 (t, J = 6.9 Hz, 1H), 4.14-4.10 (m, 1H), 4.06-4.03 (m, 1H), 4.04 (d, J = 10.4 
Hz, 1H), 1.47 (s, 3H), 1.43 (s, 9H), 1.31 (s, 3H), 1.14 (t, J = 6.8 Hz, 3H). 13-C NMR (126 MHz; 
cdcl3): δ 171.2, 156.7, 155.2, 144.0, 143.8, 141.46, 141.42, 128.5, 127.88, 127.86, 127.80, 
127.78, 127.28, 127.26, 125.25, 125.21, 120.13, 120.11, 112.7, 108.3, 85.8, 85.6, 82.1, 80.5, 
70.1, 67.5, 62.2, 54.68, 54.54, 47.3, 28.3, 26.5, 25.0, 14.0 IR (Dep. CDCl3): 3369 (bs), 2979 (s), 


































To a stirring solution of amine 312 (0.233 mmol crude, 1eq.) in 50% THF/H2O (10mL) was 
added K2CO3 (322mg, 10 eq.) and Teoc-Cl (50.42mg, 1.2 eq.).  The mixture was stirred 
overnight and the organic layer was separated.  The aqueous layer was then extracted with 
EtOAc (3x), washed with NaCl (sat.), dried over sodium sulfate and evaporated.  The resulting 
oil was purified via flash chromatography (20% EtOAc/Hexane) to give 320. [!]!!"= -84 (c 0.49, 
CHCl3) 1H-NMR (500 MHz; CDCl3): δ  7.37-7.27 (m, 5H), 5.40 (s, 1H), 5.26 (s, 1H), 4.91 (d, J 
= 12.4 Hz, 1H), 4.86 (d, J = 8.0 Hz, 1H), 4.77 (d, J = 5.9 Hz, 1H), 4.74 (d, J = 5.9 Hz, 1H), 4.60 
(d, J = 12.3 Hz, 1H), 4.31 (t, J = 10.8 Hz, 1H), 4.21 (d, J = 8.7 Hz, 1H), 4.18 (d, J = 8.8 Hz, 1H), 
4.11 (dd, J = 12.1, 5.4 Hz, 1H), 4.02 (dd, J = 12.1, 5.4 Hz, 1H), 4.00 (d, J = 11.3 Hz, 1H), 1.46 
(s, 3H), 1.41 (s, 9H), 1.30 (s, 3H), 1.12 (t, J = 7.1 Hz, 3H), 1.01 (t, J = 8.7 Hz, 2H), 0.04 (s, 9H). 
13-C NMR (126 MHz; cdcl3): δ 171.3, 157.0, 155.2, 137.5, 128.5, 127.8, 112.6, 108.29, 108.28, 
108.26, 85.8, 85.6, 82.1, 80.4, 70.1, 64.1, 62.1, 54.7, 54.3, 28.3, 26.5, 25.1, 17.9, 14.0, -1.4 IR 


































To a solution of carbamate 320 (100mg) in methanol (5mL) was added 20% Pd(OH)2/C 
(100mg).  Argon was bubbled through the resulting suspension and then it was hydrogenated at 
100 psi for 6 hours.  The mixture was filtered evaporated and purified via flash chromatography 
to give 80.5 mg (94%) of lactol 321. 1H-NMR (300 MHz; CDCl3): δ  5.60 (s, 1H), 5.53 (s, 1H), 
5.01 (d, J = 5.9 Hz, 1H), 4.75 (d, J = 6.0 Hz, 1H), 4.69 (d, J = 6.0 Hz, 1H), 4.33 (td, J = 10.8, 2.3 
Hz, 1H), 4.19-4.13 (m, 4H), 3.97 (d, J = 11.3 Hz, 1H), 1.45 (s, 3H), 1.41 (s, 9H), 1.30 (s, 3H), 

























Compound 331:  tert-butyl ((R)-((3aR,4R,6R,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[3,
4-d][1,3]dioxol-4-yl)((R)-2-oxooxazolidin-4-yl)methyl)carbamate. 
 
To a solution of methyl carbamate 336 (1.08 g, 1 eq.) in THF (20 mL) was added lithium 
borohydride (436 mg, 10 eq.).  The mixture was allowed to stir 10 hours or until complete by 
TLC.  The mixture was poured over cracked ice and sat. ammonium chloride (100 mL) was 
added and allowed to stir for 30 minutes.  The mixture was extracted with EtOAc (3x) and the 
combined extracts were washed with brine dried over sodium sulfate and evaporated.  The crude 
alcohol was dissolved in MeOH (20 mL) and finely powdered KOH (1.02 g, 10 eq.) was added.  
The mixture was refluxed until complete by TLC, allowed to cool and evaporated.  The crude 
oxazolidinone was purified via a plug of silica gel (10% MeOH/DCM) to give oxazolidinone 331 
(906 mg, 97.6%) as a white solid. [!]!!"= -72 (c 0.45, CHCl3)
 1H-NMR (400 MHz; CDCl3): δ  
7.38-7.26 (m, 5H), 5.52 (s, 1H), 5.20 (s, 1H), 4.85 (d, J = 10.4 Hz, 1H), 4.74 (d, J = 6.0 Hz, 1H), 
4.73 (d, J = 6.0 Hz, 1H), 4.65 (d, J = 12.2 Hz, 1H), 4.62 (d, J = 12.2 Hz, 1H), 4.16 (t, J = 7.6 Hz, 
1H), 4.09 (t, J = 8.8 Hz, 1H), 4.00 (dd, J = 8.5, 6.2 Hz, 1H), 3.87 (d, J = 11.2 Hz, 1H), 3.74 (td, J 
= 10.8, 1.7 Hz, 1H), 1.46 (s, 3H), 1.45 (s, 9H), 1.31 (s, 3H). 13-C NMR (101 MHz; cdcl3): δ 
160.0, 156.2, 137.0, 128.8, 128.2, 127.4, 112.8, 109.0, 86.5, 85.2, 82.4, 80.9, 70.7, 67.0, 53.1, 
52.0, 28.4, 26.6, 25.0. IR (Dep. CDCl3): 3305 (br), 2980 (s), 2938 (s), 1756 (s), 1708 (s), 1499 
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Compound 332:  tert-butyl ((R)-((3aR,4R,6R,6aR)-6-hydroxy-2,2-dimethyltetrahydrofuro[3,4-d]
[1,3]dioxol-4-yl)((R)-2-oxooxazolidin-4-yl)methyl)carbamate. 
 
To a solution of benzyl ether 331 (249 mg) in 4:1 THF/methanol (5 mL) was added 20% 
Pd(OH)2/C (125 mg).  Argon was bubbled through the resulting suspension and then it was 
hydrogenated at 100 psi until complete by TLC.  The mixture was filtered evaporated and 
purified via flash chromatography (10-20% EtOAc/Hexanes) to give 184.2 mg (91.8%) of lactol 
332. 1H-NMR (500 MHz; CDCl3): δ  6.53 (s, 1H), 5.56 (d, J = 3.0 Hz, 1H), 5.01 (d, J = 2.5 Hz, 
1H), 4.97 (t, J = 5.0 Hz, 1H), 4.74 (d, J = 5.9 Hz, 1H), 4.69 (d, J = 5.8 Hz, 1H), 4.49 (t, J = 8.9 
Hz, 1H), 4.39 (t, J = 7.9 Hz, 1H), 4.16 (dd, J = 8.1, 7.5 Hz, 1H), 3.88 (d, J = 4.1 Hz, 2H), 1.46 (s, 
10H), 1.45 (s, 2H), 1.31 (s, 3H). 13-C NMR (126 MHz; cdcl3): δ 161.0, 156.2, 112.8, 103.8, 
86.7, 85.6, 83.0, 81.0, 67.1, 52.9, 52.6, 28.4, 26.6, 25.0.  Calcd. for C16H26N2NaO8 [M+Na]: 









































Compound 336:   (2R,3R)-ethyl 3-((3aR,4R,6R,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[
3,4-d][1,3]dioxol-4-yl)-3-((tert-butoxycarbonyl)amino)-2-((methoxycarbonyl)amino)propanoate. 
 
To a solution of Mannich product 211 (5 grams, 1 eq.) in THF (150 mL) was added 1M HCl 
(150 mL).  The mixture was stirred ~30 minutes and quenched with NaHCO3 (15 g). Methyl 
chloroformate (599.2 µL, 1 eq.) was added to the mixture and stirred until complete by TLC.  
The layers were separated and the aqueous layer was extracted with CH2Cl2 (3x) the combined 
extracts were washed with brine, dried over sodium sulfate and evaporated.  The crude material 
was purified via flash chromatography (20-50% EtOAc/Hexanes) to give methyl carbamate 336 
(4.07 g, 97.4%) as a white powder. [!]!!"= -96 (c 1.04, CHCl3) 
1H-NMR (400 MHz; CDCl3): δ  
7.38-7.27 (m, 4H), 5.61 (s, 1H), 5.25 (s, 1H), 4.90 (d, J = 12.3 Hz, 2H), 4.86 (d, J = 7.7 Hz, 1H), 
4.77 (d, J = 5.9 Hz, 1H), 4.74 (d, J = 5.8 Hz, 1H), 4.60 (d, J = 12.3 Hz, 1H), 4.33 (td, J = 10.9, 
2.1 Hz, 1H), 4.15-4.06 (m, 1H), 4.06-3.99 (m, 1H), 4.01 (d, J = 7.7 Hz, 1H), 3.72 (s, 3H), 1.46 
(s, 3H), 1.40 (s, 9H), 1.29 (s, 3H), 1.13 (t, J = 7.1 Hz, 3H). 13-C NMR (101 MHz; cdcl3): δ 
171.3, 157.3, 155.2, 137.4, 128.5, 127.78, 127.64, 112.6, 108.3, 85.73, 85.55, 82.1, 80.3, 77.4, 
70.1, 62.1, 54.67, 54.56, 54.52, 52.83, 52.76, 28.3, 26.5, 25.0, 14.0. IR (Dep. CDCl3): 3584 (br), 








































Compound 338:  (R)-1-((4R,5S)-5-((dibenzylamino)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)eth
ane-1,2-diol. 
 
A solution of lactol 337 (1.0g , 1 eq.), dibenzylamine (1.2mL µL, 1.2 eq.), AcOH (913 uL 
mL, 3 eq.) and sodium cyanoborohydride (1.0g, 3 eq.) in MeOH (10 mL) was allowed to stir 4 
days.  The reaction was carefully quenched with sat. sodium bicarbonate, extracted with EtOAc 
(3x) and the combined extracts were dried over sodium sulfate and evaporated to give amine 338 
(1.24g, 63%), which was clean by NMR.  1H-NMR (500 MHz; CDCl3): δ  7.37-7.24 (m, 10H), 
4.48 (ddd, J = 11.1, 5.8, 2.7 Hz, 1H), 4.10 (dd, J = 9.6, 5.8 Hz, 1H), 3.91 (d, J = 13.0 Hz, 2H), 
3.65 (dd, J = 11.2, 3.5 Hz, 1H), 3.54 (dd, J = 11.2, 5.6 Hz, 1H), 3.30 (d, J = 13.0 Hz, 2H), 3.06 
(dd, J = 13.0, 11.4 Hz, 1H), 3.03 (ddd, J = 9.5, 5.7, 3.7 Hz, 1H), 2.41 (dd, J = 13.0, 2.6 Hz, 1H), 
2.07 (s, 1H), 1.34 (s, 3H), 1.29 (s, 3H).  13-C NMR (126 MHz; cdcl3): δ 136.3, 130.0, 128.8, 



























Compound 351:   (R)-4-((R)-amino((3aR,4R,6R,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro
[3,4-d][1,3]dioxol-4-yl)methyl)oxazolidin-2-one 
 
To a solution of carbamate 331 and 2,6-lutidine in CH2Cl2 was added TBSOTf dropwise.  
The solution was allowed to stir ~30 min and was quenched with KF/MeOH.  The mixture was 
stirred an additional 30 min. until all the spots by TLC coalesced.  The reaction mixture was 
diluted with CH2Cl2 and washed with water followed by brine.  The organic extracts were dried 
over sodium sulfate and evaporated and the resulting oil was purified by flash chromatography to 
give 351 as a white solid.  1H-NMR (400 MHz; CDCl3): δ  7.37-7.27 (m, 5H), 5.88-5.85 (m, 1H), 
5.19 (s, 1H), 4.95 (d, J = 5.7 Hz, 1H), 4.68 (d, J = 5.6 Hz, 1H), 4.66 (d, J = 11.9 Hz, 1H), 4.58 
(d, J = 11.9 Hz, 1H), 4.27-4.24 (m, 1H), 4.26 (d, J = 8.8 Hz, 1H), 4.16-4.09 (m, 1H), 3.91 (d, J = 
8.4 Hz, 1H), 2.78 (d, J = 5.1 Hz, 1H), 2.57 (s, 2H), 1.48 (s, 3H), 1.32 (s, 3H).  13-C NMR (101 
MHz; cdcl3): δ 160.0, 136.9, 128.8, 128.3, 127.7, 113.1, 108.2, 88.2, 85.2, 82.1, 67.5, 55.4, 53.3, 








































Compound 352:   (R)-4-((R)-(2,3-bis(tert-butoxycarbonyl)guanidino)((3aR,4R,6R,6aR)-6-(benzy
loxy)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl)oxazolidin-2-one. 
 
To a solution of oxazolidinone 331 (245 mg, 1eq.) and 2,6-lutidine (245.7 µL, 3eq.) in 
CH2Cl2 (5 mL) was added TMSOTf (286.4 µL, 3 eq.).  The mixture was allowed to stir until 
complete by TLC and quenched with sat. sodium bicarbonate, extracted with EtOAc (3x).  The 
combined extracts were dried over sodium sulfate and evaporate.  The crude amine was 
dissolved in DMF (5mL) and triethylamine (330.8 µL, 4.5 eq.) and guanylating reagent 222 
(153.3 mg, 1eq.) was added.  The mixture was cooled to 0°C and mercuric chloride (157.5mg, 
1.1 eq.) was added.  The cloudy suspension was allowed to room temperature and stirred until 
complete by TLC. The reaction was quenched by adding sat. sodium chloride and ethyl acetate.  
After stirring the mixture for 20 minutes the reaction was filtered through celite to remove all the 
mercury salts.  The biphasic solution was separated and the organic layer was washed with H2O 
(3x), brine and then dried over sodium sulfate and evaporated in vacuo.  The crude material was 
purified via column chromatography (20-50% EtOAc/Hexanes) to give compound 352 (216 mg, 
67.5%). [!]!!"= -91 (c 0.23, CHCl3) 
1H-NMR (400 MHz; CDCl3): δ  11.45 (s, 1H), 8.77 (d, J = 
9.4 Hz, 1H), 7.39-7.29 (m, 5H), 5.21 (s, 1H), 5.07 (s, 1H), 4.83 (dd, J = 6.0, 1.1 Hz, 1H), 4.75 (d, 
J = 6.0 Hz, 1H), 4.70 (d, J = 12.4 Hz, 1H), 4.64 (d, J = 12.3 Hz, 1H), 4.50 (td, J = 10.0, 1.5 Hz, 
1H), 4.17 (ddt, J = 8.7, 6.7, 2.0 Hz, 1H), 4.09 (t, J = 8.8 Hz, 1H), 4.04 (dd, J = 8.8, 6.7 Hz, 1H), 
3.99 (dd, J = 10.2, 1.1 Hz, 1H), 1.49 (s, 9H), 1.49 (s, 9H), 1.47 (s, 3H), 1.32 (s, 3H). 13-C NMR 
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86.6, 85.2, 84.2, 82.0, 70.6, 66.8, 52.33, 52.17, 28.4, 28.20, 28.14, 26.7, 25.2. IR (Dep. CDCl3): 





























Method A: To a solution of compound 356 (15 mg, 1eq.) and triethylamine (12.4 µL, 4.5 
eq.)  in acetonitrile (2 mL) was added mercuric chloride (5.9 mg, 1.1 eq.).  The reaction was 
stirred ~20 min. until the disappearance of stating material by TLC.  The reaction was quenched 
with conc. ammonium hydroxide (1 mL) and stirred an additional 20 min. until the 
disappearance of stating material by TLC.  The reaction mixture was filtered through celite to 
remove mercury and the mixture was extracted 3x with EtOAc.  The combined organic layers 
were dried over sodium sulfate and evaporated.  The crude material was purified by flash 
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Method B: Argon was bubbled through a vial containing 376 (53 mg) in THF (6 mL, wet) 
for 5 min.  The vial was sealed and irradiated by a Hg vapor lamp for 30 min.  The mixture was 
evaporated and purified via flash chromatography (1-5% MeOH/DCM) to give 357 (40 mg, 
89.4%, 96.7% brsm) and recovered starting material (4 mg).  1H-NMR (400 MHz; cd3cn): δ  
11.53 (s, 1H), 8.67 (d, J = 8.8 Hz, 2H), 7.75 (d, J = 8.9 Hz, 2H), 6.98 (d, J = 8.9 Hz, 2H), 6.22 (s, 
2H), 5.84 (s, 1H), 4.51 (s, 1H), 4.45 (d, J = 8.6 Hz, 1H), 4.43 (d, J = 8.6 Hz, 1H), 4.37-4.35 (m, 
1H), 4.30 (dt, J = 8.9, 2.7 Hz, 1H), 4.18 (dd, J = 12.5, 5.5 Hz, 1H), 4.07 (dd, J = 9.8, 5.7 Hz, 
1H), 4.03 (dd, J = 8.3, 7.1 Hz, 1H), 3.83 (s, 3H), 3.78 (d, J = 10.3 Hz, 1H), 3.32 (dd, J = 7.7, 5.9 













































Compound 360:   (R)-4-((1R,2R)-1-(2,3-bis(tert-butoxycarbonyl)guanidino)-2-((4R,5S)-5-((benz
ylamino)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-hydroxyethyl)oxazolidin-2-one. 
 
A solution of lactol 353 (10 mg, 1 eq.), benzylamine (43 µL, 20 eq.), AcOH (150 µL, 135 
eq.) and sodium cyanoborohydride (12.2mg 10 eq.) in MeOH (0.5 mL) was allowed to stir 6 
hours.  The reaction was carefully quenched with sat. sodium bicarbonate, extracted with EtOAc 
(3x) and the combined extracts were dried over sodium sulfate and evaporated.  The crude 
product wad purified via PTLC (10% MeOH/DCM) to give benzylamine 360 (8.5mg, 72.3%). 
[!]!!"= -1 (c 0.77, CHCl3).
 1H-NMR (500 MHz; CDCl3): δ  11.46 (s, 1H), 9.08 (d, J = 9.4 Hz, 
1H), 7.36-7.26 (m, 5H), 5.78 (s, 1H), 4.62 (dd, J = 9.4, 2.4 Hz, 1H), 4.44 (t, J = 12.0 Hz, 1H), 
4.33-4.28 (m, 3H), 4.07 (dd, J = 9.9, 5.8 Hz, 1H), 3.80 (d, J = 12.6 Hz, 1H), 3.76 (d, J = 12.7 Hz, 
1H), 2.96 (dd, J = 12.3, 3.4 Hz, 1H), 2.90 (dd, J = 12.3, 9.6 Hz, 1H), 1.51 (s, 9H), 1.46 (s, 9H), 
1.43 (s, 3H), 1.31 (s, 3H). 13-C NMR (126 MHz; cdcl3): δ 163.6, 159.3, 156.8, 152.9, 137.8, 
129.0, 128.7, 128.0, 109.2, 83.5, 79.3, 77.6, 75.8, 71.2, 67.4, 54.0, 51.9, 50.7, 48.1, 28.42, 28.23, 
27.9, 25.4. IR (Dep. CDCl3): 3306 (br), 3273 (br), 3119 (s), 2982 (s),2933 (s),1758 (s),1726 



















































To a solution of compound 361 (23.5 mg, 1eq.) and triethylamine (19.3 µL, 5 eq.)  in 
acetonitrile (1 mL) was added mercury (II) chloride (9 mg, 1.2 eq.).  The reaction was stirred ~20 
min. until the disappearance of stating material by TLC.  The reaction was quenched with conc. 
ammonium hydroxide (1 mL) and stirred an additional 20 min. until the disappearance of stating 
material by TLC.  The reaction mixture was filtered through celite to remove mercury and the 
mixture was extracted 3x with EtOAc.  The combined organic layers were dried over sodium 
sulfate and evaporated.  The crude material was purified by flash chromatography (1-5% 
MeOH/DCM) to give 362 as a white solid (19.5 mg, 86.0%).  1H-NMR (400 MHz; cd3cn): δ  
11.49 (s, 1H), 8.62 (d, J = 9.1 Hz, 1H), 7.72 (d, J = 8.8 Hz, 2H), 7.29 (d, J = 7.7 Hz, 2H), 7.15 
(d, J = 7.9 Hz, 2H), 6.97 (d, J = 8.9 Hz, 2H), 6.70 (s, 2H), 5.78 (s, 1H), 4.67 (d, J = 16.5 Hz, 1H), 
4.63 (d, J = 16.1 Hz, 1H), 4.41 (t, J = 8.7 Hz, 1H), 4.34-4.27 (m, 3H), 4.05 (dd, J = 9.4, 6.0 Hz, 
1H), 3.99 (dd, J = 8.4, 7.1 Hz, 1H), 3.84 (s, 2H), 3.76-3.74 (m, 1H), 3.37-3.31 (m, 1H), 3.28-3.27 
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To a solution of compound 364 (95 mg, 1eq.) and triethylamine (73 µL, 5 eq.)  in 
acetonitrile (5 mL) was added mercury (II) chloride (49.9 mg, 2 eq.).  The reaction was stirred 
~20 min. until the disappearance of stating material by TLC.  The reaction was quenched with 
conc. ammonium hydroxide (5 mL) and stirred an additional 20 min. until the disappearance of 
stating material by TLC.  The reaction mixture was filtered through celite to remove mercury and 
the mixture was extracted 3x with EtOAc.  The combined organic layers were dried over sodium 
sulfate and evaporated.  The crude material was purified by flash chromatography (1-5% 
MeOH/DCM) to give 365 as a white solid (65 mg, 70.1%).  [!]!!"= -23 (c 0.32, CHCl3).  
1H-NMR (400 MHz; cd3cn): δ  11.53 (s, 1H), 8.66 (d, J = 9.0 Hz, 1H), 7.73 (d, J = 8.8 Hz, 2H), 
6.98 (d, J = 8.9 Hz, 2H), 6.95 (d, J = 8.4 Hz, 1H), 6.68 (s, 2H), 6.52 (d, J = 2.3 Hz, 1H), 6.41 
(dd, J = 8.3, 2.1 Hz, 1H), 5.82 (s, 1H), 4.53 (d, J = 16.0 Hz, 1H), 4.45-4.40 (m, 3H), 4.36-4.26 
(m, 3H), 4.05-4.03 (dd, 1H), 4.01 (dd, J = 8.4, 6.8 Hz, 1H), 3.83 (s, 3H), 3.76 (s, 1H), 3.76 (s, 
3H), 3.28 (s, 2H), 1.50 (s, 9H), 1.46 (s, 3H), 1.40 (s, 9H), 1.22 (s, 3H).  13-C NMR (101 MHz; 
cdcl3): δ 162.8, 162.1, 160.9, 159.2, 158.0, 157.5, 156.9, 152.8, 135.8, 130.7, 128.1, 113.8, 
109.7, 104.7, 98.75, 98.69, 84.0, 79.8, 77.9, 76.4, 71.4, 67.6, 55.63, 55.52, 55.51, 54.1, 52.0, 





























































Compound 369:   (R)-4-((1R,2R)-1-(2,3-bis(tert-butoxycarbonyl)guanidino)-2-hydroxy-2-((4R,5
S)-5-(((4-methoxybenzyl)amino)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethyl)oxazolidin-2-one. 
 
A solution of lactol 353 (50 mg, 1 eq.), p-methoxybenzylamine (253 µL, 20 eq.), AcOH 
(887 µL, 160 eq.) and sodium cyanoborohydride (30.4 mg, 5 eq.) in MeOH (3 mL) was allowed 
to stir 6 hours.  The reaction was carefully quenched with sat. sodium bicarbonate, extracted with 
EtOAc (3x) and the combined extracts were dried over sodium sulfate and evaporated.  The 
crude product wad purified via PTLC (10% MeOH/DCM) to give benzylamine 369 (36 mg, 
61.7%). [!]!!"= -7 (c 0.37, CHCl3)  1H-NMR (400 MHz; cd3cn): δ  11.62 (s, 1H), 8.80 (d, J = 9.6 
Hz, 1H), 7.24 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 5.76 (s, 1H), 4.40-4.33 (m, 3H), 4.24 
(dd, J = 8.0, 5.8 Hz, 1H), 4.18 (dd, J = 9.6, 5.8 Hz, 1H), 4.11 (dd, J = 7.4, 5.1 Hz, 1H), 3.76 (s, 
3H), 3.75 (d, J = 12.4 Hz, 1H), 3.62 (dd, J = 9.6, 3.4 Hz, 1H), 3.60 (d, J = 12.4 Hz, 1H), 
2.74-2.72 (m, 2H), 1.52 (s, 9H), 1.43 (s, 9H), 1.33 (s, 3H), 1.27 (s, 3H). 13-C NMR (101 MHz; 
cd3cn): δ 164.6, 160.1, 159.8, 157.8, 153.8, 131.8, 131.1, 114.7, 109.6, 84.4, 79.7, 78.4, 76.7, 
71.6, 67.9, 55.8, 53.2, 52.7, 52.2, 48.9, 28.4, 28.21, 28.15, 25.4 HRMS (FAB+): Calcd for 






















































To a solution of isothiourea 370 (53mg, 1eq.) and triethylamine (75 µL, 9 eq.) in MeCN (2 
mL) was added mercuric chloride (32.7 mg, 2 eq.) and the mixture was stirred until complete by 
TLC.  The reaction was quenched by adding conc. Ammonium hydroxide (2 mL) and allowed to 
stir until complete by TLC.  The reaction was diluted with EtOAc, filtered and evaporated.  The 
crude alcohol was purified via flash chromatography to give alcohol 372 (41 mg, 79.6%). 
[!]!!"= -23 (c 0.31, CHCl3) 1H-NMR (400 MHz; cd3cn): δ  11.49 (s, 1H), 8.64 (s, 1H), 7.73 (d, J 
= 8.9 Hz, 2H), 7.09 (d, J = 8.7 Hz, 2H), 6.98 (d, J = 8.9 Hz, 2H), 6.83 (d, J = 8.7 Hz, 2H), 6.68 
(s, 2H), 5.77 (s, 1H), 4.60 (d, J = 15.5 Hz, 1H), 4.54 (d, J = 15.9 Hz, 1H), 4.42 (t, J = 8.7 Hz, 
1H), 4.32-4.26 (m, 3H), 4.05 (dd, J = 9.3, 6.0 Hz, 1H), 3.99 (dd, J = 8.5, 7.2 Hz, 1H), 3.84 (s, 
3H), 3.76 (d, 1H), 3.76 (s, 3H), 3.31 (dd, J = 15.0, 9.7 Hz, 1H), 1.50 (s, 9H), 1.48 (s, 3H), 1.40 
(s, 9H), 1.23 (s, 3H). 13-C NMR (101 MHz; cd3cn): δ 162.9, 160.1, 159.8, 158.2, 158.0, 153.7, 
137.4, 129.6, 128.7, 114.87, 114.75, 110.4, 84.5, 79.9, 77.9, 76.9, 70.9, 68.0, 56.3, 55.9, 54.4, 
52.0, 51.8, 49.2, 28.4, 28.15, 28.05, 25.5. (Dep. CH3CN): 3416 (br), 3321 (br), 2982 (s), 2936(s), 
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To a solution of alcohol 372 (37 mg, 1 eq.) in CH2Cl2 (2 mL) was added Dess-Martin 
periodinane (36.9 mg, 2 eq.).  The solution turned cloudy over time and was allowed to stir for 
~1 hour.  The reaction was quenched with Na2S2O3 and was allowed to stir until the biphasic 
system turned clear.  The mixture was extracted with EtOAc (3x), dried over sodium sulfate and 
evaporated in vacuo to give crude ketone 6. The crude material was purified via column 
chromatography (20% EtOAc/Hexanes) to give ketone 373 (28 mg, 75.9%).  1H-NMR (400 
MHz; cd3cn): δ  11.43 (s, 1H), 8.77 (d, J = 9.1 Hz, 1H), 7.71 (d, J = 8.9 Hz, 2H), 7.05 (d, J = 8.7 
Hz, 2H), 6.97 (d, J = 8.9 Hz, 2H), 6.81 (d, J = 8.7 Hz, 2H), 6.62 (s, 2H), 5.78 (s, 1H), 5.36 (dd, J 
= 9.1, 2.0 Hz, 1H), 4.71 (d, J = 7.9 Hz, 1H), 4.61 (d, J = 15.4 Hz, 1H), 4.53 (ddd, J = 9.8, 8.0, 1.8 
Hz, 1H), 4.48 (s, 1H), 4.44 (d, J = 15.7 Hz, 1H), 4.14 (d, J = 3.4 Hz, 1H), 3.84 (s, 3H), 3.76 (s, 
3H), 3.15-3.08 (m, 1H), 1.62 (s, 3H), 1.51 (s, 9H), 1.37 (s, 9H), 1.31 (s, 3H). 13-C NMR (101 
MHz; cd3cn): δ 207.0, 164.1, 162.9, 160.1, 159.6, 158.0, 157.6, 153.7, 137.4, 129.7, 128.81, 
128.67, 114.86, 114.75, 112.3, 84.8, 80.9, 80.2, 77.8, 67.6, 59.0, 56.3, 55.9, 52.3, 51.9, 49.5, 




































































To a solution of amine 390 (209 mg, 1 eq.) and triethylamine (171 µL, 3 eq.) in CH2Cl2 (4 
mL, 0.1M) was added 344 (229.1 mg, 2 eq.).  The mixture was allowed to stir until complete by 
TLC.  The crude compound was cleaned up via flash chromatography (1-5% MeOH/DCM) to 
give the isothiourea.  The isothiourea was dissolved in MeCN (10 mL) and triethylamine (171 
µL, 3 eq.) was added followed by mercuric chloride (166.7 mg, 1.5 eq.) and the mixture was 
stirred until complete by TLC.  The reaction was quenched by adding conc. Ammonium 
hydroxide (2 mL) and allowed to stir ~20 min.  The reaction was diluted with EtOAc, filtered 
and evaporated.  The crude alcohol was purified via flash chromatography to give alcohol 419 
(235 mg, 79.4%).  1H-NMR (400 MHz; cd3cn): δ  11.49 (s, 1H), 8.62 (d, J = 8.7 Hz, 1H), 8.00 
(d, J = 8.1 Hz, 1H), 7.65 (t, J = 7.4 Hz, 1H), 7.55 (s, 1H), 7.48 (t, J = 7.7 Hz, 1H), 7.25 (d, J = 
7.6 Hz, 1H), 6.87 (d, J = 8.1 Hz, 1H), 5.72 (s, 1H), 5.22 (d, J = 16.3 Hz, 1H), 5.02 (d, J = 17.6 
Hz, 1H), 4.42 (t, J = 8.6 Hz, 1H), 4.41 (s, 1H), 4.31-4.27 (m, 1H), 4.22 (dd, J = 14.4, 1.8 Hz, 
1H), 4.00 (dd, J = 8.5, 7.2 Hz, 1H), 3.94 (s, 1H), 3.83 (s, 3H), 3.68 (d, J = 8.8 Hz, 1H), 2.64 (s, 
3H), 1.49 (s, 9H), 1.41 (s, 3H), 1.39 (s, 9H), 1.21 (s, 3H). 
13-C NMR (101 MHz; cd3cn): δ 168.6, 164.3, 162.9, 159.8, 157.9, 153.7, 148.7, 137.2, 134.9, 
133.0, 129.4, 129.0, 128.6, 126.2, 114.7, 110.5, 84.5, 79.8, 76.88, 76.74, 70.6, 68.0, 56.4, 54.3, 


























1762 (s), 1727 (s), 1639 (s), 1613 (s), 1579 (s), 1529 (s). HRMS (FAB+): Calcd for 































To a solution of compound 375 (22 mg, 1eq.) and triethylamine (31 µL, 5 eq.)  in 
acetonitrile (2 mL) was added mercury (II) chloride (13.3 mg, 2 eq.).  The reaction was stirred 
~20 min. until the disappearance of stating material by TLC.  The reaction was quenched with 
conc. ammonium hydroxide (2 mL) and stirred an additional 20 min. until the disappearance of 
stating material by TLC.  The reaction mixture was filtered through celite to remove mercury and 
the mixture was extracted 3x with EtOAc.  The combined organic layers were dried over sodium 
sulfate and evaporated.  The crude material was purified by flash chromatography (1-5% 
MeOH/DCM) to give 376 as a white solid (15.1 mg, 71.1%).  1H-NMR (400 MHz; cd3cn): δ  
11.48 (s, 1H), 8.64 (d, J = 8.8 Hz, 1H), 8.08 (d, J = 8.0 Hz, 1H), 7.65 (d, J = 8.2 Hz, 2H), 7.56 (t, 
J = 7.4 Hz, 1H), 7.48 (t, J = 7.5 Hz, 1H), 7.15 (d, J = 7.3 Hz, 1H), 6.94 (d, J = 8.7 Hz, 2H), 6.75 
(s, 2H), 5.76 (s, 1H), 4.95 (s, 1H), 4.42 (t, J = 8.6 Hz, 1H), 4.36 (ddd, J = 9.7, 6.1, 1.7 Hz, 1H), 
4.34-4.28 (m, 2H), 4.03 (dd, J = 9.6, 5.7 Hz, 1H), 3.99 (dd, J = 8.2, 6.7 Hz, 1H), 3.84 (s, 3H), 
3.76 (d, J = 10.0 Hz, 1H), 3.40 (s, 2H), 1.49 (s, 9H), 1.45 (s, 3H), 1.39 (s, 1H), 1.22 (s, 3H).  
13-C NMR (101 MHz; cd3cn): δ 164.2, 163.0, 159.8, 158.3, 157.9, 153.7, 149.0, 137.1, 134.9, 
133.8, 129.3, 128.67, 128.62, 126.2, 114.7, 110.5, 84.5, 79.9, 77.7, 76.8, 70.9, 68.0, 56.3, 54.3, 
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Compound 390:   (R)-4-((1R,2R)-1-(2,3-bis(tert-butoxycarbonyl)guanidino)-2-((4R,5S)-2,2-dim
ethyl-5-(((2-nitrobenzyl)amino)methyl)-1,3-dioxolan-4-yl)-2-hydroxyethyl)oxazolidin-2-one. 
 
A solution of lactol 353 (250 mg, 1 eq.), o-nitrobenzylamine HCl (456.4 mg, 5 eq.), AcOH 
(693 µL, 25 eq.), sodium acetate (397 mg, 10 eq.) and sodium cyanoborohydride (152 mg, 5 eq.) 
in MeOH (2.4 mL) was allowed to stir 1.5 hours.  The reaction was carefully quenched with sat. 
sodium bicarbonate, extracted with EtOAc (3x) and the combined extracts were dried over 
sodium sulfate and evaporated.  The crude product wad purified via PTLC (10% MeOH/DCM) 
to give benzylamine 390 (276 mg, 87.4%). [!]!!"= -23 (c 0.54, CHCl3).  1H-NMR (400 MHz; 
cd3cn): δ  11.59 (s, 1H), 8.72 (d, J = 9.6 Hz, 1H), 8.00 (dd, J = 8.2, 1.0 Hz, 1H), 7.69 (td, J = 7.5, 
1.1 Hz, 1H), 7.58 (dd, J = 7.7, 1.2 Hz, 1H), 7.55-7.50 (m, 1H), 5.79 (s, 1H), 4.44-4.36 (m, 3H), 
4.30 (ddd, J = 9.9, 5.9, 3.9 Hz, 1H), 4.18 (dd, J = 9.7, 5.7 Hz, 1H), 4.10 (dd, J = 7.2, 4.9 Hz, 1H), 
4.05 (d, J = 13.5 Hz, 1H), 3.98 (d, J = 13.5 Hz, 1H), 3.75 (dd, J = 9.7, 3.7 Hz, 1H), 2.87 (dd, J = 
12.1, 10.1 Hz, 1H), 2.81 (dd, J = 12.2, 3.7 Hz, 1H), 1.51 (s, 9H), 1.43 (s, 9H), 1.36 (s, 3H), 1.28 
(s, 3H). 13-C NMR (101 MHz; cd3cn): δ 164.6, 159.9, 157.9, 153.8, 150.0, 134.7, 134.5, 133.2, 
129.9, 125.9, 109.6, 84.3, 79.7, 78.5, 76.7, 71.6, 67.9, 53.0, 52.2, 50.7, 49.3, 28.4, 28.20, 28.18, 























































To a solution of amine 390 (62.4 mg, 1 eq.) and triethylamine (53 µL, 4 eq.) in MeCN (3 
mL) was added 386 (57.4 mg, 2 eq.).  The mixture was allowed to stir until complete by TLC.  
The crude compound was cleaned up via flash chromatography (10% iPrOH/Hexanes) to give 
the isothiourea 391 (37 mg, 45%). 1H-NMR (400 MHz; cd3cn): δ  11.49 (s, 1H), 8.64 (d, J = 8.9 
Hz, 1H), 8.07 (dd, J = 8.2, 1.2 Hz, 1H), 7.69 (td, J = 7.6, 1.2 Hz, 1H), 7.51 (ddd, J = 8.1, 7.4, 1.4 
Hz, 1H), 7.36 (dd, J = 7.4, 1.2 Hz, 1H), 7.37-7.31 (m, 5H), 5.77 (s, 1H), 5.29 (d, J = 18.1 Hz, 
1H), 5.12 (d, J = 18.1 Hz, 1H), 5.04 (s, 2H), 4.50 (ddd, J = 9.8, 5.9, 2.1 Hz, 1H), 4.42 (t, J = 8.6 
Hz, 1H), 4.33-4.27 (m, 2H), 4.24 (d, J = 14.3 Hz, 1H), 4.07 (dd, J = 9.9, 5.9 Hz, 1H), 4.00 (dd, J 
= 8.4, 7.2 Hz, 1H), 3.72 (dd, J = 9.9, 3.0 Hz, 1H), 3.43 (dd, J = 13.9, 11.0 Hz, 1H), 2.26 (s, 3H), 
1.48 (s, 9H), 1.41 (s, 3H), 1.39 (s, 9H), 1.23 (s, 3H).  13-C NMR (101 MHz; cd3cn): δ 168.5, 
164.3, 159.8, 158.8, 157.9, 153.7, 149.1, 138.1, 134.9, 133.3, 129.38, 129.33, 129.13, 129.09, 
128.9, 126.2, 110.4, 84.4, 79.8, 77.0, 70.7, 68.15, 67.99, 54.4, 53.2, 51.95, 51.92, 28.4, 28.14, 

























































To a solution of isothiourea 391 (15 mg, 1eq.) and triethylamine (22 µL, 9 eq.) in MeCN (2 
mL) was added mercuric chloride (9.5 mg, 2 eq.).  The mixture was stirred 20 min, then was 
quenched with adding conc. ammonium hydroxide (3 mL) and allowed to stir another 20 min.  
The reaction was diluted with EtOAc, filtered and evaporated.  The crude alcohol was purified 
via flash chromatography to give alcohol 392 (14.2 mg, 98.2%).  1H-NMR (400 MHz; cd3cn): δ  
11.52 (s, 1H), 8.71 (d, J = 8.9 Hz, 1H), 8.13 (d, J = 8.1 Hz, 1H), 7.69 (t, J = 7.6 Hz, 1H), 7.52 (t, 
J = 7.7 Hz, 1H), 7.36-7.27 (m, 6H), 5.79 (s, 1H), 5.07 (d, J = 18.8 Hz, 1H), 5.05 (s, 2H), 5.01 (d, 
J = 18.7 Hz, 1H), 4.46 (ddd, J = 8.0, 6.1, 2.2 Hz, 1H), 4.41 (t, J = 8.7 Hz, 1H), 4.37-4.32 (m, 
2H), 4.11 (dd, J = 9.7, 5.8 Hz, 1H), 4.03 (dd, J = 8.1, 7.0 Hz, 1H), 3.82 (dd, J = 9.8, 2.7 Hz, 1H), 
3.29 (s, 2H), 1.49 (s, 9H), 1.43 (s, 3H), 1.40 (s, 9H), 1.27 (s, 3H).  13-C NMR (101 MHz; 
cd3cn): δ 164.3, 163.0, 159.8, 157.9, 153.7, 149.1, 138.9, 135.1, 133.7, 129.38, 129.35, 128.77, 
128.61, 128.59, 126.3, 110.3, 84.4, 79.8, 78.5, 77.3, 71.5, 68.0, 67.0, 53.9, 52.1, 51.0, 49.9, 28.4, 





























































To a solution of 390 (10 mg, 1 eq.) in CH2Cl2 (1 mL) was added CbzNCS (3.8 mg, 1.2 eq.).  
The reaction was stirred for 5 min. and then evaporated.  The crude material was purified via 
flash chromatography (1-5% MeOH/DCM) to give 393 (12.2 mg, 92.6%).  1H-NMR (400 MHz; 
cd3cn): δ  11.50 (s, 1H), 9.29 (s, 1H), 8.62 (d, J = 8.9 Hz, 1H), 8.08 (d, J = 8.2 Hz, 1H), 7.66 (t, J 
= 7.6 Hz, 1H), 7.51 (t, J = 7.7 Hz, 1H), 7.45-7.32 (m, 5H), 5.78 (d, J = 5.0 Hz, 1H), 5.69 (d, J = 
16.8 Hz, 1H), 5.27 (d, J = 17.2 Hz, 1H), 5.18 (s, 2H), 4.58 (dd, J = 10.7, 5.9 Hz, 1H), 4.39 (t, J = 
8.7 Hz, 1H), 4.32-4.26 (m, 3H), 4.10 (dd, J = 9.5, 6.2 Hz, 1H), 3.97 (dd, J = 8.4, 7.1 Hz, 1H), 
3.86 (s, 1H), 3.70 (dd, J = 9.5, 3.5 Hz, 1H), 1.49 (s, 9H), 1.46 (s, 3H), 1.39 (s, 9H), 1.27 (s, 3H).  














































Argon was bubbled through a vial containing 394 (14 mg) in THF (1 mL, wet) for 5 min.  
The vial was sealed and irradiated by a Hg vapor lamp for 30 min.  The mixture was evaporated 
and purified via flash chromatography (2-5% MeOH/DCM) to give 395 (8.5 mg, 72.5%).  
1H-NMR (400 MHz; cd3cn): δ  11.53 (s, 1H), 8.70 (d, J = 9.1 Hz, 1H), 7.38-7.27 (m, 5H), 5.94 
(s, 1H), 5.06 (s, 2H), 4.40 (dd, J = 16.9, 8.8 Hz, 1H), 4.37-4.33 (m, 2H), 4.13 (dd, J = 9.9, 5.7 
Hz, 1H), 4.06 (dd, J = 7.8, 6.6 Hz, 1H), 3.82 (dd, J = 9.8, 2.7 Hz, 1H), 3.60 (d, J = 13.9 Hz, 1H), 
3.37 (dd, J = 14.4, 5.6 Hz, 1H).  13-C NMR (101 MHz; cd3cn): δ 164.4, 162.5, 159.9, 158.0, 
153.8, 138.9, 129.4, 128.67, 128.62, 109.6, 84.4, 79.7, 78.0, 77.4, 71.1, 68.0, 66.9, 53.9, 52.2, 






























































To a solution of 373 (10 mg) in MeOH (1.5 mL) was added 6M HCl (0.5 mL).  The mixture 
was allowed to stir for 3 days and then evaporated.  The mixture was purified via RP-18 flash 
chromatography (100-80% 0.1% TFA in H2O/MeCN) to give 402 (5.7 mg, 82.0%) as the TFA 
salt.  1H-NMR (500 MHz; aceton-d6): δ  7.87 (s, 1H), 7.77 (d, J = 8.7 Hz, 2H), 7.14 (d, J = 8.6 
Hz, 2H), 7.01 (d, J = 8.7 Hz, 2H), 6.81 (d, J = 8.6 Hz, 2H), 5.26 (t, J = 8.3 Hz, 1H), 4.75 (d, J = 
15.4 Hz, 1H), 4.65 (d, J = 5.9 Hz, 1H), 4.63 (s, 1H), 4.60 (t, J = 8.9 Hz, 1H), 4.31 (t, J = 8.4 Hz, 
1H), 4.09 (td, J = 7.5, 2.2 Hz, 1H), 3.88 (s, 3H), 3.77 (s, 3H), 3.61 (d, J = 14.5 Hz, 1H), 3.47 (dd, 
J = 14.1, 7.5 Hz, 1H). 13-C NMR (126 MHz; acetone): δ 161.8, 161.3, 159.1, 158.0, 157.8, 
148.4, 129.1, 127.8, 125.0, 121.7, 113.73, 113.56, 72.2, 68.3, 66.1, 55.0, 54.6, 50.6, 50.1, 46.8.  


































































To a solution of 378 (29 mg) in THF (3 mL) was added 6M HCl (3 mL).  The mixture was 
allowed to stir for 24 hr. and then evaporated.  The mixture was purified via RP-18 flash 
chromatography (100-80% 0.1% TFA in H2O/MeCN) to give 409 (16 mg, 85.5%) as the TFA 
salt.  1H-NMR (400 MHz; D2O): δ  7.67 (d, J = 9.0 Hz, 2H), 6.95 (d, J = 9.0 Hz, 2H), 5.01 (s, 
1H), 4.53 (t, J = 9.5 Hz, 1H), 4.44 (s, 1H), 4.14 (dd, J = 9.2, 7.2 Hz, 1H), 3.78-3.74 (m, 1H), 3.73 
(s, 3H), 3.31 (d, J = 12.8 Hz, 1H), 3.11 (dd, J = 13.9, 5.8 Hz, 1H).  13-C NMR (101 MHz; D2O): 
δ 162.3, 161.0, 157.3, 147.4, 133.0, 127.9, 123.5, 121.8, 114.3, 71.4, 69.5, 64.7, 55.6, 46.6, 43.7.  





























































Compound 414:   (1S,5R,8aR)-5-((carbamoyloxy)methyl)-1-hydroxy-4,5,8,8a-tetrahydro-1H-2a,
4,6,8-tetraazaacenaphthylene-3,7(2H,6H)-diiminium 2,2,2-trifluoroacetate. 
 
Ketone 378 (10 mg) was cooled to 0°C and 0.25 B(TFA)3 in TFA (1 mL) was added.  The 
mixture was allowed to warm to rt slowly (leave in the ice bath) and stirred a total of 48 hours.  
The mixture was cooled to 0°C and quenched with methanol.  The reaction was evaporated and 
diluted with methanol 3x.  The crude solid was purified via RP-18 flash chromatography (100-
80% 0.1% TFA in H2O/MeCN) to give 414 (5 mg, 92%).  1H-NMR (500 MHz; D2O): δ  5.26 
(dd, J = 9.5, 7.3 Hz, 1H), 4.87 (d, J = 2.9 Hz, 1H), 4.77 (t, J = 9.5 Hz, 1H), 4.35 (dd, J = 9.5, 7.4 
Hz, 1H), 4.22 (q, J = 3.1 Hz, 1H), 3.58 (dd, J = 13.6, 2.1 Hz, 1H), 3.38 (dd, J = 13.5, 3.8 Hz, 
1H).  13-C NMR (126 MHz; d2o): δ 161.84, 161.75, 158.01, 158.01, 157.54, 157.54, 91.80, 
91.80, 72.57, 72.57, 69.84, 69.84, 68.09, 68.09, 63.05, 63.05, 51.62, 51.62, 44.85, 44.85.  Calcd. 





































































HSQC= green is positive and orange is negative


















To a flask containing compound 409 (10 mg) was added TFA (2 mL).  The reaction was 
stirred 48 hr. and evaporated.  The compound was purified via HPLC (YMC-Pack ODS-AM-
322, 150x10mm, 5Å; 95-0% 0.1% TFA H2O/MeCN over 45 min; tr= 14.409 min.) to give 416 (9 
mg, 94%) as a 1:1 mixture of diastereomers. 
anti-416: 1H-NMR (500 MHz; D2O): δ  7.80 (d, J = 9.0 Hz, 2H), 7.07 (d, J = 8.9 Hz, 2H), 
5.32 (d, J = 4.1 Hz, 1H), 5.22 (dd, J = 9.2, 6.9 Hz, 1H), 4.77 (t, J = 9.4 Hz, 1H), 4.27 (dd, J = 
9.2, 7.2 Hz, 1H), 4.15 (dd, J = 7.3, 3.1 Hz, 1H), 3.80 (s, 3H), 3.29 (dd, J = 14.2, 3.2 Hz, 1H), 
3.16 (dd, J = 14.2, 4.1 Hz, 2H).  13-C NMR (126 MHz; d2o): δ 165.5, 162.7, 161.0, 152.0, 
130.6, 125.6, 123.1, 119.1, 115.1, 69.4, 63.7, 56.0, 54.1, 46.5, 42.0 
syn-416: 1H-NMR (500 MHz; D2O): δ  7.74 (d, J = 9.0 Hz, 2H), 7.05 (d, J = 9.0 Hz, 2H), 
5.49 (d, J = 5.1 Hz, 1H), 5.21 (dd, J = 9.2, 6.0 Hz, 1H), 4.63 (t, J = 9.5 Hz, 1H), 4.24 (dt, J = 7.9, 
4.1 Hz, 1H), 4.17 (dd, J = 7.9, 6.8 Hz, 1H), 3.80 (s, 3H), 3.26 (dd, J = 13.0, 3.5 Hz, 1H), 2.98 
(dd, J = 13.4, 7.6 Hz, 1H).  13-C NMR (126 MHz; d2o): δ 165.5, 162.7, 161.0, 152.0, 148.2, 
130.6, 125.6, 123.1, 119.1, 115.1, 69.4, 63.7, 56.0, 54.1, 46.5, 42.0.  Calcd. for C17H22N7O6S 



























































To a flask containing compound 408 (10mg) was added TFA (2 mL).  The reaction was 
stirred 24 hr. and evaporated.  The compound was purified via HPLC (YMC-Pack ODS-AM-
322, 150x10mm, 5Å; 95-0% 0.1% TFA H2O/MeCN over 45 min; tr= 14.409 min.) to give 417 (6 
mg, 62%) as a 1:1 mixture of diastereomers. 
anti-417: 1H-NMR (400 MHz; D2O): δ  8.10 (d, J = 4.9 Hz, 1H), 7.91 (d, J = 9.1 Hz, 2H), 
7.43 (t, J = 7.8 Hz, 1H), 7.30 (t, J = 7.6 Hz, 1H), 7.14 (d, J = 9.0 Hz, 2H), 6.08 (d, J = 7.9 Hz, 
1H), 5.31 (d, J = 7.2 Hz, 1H), 5.31 (dd, J = 9.5, 6.7 Hz, 1H), 5.09 (d, J = 18.5 Hz, 1H), 4.87 (d, J 
= 18.4 Hz, 1H), 4.76 (t, J = 9.5 Hz, 1H), 4.28 (t, J = 6.7 Hz, 1H), 4.18 (ddd, J = 8.7, 7.5, 3.9 Hz, 
1H), 3.85 (s, 3H), 3.41 (dd, J = 13.7, 6.5 Hz, 1H), 3.15 (dd, J = 13.4, 9.0 Hz, 1H). 
syn-417: 1H-NMR (400 MHz; D2O): δ  8.08 (d, J = 4.9 Hz, 1H), 7.89 (d, J = 9.4 Hz, 2H), 
7.43 (t, J = 7.8 Hz, 1H), 7.30 (t, J = 7.6 Hz, 1H), 7.14 (d, J = 9.0 Hz, 2H), 6.04 (d, J = 7.7 Hz, 
1H), 5.68 (d, J = 5.4 Hz, 1H), 5.25 (dd, J = 9.5, 7.3 Hz, 1H), 5.18 (d, J = 18.1 Hz, 1H), 4.81 (d, J 
= 18.2 Hz, 1H), 4.68 (t, J = 9.4 Hz, 1H), 4.42 (dd, J = 4.9, 3.6 Hz, 1H), 4.25 (t, J = 6.6 Hz, 1H), 










































Compound 418:  tert-butyl ((1R,2R)-2-((4R,5S)-2,2-dimethyl-5-(((2-nitrobenzyl)amino)methyl)-
1,3-dioxolan-4-yl)-2-hydroxy-1-((R)-2-oxooxazolidin-4-yl)ethyl)carbamate. 
 
A solution of lactol 332 (204 mg, 1 eq.), o-nitrobenzylamine HCl (414 mg, 5 eq.), AcOH 
(693 µL, 25 eq.), sodium acetate (447 mg, 10 eq.) and sodium cyanoborohydride (171 mg, 5 eq.) 
in MeOH (3 mL) was allowed to stir 1.5 hours.  The reaction was carefully quenched with sat. 
sodium bicarbonate, extracted with EtOAc (3x) and the combined extracts were dried over 
sodium sulfate and evaporated.  The crude product wad purified via flash chromatography (0-2% 
MeOH/DCM) to give benzylamine 418 (209 mg, 75.1%).  1H-NMR (500 MHz; CDCl3): δ  8.03 
(d, J = 8.2 Hz, 1H), 7.65 (td, J = 7.5, 1.1 Hz, 1H), 7.50 (td, J = 7.8, 1.1 Hz, 1H), 7.44 (d, J = 7.5 
Hz, 1H), 5.73 (s, 1H), 5.35 (d, J = 10.2 Hz, 1H), 4.43 (t, J = 8.4 Hz, 1H), 4.34 (ddd, J = 9.9, 6.0, 
3.8 Hz, 1H), 4.27 (t, J = 7.6 Hz, 1H), 4.21 (t, J = 7.4 Hz, 1H), 4.08 (dd, J = 9.8, 5.9 Hz, 1H), 4.01 
(d, J = 13.0 Hz, 1H), 3.97 (d, J = 13.1 Hz, 1H), 3.97 (dd, J = 9.2, 2.4 Hz, 1H), 3.80 (dd, J = 9.8, 
2.7 Hz, 1H), 2.99 (dd, J = 12.1, 3.5 Hz, 1H), 2.93 (dd, J = 12.1, 10.2 Hz, 1H), 1.45 (s, 9H), 1.38 
(s, 3H), 1.30 (s, 3H).  13-C NMR (126 MHz; cdcl3): δ 159.7, 156.1, 149.1, 134.1, 132.8, 132.6, 
129.4, 125.5, 109.1, 80.1, 77.7, 75.6, 72.0, 67.5, 51.9, 51.11, 50.96, 48.3, 28.4, 27.8, 25.1.  Calcd. 












































To a solution of amine 418 (209 mg, 1 eq.) and triethylamine (171 µL, 3 eq.) in DCM (4 
mL, 0.1M) was added 344 (229.1 mg, 2 eq.).  The mixture was allowed to stir until complete by 
TLC.  The crude compound was cleaned up via flash chromatography (1-5% MeOH/DCM) to 
give the isothiourea.  The isothiourea was dissolved in MeCN (10 mL) and triethylamine (171 
µL, 3 eq.) was added followed by mercuric chloride (166.7 mg, 1.5 eq.) and the mixture was 
stirred until complete by TLC.  The reaction was quenched by adding conc. Ammonium 
hydroxide (2 mL) and allowed to stir ~20 min.  The reaction was diluted with EtOAc, filtered 
and evaporated.  The crude alcohol was purified via flash chromatography to give alcohol 419 
(235 mg, 79.4%).  1H-NMR (500 MHz; cd3cn): δ  8.07 (d, J = 7.9 Hz, 1H), 7.64 (s, 2H), 7.55 (t, 
J = 6.9 Hz, 1H), 7.48 (t, J = 7.6 Hz, 1H), 7.14 (d, J = 7.8 Hz, 1H), 6.94 (d, J = 8.2 Hz, 2H), 6.78 
(s, 2H), 5.65 (s, 1H), 5.55 (d, J = 9.7 Hz, 1H), 4.99 (d, J = 18.6 Hz, 1H), 4.95 (d, J = 18.1 Hz, 
1H), 4.38 (t, J = 8.8 Hz, 1H), 4.34 (dd, J = 10.6, 6.6 Hz, 1H), 4.20 (t, J = 7.5 Hz, 1H), 4.03-3.97 
(m, 2H), 3.84 (s, 3H), 3.78-3.71 (m, 2H), 3.66 (s, 1H), 3.47 (s, 1H), 1.41 (s, 3H), 1.40 (s, 9H), 
1.23 (s, 3H).  13-C NMR (126 MHz; cd3cn): δ 163.0, 160.0, 157.3, 149.0, 137.1, 134.8, 129.2, 
128.7, 126.1, 114.7, 109.9, 80.3, 77.5, 77.1, 71.6, 68.2, 56.3, 54.1, 52.3, 51.1, 50.4, 28.5, 27.8, 
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To a solution of 419 (69 mg, 1 eq.) in CH2Cl2 (1 mL) was added TFA (1 mL).  The solution 
was stirred ~30 min. until complete by TLC. The mixture was evaporated and diluted with 
CH2Cl2 and reevaporated (3x) to remove trace TFA.  The crude amine was dissolved in DMF 
(3mL) and triethylamine (66 µL, 5 eq.) and guanylating reagent 420 (40.1 mg, 1.5eq.) was 
added.  The mixture was cooled to 0°C and mercuric chloride (38.9 mg, 1.5 eq.) was added.  The 
cloudy suspension was allowed to room temperature and stirred until complete by TLC. The 
reaction was quenched by adding sat. sodium chloride and ethyl acetate.  After stirring the 
mixture for 20 minutes the reaction was filtered through celite to remove all the mercury salts.  
The biphasic solution was separated and the organic layer was washed with H2O (3x), brine and 
then dried over sodium sulfate and evaporated in vacuo.  The crude material was purified via 
column chromatography (20-50% EtOAc/Hexanes) to give compound 421 (18 mg, 20.2%) and 
422 (33 mg, 43.2%).   
Compound 421: 1H-NMR (400 MHz; cd3cn): δ  11.59 (s, 1H), 8.95 (d, J = 8.6 Hz, 1H), 
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 221 
(m, 5H), 7.37-7.31 (m, 5H), 7.13 (d, J = 6.8 Hz, 1H), 6.94 (d, J = 8.5 Hz, 3H), 6.94 (d, J = 8.5 
Hz, 2H), 6.76 (s, 2H), 5.90 (s, 1H), 5.27 (d, J = 12.2 Hz, 1H), 5.23 (d, J = 12.2 Hz, 1H), 5.11 (d, 
J = 12.5 Hz, 1H), 5.09 (d, J = 12.5 Hz, 1H), 4.95 (s, 2H), 4.43 (t, J = 8.6 Hz, 1H), 4.40-4.35 (m, 
3H), 4.07 (dd, J = 9.6, 6.0 Hz, 1H), 4.02 (dd, J = 8.3, 6.5 Hz, 1H), 3.84 (s, 3H), 3.82 (q, J = 2.9 
Hz, 1H), 3.43 (s, 2H), 1.39 (s, 3H), 1.19 (s, 3H).  13-C NMR (101 MHz; d2o): δ 164.5, 163.0, 
159.9, 157.8, 154.4, 149.0, 138.0, 137.0, 136.2, 134.9, 129.65, 129.63, 129.40, 129.29, 128.9, 
128.7, 126.2, 114.7, 110.3, 77.6, 76.9, 70.7, 69.1, 68.0, 67.8, 56.3, 54.3, 51.8, 51.15, 51.13, 50.2, 
28.0, 25.5.  Calcd. for C43H49N8O14S [M+H]: 933.3089 Found 933.3095. 
Compound 422: 1H-NMR (400 MHz; cd3cn): δ  8.25 (s, 1H), 8.21 (d, J = 9.4 Hz, 1H), 8.08 
(d, J = 7.8 Hz, 1H), 7.64 (s, 2H), 7.54 (t, J = 7.4 Hz, 1H), 7.47 (t, J = 7.3 Hz, 1H), 7.41-7.35 (m, 
5H), 7.13 (d, J = 7.8 Hz, 1H), 6.93 (d, J = 8.3 Hz, 2H), 6.79 (s, 2H), 5.85 (s, 1H), 5.18 (d, J = 
12.5 Hz, 1H), 5.15 (d, J = 12.4 Hz, 1H), 4.95 (s, 2H), 4.40 (t, J = 8.8 Hz, 1H), 4.39-4.33 (m, 1H), 
4.30 (ddt, J = 8.8, 7.0, 1.7 Hz, 1H), 4.05 (ddd, J = 9.2, 3.6, 2.2 Hz, 1H), 4.03 (dd, J = 9.0, 5.9 Hz, 
1H), 4.00 (dd, J = 8.5, 6.8 Hz, 1H), 3.90 (d, J = 5.7 Hz, 1H), 3.84 (s, 3H), 3.79 (ddd, J = 9.2, 5.8, 
3.5 Hz, 1H), 3.45 (s, 2H), 1.40 (s, 2H), 1.21 (s, 2H).  13-C NMR (101 MHz; cd3cn): δ 162.9, 
160.0, 158.3, 155.4, 154.2, 149.0, 137.0, 136.7, 134.9, 129.6, 129.4, 129.17, 129.01, 128.95, 
128.7, 126.2, 114.7, 110.1, 77.5, 77.0, 71.0, 68.34, 68.16, 56.3, 53.2, 51.9, 51.1, 50.2, 27.9, 25.5.  

































































Compound 425:   (3aR,4R,9S,10R,10aR)-4-((carbamoyloxy)methyl)-9,10-dihydroxyhexahydrop
yrrolo[1,2-c]purine-2,6(1H,8H)-diiminium 2,2,2-trifluoroacetate. 
 




Ketone 424 (10 mg) was cooled to 0°C and 0.25 B(TFA)3 in TFA (1 mL) was added.  The 
mixture was allowed to warm to rt slowly (leave in the ice bath) and stirred a total of 20 hours.  
The mixture was cooled to 0°C and quenched with methanol.  The reaction was evaporated and 
diluted with methanol 3x.  The crude solid was purified via RP-18 flash chromatography (100-
80% 0.1% TFA in H2O/MeCN) to give a mixture of 3:1 425/426 (5mg, 69%). 
Compound 425: 1H-NMR (500 MHz; D2O): δ  4.65 (dd, J = 9.7, 8.6 Hz, 1H), 4.43 (ddd, J = 
8.9, 5.0, 3.8 Hz, 1H), 4.35 (dd, J = 9.5, 4.8 Hz, 1H), 4.27 (d, J = 3.5 Hz, 1H), 4.02 (ddd, J = 8.8, 
6.5, 3.0 Hz, 1H), 3.69 (d, J = 8.8 Hz, 1H), 3.54 (dd, J = 14.6, 3.1 Hz, 1H), 3.44 (dd, J = 14.6, 6.6 
Hz, 1H).  13-C NMR (126 MHz; d2o): δ 161.84, 161.75, 158.01, 158.01, 157.54, 157.54, 91.80, 
91.80, 72.57, 72.57, 69.84, 69.84, 68.09, 68.09, 63.05, 63.05, 51.62, 51.62, 44.85, 44.85.  Calcd. 
for C10H18N7O4 [M+H]: 300.1409 Found 300.1414. 
Compound 426: 1H-NMR (500 MHz; D2O): δ  5.28 (dd, J = 9.5, 7.0 Hz, 1H), 4.79 (t, J = 
9.5 Hz, 1H), 4.66 (d, J = 7.4 Hz, 1H), 4.38 (dd, J = 9.5, 7.0 Hz, 1H), 3.96 (td, J = 7.2, 3.0 Hz, 
1H), 3.52 (dd, J = 14.4, 3.0 Hz, 1H), 3.31 (dd, J = 14.5, 7.2 Hz, 1H).  Calcd. for C10H18N7O4 
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Appendix 1: X-ray Data 
Compound 211 
Empirical formula  C37H45N2O8 
Formula weight  645.75 
Temperature  298 (2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 10.2637(4) Å α= 90°. 
 b = 15.9663(7) Å β= 90°. 
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 c = 22.8323(10) Å γ = 90°. 
Volume 3741.6(3) Å3 
Z 4 
Density (calculated) 1.146 Mg/m3 
Absorption coefficient 0.080 mm-1 
F(000) 1380 
Crystal size 0.68 x 0.42 x 0.23 mm3 
Theta range for data collection 2.18 to 23.26°. 
Index ranges -11<=h<=8, -17<=k<=17, -19<=l<=25 
Reflections collected 14581 
Independent reflections 5321 [R(int) = 0.0278] 
Completeness to theta = 23.26° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9816 and 0.9473 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5321 / 0 / 430 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma(I)] R1 = 0.0433, wR2 = 0.0982 
R indices (all data) R1 = 0.0647, wR2 = 0.1094 
Largest diff. peak and hole 0.116 and -0.264 e.Å-3 
Comment:  Large thermal ellipsoids are due to the room temperature data.
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Table 1.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 x y z U(eq) 
C(1) 3639(3) 5001(2) 3674(1) 47(1) 
C(2) 4550(3) 4752(2) 4078(1) 86(1) 
C(3) 4198(4) 4592(3) 4656(1) 100(1) 
C(4) 2949(4) 4689(2) 4831(1) 77(1) 
C(5) 2024(3) 4941(2) 4436(1) 74(1) 
C(6) 2364(3) 5089(2) 3865(1) 60(1) 
C(7) 5374(3) 5011(2) 2874(1) 49(1) 
C(8) 6262(3) 5657(2) 2880(2) 80(1) 
C(9) 7548(4) 5517(3) 2700(2) 102(1) 
C(10) 7916(4) 4737(3) 2524(2) 102(1) 
C(11) 7058(4) 4104(3) 2515(2) 90(1) 
C(12) 5786(3) 4233(2) 2693(1) 67(1) 
C(13) 5085(3) 3923(2) 918(1) 75(1) 
C(14) 5758(3) 4354(2) 421(1) 63(1) 
C(15) 5974(4) 5204(3) 428(2) 93(1) 
C(16) 6535(4) 5598(3) -46(2) 112(2) 
C(17) 6866(4) 5148(3) -534(2) 102(1) 
C(18) 6666(4) 4308(3) -541(2) 96(1) 
C(19) 6093(3) 3919(2) -70(2) 77(1) 
C(20) 1820(2) 4369(2) 1818(1) 47(1) 
C(21) 820(3) 4067(2) 1376(1) 54(1) 
C(22) 1579(3) 3478(2) 971(1) 60(1) 
C(23) 2962(3) 3483(2) 1198(1) 55(1) 
C(24) -267(3) 2812(2) 1297(2) 66(1) 
C(25) -618(4) 2089(2) 1684(2) 96(1) 
C(26) -1238(4) 2962(3) 812(2) 116(2) 
C(27) 2218(2) 5285(2) 1723(1) 45(1) 
C(28) 3413(3) 5526(2) 2085(1) 46(1) 
C(29) 477(3) 6308(2) 1505(1) 51(1) 
C(30) -1088(3) 7458(2) 1496(1) 70(1) 
C(31) -120(5) 8072(3) 1275(3) 186(3) 
C(32) -1943(4) 7810(2) 1977(2) 110(2) 
 235 
C(33) -1937(5) 7120(3) 1023(2) 144(2) 
C(34) 3915(6) 7451(3) 592(2) 133(2) 
C(35) 3996(3) 5149(2) 3055(1) 44(1) 
C(36) 3745(3) 6445(2) 1978(1) 55(1) 
C(37) 4114(4) 7429(2) 1216(2) 86(1) 
N(1) 3122(2) 5394(1) 2702(1) 49(1) 
N(2) 1124(2) 5813(1) 1886(1) 48(1) 
O(1) -390(2) 6781(1) 1791(1) 59(1) 
O(2) 666(2) 6302(2) 985(1) 84(1) 
O(3) -111(2) 3538(1) 1651(1) 71(1) 
O(4) 999(2) 2688(1) 1059(1) 76(1) 
O(5) 2904(2) 3807(1) 1772(1) 52(1) 
O(6) 3811(3) 6974(1) 2342(1) 89(1) 
O(7) 3952(2) 6561(1) 1411(1) 68(1) 





Table 2.   Bond lengths [Å] and angles [°] 
C(1)-C(2)  1.373(4) 
C(1)-C(6)  1.387(4) 
C(1)-C(35)  1.479(4) 
C(2)-C(3)  1.392(5) 
C(3)-C(4)  1.351(5) 
C(4)-C(5)  1.370(5) 
C(5)-C(6)  1.369(4) 
C(7)-C(12)  1.375(4) 
C(7)-C(8)  1.377(4) 
C(7)-C(35)  1.490(4) 
C(8)-C(9)  1.400(5) 
C(9)-C(10)  1.362(6) 
C(10)-C(11)  1.340(6) 
C(11)-C(12)  1.383(4) 
C(13)-O(8)  1.435(3) 
C(13)-C(14)  1.496(4) 
C(14)-C(19)  1.362(4) 
C(14)-C(15)  1.374(5) 
C(15)-C(16)  1.376(5) 
C(16)-C(17)  1.370(6) 
C(17)-C(18)  1.358(6) 
C(18)-C(19)  1.375(5) 
C(20)-O(5)  1.434(3) 
C(20)-C(21)  1.518(4) 
C(20)-C(27)  1.534(4) 
C(21)-O(3)  1.421(3) 
C(21)-C(22)  1.532(4) 
C(22)-O(4)  1.408(3) 
C(22)-C(23)  1.512(4) 
C(23)-O(8)  1.393(3) 
C(23)-O(5)  1.410(3) 
C(24)-O(4)  1.422(4) 
C(24)-O(3)  1.422(4) 
C(24)-C(25)  1.498(4) 
C(24)-C(26)  1.509(5) 
C(27)-N(2)  1.453(3) 
C(27)-C(28)  1.529(4) 
C(28)-N(1)  1.455(3) 
C(28)-C(36)  1.525(4) 
C(29)-O(2)  1.202(3) 
C(29)-O(1)  1.338(3) 
C(29)-N(2)  1.351(3) 
C(30)-O(1)  1.463(3) 
C(30)-C(31)  1.484(5) 
C(30)-C(33)  1.489(5) 
C(30)-C(32)  1.514(5) 
C(34)-C(37)  1.440(5) 
C(35)-N(1)  1.267(3) 
C(36)-O(6)  1.187(3) 
C(36)-O(7)  1.327(3) 

















































































Table 3.   Anisotropic displacement parameters (Å2x 103). The anisotropic displacement 
factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 U11 U22 U33 U23 U13 U12 
C(1) 50(2)  52(2) 37(2)  -2(1) -1(1)  6(1) 
C(2) 63(2)  149(4) 44(2)  10(2) 0(2)  29(2) 
C(3) 91(3)  169(4) 41(2)  15(2) -9(2)  42(3) 
C(4) 95(3)  102(3) 35(2)  3(2) 12(2)  14(2) 
C(5) 73(2)  101(3) 47(2)  2(2) 15(2)  9(2) 
C(6) 59(2)  79(2) 42(2)  2(2) 0(2)  13(2) 
C(7) 47(2)  63(2) 38(2)  7(1) 0(1)  5(2) 
C(8) 66(2)  78(2) 96(3)  0(2) 9(2)  -4(2) 
C(9) 58(3)  122(4) 125(4)  15(3) 6(2)  -22(2) 
C(10) 61(3)  140(4) 106(3)  10(3) 21(2)  16(3) 
C(11) 72(3)  109(3) 88(3)  -4(2) 13(2)  25(2) 
C(12) 59(2)  75(2) 68(2)  6(2) 7(2)  14(2) 
C(13) 54(2)  102(3) 69(2)  2(2) -4(2)  17(2) 
C(14) 44(2)  87(3) 59(2)  -12(2) 4(2)  3(2) 
C(15) 94(3)  101(3) 84(3)  -27(2) 14(2)  -17(2) 
C(16) 116(4)  102(3) 117(4)  -6(3) 17(3)  -47(3) 
C(17) 77(3)  139(4) 89(3)  -1(3) 31(2)  -22(3) 
C(18) 84(3)  119(4) 85(3)  -18(3) 23(2)  3(2) 
C(19) 73(2)  85(2) 74(2)  -12(2) 6(2)  6(2) 
C(20) 46(2)  54(2) 41(2)  8(1) 5(1)  7(1) 
C(21) 54(2)  43(2) 64(2)  4(1) -3(2)  6(1) 
C(22) 61(2)  62(2) 56(2)  -2(2) 1(2)  -3(2) 
C(23) 60(2)  54(2) 52(2)  -3(2) 5(2)  7(2) 
C(24) 56(2)  65(2) 78(2)  -3(2) -8(2)  -5(2) 
C(25) 95(3)  74(2) 117(3)  9(2) -8(2)  -30(2) 
C(26) 92(3)  133(4) 124(4)  0(3) -40(3)  -8(3) 
C(27) 55(2)  48(2) 31(1)  1(1) 5(1)  7(1) 
C(28) 54(2)  51(2) 33(2)  1(1) 3(1)  5(1) 
C(29) 61(2)  53(2) 40(2)  -3(1) -4(2)  7(2) 
C(30) 77(2)  66(2) 68(2)  3(2) -12(2)  29(2) 




C(32) 133(4)  106(3) 91(3)  -23(2) -15(3)  74(3) 
C(33) 128(4)  208(6) 95(3)  -56(4) -58(3)  82(4) 
C(34) 212(6)  103(3) 84(3)  36(3) -23(3)  -20(4) 
C(35) 44(2)  49(2) 39(2)  4(1) -2(1)  3(1) 
C(36) 56(2)  64(2) 45(2)  4(2) 1(1)  3(2) 
C(37) 114(3)  70(2) 74(3)  21(2) -2(2)  -21(2) 
N(1) 48(1)  61(2) 39(1)  2(1) 7(1)  8(1) 
N(2) 56(1)  56(1) 34(1)  5(1) 4(1)  16(1) 
O(1) 75(1)  57(1) 45(1)  -4(1) -3(1)  28(1) 
O(2) 105(2)  109(2) 38(1)  4(1) 1(1)  52(2) 
O(3) 59(1)  65(1) 88(2)  -9(1) 19(1)  -8(1) 
O(4) 70(2)  59(1) 98(2)  -21(1) 7(1)  -9(1) 
O(5) 56(1)  51(1) 50(1)  4(1) -3(1)  12(1) 
O(6) 146(2)  63(1) 59(1)  -14(1) -3(2)  -11(1) 
O(7) 96(2)  59(1) 50(1)  9(1) 7(1)  -12(1) 




Table 4.   Hydrogen coordinates (x104) and isotropic displacement parameters (Å2x 103)
x  y  z  U(eq) 
H(2) 5433 4687 3962 103 
H(3) 4839 4414 4929 120 
H(4) 2713 4583 5226 93 
H(5) 1146 5013 4558 88 
H(6) 1711 5255 3594 72 
H(8) 6002 6198 3006 96 
H(9) 8160 5963 2701 122 
H(10) 8792 4640 2407 123 
H(11) 7325 3565 2386 108 
H(12) 5189 3778 2690 81 
H(13A) 5361 3330 938 90 
H(13B) 5315 4197 1293 90 
H(15) 5735 5522 762 111 
H(16) 6692 6184 -33 134 
H(17) 7232 5422 -865 122 
H(18) 6922 3988 -873 115 
H(19) 5928 3334 -86 92 
H(20) 1438 4315 2219 57 
H(21) 403 4539 1158 64 
H(22) 1529 3659 552 71 
H(23) 3313 2899 1206 66 
H(25A) -593 1569 1456 143 
H(25B) -1497 2172 1841 143 
H(25C) 6 2053 2008 143 
H(26A) -952 3438 573 175 
H(26B) -2094 3085 982 175 
H(26C) -1300 2461 566 175 
H(27) 2417 5373 1298 54 
H(28) 4169 5168 1969 55 
H(31A) 422 8268 1601 279 
H(31B) -576 8550 1100 279 




H(32A) -2580 7387 2097 165 
H(32B) -2401 8307 1831 165 
H(32C) -1401 7965 2313 165 
H(33A) -1394 6910 702 216 
H(33B) -2508 7565 877 216 
H(33C) -2469 6661 1179 216 
H(34A) 4613 7139 397 200 
H(34B) 3924 8034 457 200 
H(34C) 3072 7196 497 200 
H(37A) 3472 7795 1415 103 
H(37B) 5000 7631 1314 103 
H(1) 2327 5485 2832 59 




List of Abbreviations 
Ac Acetyl 
AcOH Acetic acid 
2,6-lutidine  2,6-dimethylpyridine 
Boc tert-Buty carbamoyl 
BOC2O di-tert-butyldicarbonate 
brsm Based on recovered starting material 
BuLi Butyl Lithium 





DDQ  2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DIBAL diisobutylaluminium hydride  
DMAP 4-Dimethylaminopyridine 
Dmb Dimethylbenzyl 
DMP Dess-Martin periodinane 
DMSO Dimethyl sulfoxide 
eq. Equivalent 
Et2O Diethyl ether 







IBX 2-Iodoxybenzoic acid 
im. Imidazole 
IR Infrared spectroscopy 
LDA Lithium diisopropylamide 
LiHMDS Lithium bis(trimethylsilyl)amide 
Mbs Methoxybenzyl sulfonamide 
Ms Methanesulfonyl 
NaHMDS Sodium bis(trimethylsilyl)amide 
NMR Nuclear magnetic resonance 





psi Pound per square inch 
PTLC  Preparative thin layer chromatography 
py. Pyridine 
t-BuOK  Potassium tert-butoxide 






TCC Trichloroisocyanuric Acid 
TEMPO 2,2,6,6-Tetramethyl-1-piperidinyloxy 
Teoc 2-(Trimethylsilyl)ethylcarbamoyl 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TIPS Triisopropylsilyl  
TLC  Thin layer chromatography 
TMSCl  Trimethylsilyl chloride 
TMSOTf Trimethylsilyl triflate 
